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ORIGINAL ARTICLE
BACKGROUND: A systems biology approach to cardiac physiology 
requires a comprehensive representation of how coordinated processes 
operate in the heart, as well as the ability to interpret relevant 
transcriptomic and proteomic experiments. The Gene Ontology (GO) 
Consortium provides structured, controlled vocabularies of biological 
terms that can be used to summarize and analyze functional knowledge 
for gene products.
METHODS AND RESULTS: In this study, we created a computational 
resource to facilitate genetic studies of cardiac physiology by integrating 
literature curation with attention to an improved and expanded 
ontological representation of heart processes in the Gene Ontology. As 
a result, the Gene Ontology now contains terms that comprehensively 
describe the roles of proteins in cardiac muscle cell action potential, 
electrical coupling, and the transmission of the electrical impulse from 
the sinoatrial node to the ventricles. Evaluating the effectiveness of this 
approach to inform data analysis demonstrated that Gene Ontology 
annotations, analyzed within an expanded ontological context of 
heart processes, can help to identify candidate genes associated with 
arrhythmic disease risk loci.
CONCLUSIONS: We determined that a combination of curation and 
ontology development for heart-specific genes and processes supports 
the identification and downstream analysis of genes responsible for the 
spread of the cardiac action potential through the heart. Annotating 
these genes and processes in a structured format facilitates data 
analysis and supports effective retrieval of gene-centric information 
about cardiac defects.
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Cardiac electrical conduction systems enable coor-dinated regulation of heart contraction in meta-zoans, ranging from fly to human. Disturbances 
of normal heart rhythm can occur de novo, but, more 
critically and commonly, they are an important feature of 
many cardiac diseases, and have substantial impacts on 
patient morbidity and mortality. To gain insight into the 
mechanisms of arrhythmia, high-throughput genome-
scale methodologies (including genome-wide association 
studies [GWAS], transcriptomics, exon sequencing, and 
proteomics) are being used.1–3 However, interpretation of 
these high-throughput experiments relying on descrip-
tions of the cellular and physiological roles of gene prod-
ucts, and a computational approach to interrogation of 
cardiac gene function, is a bottleneck in these analyses. 
Our work aims to fill this gap by capturing information 
in the Gene Ontology (GO) resource in a structured way, 
thus integrating knowledge about genes, cells, tissues 
and organs. To support data interpretation, the GO Con-
sortium (GOC) provides a freely available, structured, con-
trolled vocabulary, the ontology,4 that enables association 
of defined terms, describing cellular roles and locations, 
with a protein or RNA. This association process, called GO 
annotation, provides a computer-interpretable summary 
of the results of many independent experiments. GO 
terms describe Molecular Functions (molecular activities 
of a gene product), Biological Processes (the broader con-
text in which a gene product acts), and Cellular Compo-
nents (the subcellular location of a gene product). Some 
examples of GO terms relevant to cardiac research are, 
respectively, voltage-gated sodium channel activity, Pur-
kinje myocyte action potential, and Z disc.
GO provides users with a summary of experimentally 
verified or predicted functions of genes, proteins, and 
RNAs.3,5 Because of this high-impact information, GO 
data are incorporated into over 50 functional analysis 
tools and is routinely used to analyze large data sets.6 The 
coordinated action of gene products involved in cardiac 
conduction at the cellular level results in proper heart 
functioning at the organ level and in healthy conditions at 
the whole organism level. Therefore, detailed and interop-
erable knowledge about gene products’ roles is essential 
to better analyze heart failure phenotypes and ultimately 
to address potentially fatal conditions. The features listed 
above make GO an ideal resource to aid the interpreta-
tion of large-scale cardiac physiology investigations.
Before our expansion of the cardiac function domain, 
there were only 3 GO terms to describe how the cardiac 
cycle is coordinated: cardiac conduction, membrane 
depolarization during atrial cardiac muscle cell action 
potential, and membrane repolarization during atrial 
cardiac muscle cell action potential. In this article, we 
detail how GO editors and biocurators worked togeth-
er with experimental researchers to ensure provision 
of accurate structured terminology7 that describes fea-
tures of gene products involved in cardiac physiology, 
and to generate GO annotations8 that capture those 
roles based on published literature, thereby improving 
representation of this area of biology. In particular, we 
focused on processes involved in and regulating the 
coordinated contraction of the heart. We also show 
that our effort improves the investigation of heart-relat-
ed GWAS and transcriptomic data sets.
METHODS
The data, analytic methods, and study materials have been made 
available to other researchers for purposes of reproducing the 
results or replicating the procedure. Protein, RNA, and macromo-
lecular complex GO annotations are available from the UniProt 
GO annotation and GOC sites (https://www.ebi.ac.uk/GOA/
downloads, http://www.geneontology.org/gene-associations/) 
and searchable in the AmiGO27 and QuickGO9 browsers; GO 
Clinical Perspective
Identification of critical proteins and RNAs as poten-
tial drug targets requires computationally accessible 
descriptors, both in terms of their roles in biologi-
cal pathways and the molecules they interact with 
to fulfill their actions. This information is also vital 
in choosing prognostic and diagnostic biomark-
ers, particularly for multifactorial diseases such as 
heart disease that might benefit from measure-
ment of multiple biomarkers. Recent improvements 
in omic technologies have led to projects such as 
the 100 000 Genomes Project and genome-wide 
association studies, which are producing vast 
amounts of genetic data pertinent to human health. 
Furthermore, it is now possible to catalog which 
proteins or RNAs are present in normal or disease 
tissues, or individual cells. Understanding the molec-
ular network or biological processes associated with 
a drug target can help predict off-target effects or 
the potential for drug repurposing because many 
gene products are active in multiple pathways. In 
addition, these networks can be used to predict the 
most efficacious molecules within the networks, 
through the identification of key positions at which 
the whole networks may be perturbed; these mol-
ecules are often associated with disease-causing 
mutations or identified as drug targets. One of the 
major resources used by omic researchers is the 
Gene Ontology. This article explains the consider-
able improvements made by the Gene Ontology 
Consortium in the bioinformatic description of 
cardiac physiology. These new descriptions are all 
based on published data and are now included in 
all major biological databases, thus available for use 
by the global scientific community to enhance the 
understanding of cardiovascular-relevant data.
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terms are downloadable from the GOC site (http://www.geneon-
tology.org/ontology/) and searchable in AmiGO2 and QuickGO. 
The annotations have also been incorporated into many bio-
logical knowledge bases, including Ensembl,10 UniProtKB,11 
and NCBI-Gene,12 and exploited by numerous freely available 
functional analysis tools, including Database for Annotation, 
Visualization and Integrated Discovery,13 g:profiler,14 Protein 
Analysis Through Evolutionary Relationships (PANTHER),15 and 
Visual Annotation Display (VLAD).16 Full methods are available in 
the Data Supplement.
Generation of a Prioritized List of Cardiac 
Physiology-Relevant Gene Products
A list of 88 human proteins known to be required for normal 
cardiac function was compiled based on 8 literature reviews17–24 
(Table I in the Data Supplement). To keep the focus more spe-
cifically on ion channels, the following were not retained in 
the prioritized list of genes: ATPases, ATPase regulatory pro-
teins, hormones, hormone receptors, and proteins required for 
normal heart development. However, angiotensinogen and 2 
angiotensin I–converting enzymes were included in the priori-
tized protein list to ensure that the ontology was sufficiently 
developed to enable future projects to capture the role of gene 
products that regulate heart rate and contraction.25 Orthologs 
of these 88 human proteins were identified in mouse, rat, 
zebrafish, and Drosophila using the Protein Analysis Through 
Evolutionary Relationships orthology prediction tool.15 In addi-
tion, a list of 7 human microRNAs (miRNAs) identified as key 
players in modulating cardiac excitability at the time we started 
our curation effort was determined from 3 reviews26–28; litera-
ture available for these miRNAs was curated up to March 2016. 
Prioritized human gene products described above are listed in 
Table I in the Data Supplement, and for all of them, GO annota-
tions supported by experimental data were included in the GO 
database according to established procedural guidelines8,29,30 
(details are given in Methods in the Data Supplement).
Identification of Candidate Genes 
Associated With Arrhythmia Risk Loci
We compiled a list of Mendelian inherited arrhythmia disorder 
genes associated with atrial fibrillation, long-QT syndrome, 
short-QT syndrome, catecholaminergic polymorphic ventricular 
tachycardia, and Brugada syndrome1,31,32 and candidate genes 
associated with GWAS risk loci for these disorders2,31 (literature 
search February 2016; Table II in the Data Supplement). Nine 
GO terms relevant to normal cardiac physiology (such as car-
diac conduction, muscle contraction, and response to oxygen 
levels) were selected to investigate whether gene annotations 
to these normal processes could be correlated with arrhythmia 
candidate genes (Table III in the Data Supplement), and the 
associated annotations were downloaded on March 11, 2016 
using the QuickGO browser9 (http://www.ebi.ac.uk/QuickGO/; 
Methods in the Data Supplement).
GO Functional Analysis of Transcriptomic 
Data Sets
A ventricular cardiomyocyte (VCM) data set3 was analyzed using 
the BinGO plugin33 within the Cytoscape v3.3.0 tool,34 applying 
the recommended hypergeometric test and Benjamini and 
Hochberg False Discovery Rate correction, and a P value <0.05 
(full details in Methods in the Data Supplement). To determine 
the impact of this focused project, we used gene association 
files from November 2011 (ie, the start of this project) and 
February 2016 (ie, the end of the project; files available from 
ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/). For both analyses, 
the ontology version March 7, 2016 was included (available 
from http://geneontology.org/page/download-ontology).
RESULTS
Representation of Cardiac-Relevant 
Gene Products’ Features Via Ontology 
Development
A coordinated working group of GO editors, GO biocu-
rators, and field experts expanded the cardiac physiol-
ogy domain by adding 197 new cardiac-relevant GO 
terms (Methods and Table IV in the Data Supplement). 
Of these, 87 refer to processes that contribute to cardiac 
conduction and thus describe the propagation of the 
action potential through the conduction system and car-
diac chambers. An example of an ontology branch rep-
resenting cardiac-relevant GO terms is shown in Figure.
The expansion of the cardiac-related processes in GO 
describes events that occur at 3 key biological levels: 
the single cell, the tissue (multicellular), and the organ. 
In addition to these biological levels, the ontology was 
expanded to cover generic processes (such as regulation 
of potassium ion export) or developmental processes 
(such as cardiac pacemaker cell differentiation) required 
for the annotation of cardiac-relevant gene products. 
These new ontology terms enable biocurators to capture 
the role of gene products in specific tissues of the heart (by 
applying GO terms such as adrenergic receptor signaling 
pathway involved in cardiac muscle relaxation), specific 
cell types (eg, atrioventricular (AV) node cell to bundle of 
His cell communication), and the whole organ (eg, regu-
lation of the force of heart contraction by cardiac con-
duction). The addition of both generic terms, and terms 
that reference specific anatomical structures, allowed us 
to overcome challenges with respect to granularity of 
organism specificity. For example, the term cell commu-
nication involved in cardiac conduction can be used for 
any organism with a cardiac organ, and a child term like 
AV node cell to bundle of His cell communication can be 
used specifically for species that have the relevant ana-
tomical structures, in this case AV node and bundle of 
His. By describing processes at the various levels, curators 
can choose appropriate terms with respect to the experi-
ments and organisms they are curating. Where possible, 
terms were defined by creating necessary and sufficient 
statements using relationships between GO terms and 
terms from cross-referenced external ontologies, such 
as Uberon for anatomical structures, the Cell Ontol-
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ogy for cell types, and Chemicals of Biological Interest 
for chemicals (ChEBI), taking advantage of their species 
interoperability and thus making the terms accessible to 
computational reasoning.35
Cell-to-Cell Communication in the Heart
Cell communication is a key aspect of the coordinated 
activity of the heart. We created new terms, such as 
cell communication involved in cardiac conduction, to 
bring together all processes that mediate interactions 
between a cell and its surroundings and that also con-
tribute to the process of cardiac conduction. This part 
of the ontology now includes terms to describe cell-
to-cell impulse propagation by means of cardiac action 
potentials and electrical coupling (such as AV node 
cell to bundle of His cell communication by electrical 
coupling), as well as terms to describe the attachment 
of one cell to another or to the extracellular matrix 
(such as bundle of His cell-Purkinje myocyte adhesion 
involved in cell communication). In addition, many of 
the 22 new cardiac conduction-relevant Molecular 
Function terms describe channel or transporter activi-
ties that are necessary to propagate the electrical sig-
nals between specific cells and across the heart (eg, gap 
junction channel activity involved in cardiac conduction 
electric coupling).
The cardiac action potential branch of GO includes 
terms referring to a variety of cell types within the 
heart (Figure), such as AV node cell action potential, 
membrane depolarization during AV node cell action 
potential and membrane repolarization during AV node 
cell action potential, as well as terms that describe the 
regulation of the action potential (not shown). Similar 
terms also describe action potentials in SA node cells, 
bundle of His cells, and Purkinje myocytes (not shown).
Ensuring Capture of Robust Information 
About Genetic Contributions to Cardiac 
Physiology via GO Annotation
There is a considerable volume of literature describing the 
physiological characterization of the heart. This project 
brought together expertise from University College Lon-
don,36 Queen Mary University of London, University of 
Oxford, Mouse Genome Informatics,37 the Rat Genome 
Database,38 the Zebrafish Information Network,39 and 
FlyBase.40 It was unrealistic for the information from all 
Figure. Part of the ontology 
describing AV node cell action 
potential and the regulation of 
ventricular cardiac muscle cell  
action potential.  
The entire model is not shown; this 
portion graphically illustrates how 
ontology terms relate to each other. 
Blue lines marked with I indicate the 
child term is a type of its parent, and 
orange lines marked with P indicate 
that child term is always a part of its 
parent. Purple lines marked with R in-
dicate regulates, positively regulates, 
or negatively regulates relations.
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cardiac physiology research papers to be captured dur-
ing this project; however, over 500 papers have been 
reviewed and used to annotate cardiac-relevant gene 
products with the expanded GO structure. A key aspect 
of gene product GO annotation is the recognition that 
a single gene product may have several functions, may 
participate in multiple processes, and can be found in 
a variety of subcellular locations. Consequently, fully 
describing how a gene functions typically results in >1 
GO term associated with a single gene product4 (Table 1).
The aim of creating multiple statements (annota-
tions) about a single gene product is to comprehensively 
capture the knowledge about its biological role, as sup-
ported by published experimental data. For example, 
over 30 papers were curated to provide information 
about the human sodium channel SCN5A (Q14524). 
Individual experiments, such as immunostaining, expres-
sion of various sodium channel constructs in Xenopus 
oocytes or rat cardiomyocytes, combined with descrip-
tions of cardiac disease associated with the protein, 
such as long-QT and Brugada syndromes, have provided 
evidence that this protein is found in the Z disk,41 has 
voltage-gated sodium channel activity involved in car-
diac muscle cell action potential,42 and is involved in 
membrane depolarization during Purkinje myocyte cell 
action potential.43 In contrast, the experimental data 
described in a single paper44 supported 9 annotations 
for the human protein RNF207 (Q6ZRF8). This article also 
resulted in 18 experimentally supported annotations to 
5 other human proteins (DNAJA1, P31689; HSPA1A, 
P0DMV8; HSPA1B, P0DMV9; HSPA8, P11142; KCNH2, 
Q12809) and 1 zebrafish protein (Rnf207b, E9QHE3).
There is increasing evidence for the role of miRNAs in 
controlling cardiac physiology, particularly in the regulation 
of potassium and calcium ion channel function, where 
dysregulation can lead to aberrant action potential dura-
tion and cardiac conduction.27,28 For this project, 7 miR-
NAs were prioritized for annotation (Methods and Table I 
in the Data Supplement), resulting in 27 annotations with 
relevance to cardiac function. For example, Li et al45 dem-
onstrated that miR-1 (URS00001DC04F_9606) and miR-
133a (URS00004C9052_9606) could regulate the slow 
delayed rectifier potassium current (IKs) in human cells dur-
ing simulated hyperglycemia. Furthermore, they showed 
that this was because of their ability to regulate the expres-
sion of 2 potassium channel proteins, KCNE1 (P15382) 
and KCNQ1 (P51787), which mediate IKs. These roles of 
miR-1 and miR-133a have been captured by the terms 
negative regulation of membrane repolarization during 
cardiac muscle cell action potential and negative regula-
tion of delayed rectifier potassium channel activity, as well 
as gene silencing by miRNA, with KCNE1 included as the 
target of miR-1 and KCNQ1 as the target of miR-133a in 
annotation extensions (Methods in the Data Supplement).
Table 1. Selection of GO Annotations Associated With Human ACE2
GO Identifier GO Term Name Code Reference With
Biological process
  GO:0002005 Angiotensin catabolic process in blood IC PMID:10924499 GO:0004180




  GO:0019229 Regulation of vasoconstriction IC PMID:15380922 GO:0004180
  GO:0046813 Receptor-mediated virion attachment to host cell IDA PMID:18343844 …
  GO:0060452
Positive regulation of cardiac muscle contraction IEA GO_REF:0000019
Ensembl: 
ENSMUSP00000107890
  GO:1903598 Positive regulation of gap junction assembly IMP PMID:12967627 …
  GO:1903779 Regulation of cardiac conduction IMP PMID:12967627 …
Molecular function
  GO:0004175 Endopeptidase activity IDA PMID:15283675 …
  GO:0004180 Carboxypeptidase activity IDA PMID:10969042 …
  GO:0005515 Protein binding IPI PMID:21068237 UniProtKB:O15393
Cellular component
  GO:0005576 Extracellular region IEA GO_REF:0000037 UniProtKB-KW:KW-0964
  GO:0070062 Extracellular exosome IDA PMID:19056867 …
  GO:0016020 Membrane IEA GO_REF:0000002 InterPro:IPR001548
A selection of the 61 annotations associated with human ACE2 (Q9BYF1) illustrates the range of annotations associated with a single protein. 
Code indicates the evidence code used to support the annotation (www.geneontology.org/GO.evidence.shtml)8; Reference lists the source of the 
data supporting the annotation, this may be the curated article or information about the electronic annotation pipeline; and the With field provides 
additional information to support the annotation, such as the Gene Ontology (GO) identifier which supports an IC annotation or the Ensembl 
identifier from which the annotation is propagated.8
IC indicates Inferred by Curator; IMP, Inferred from Mutant Phenotype; IDA, Inferred from Direct Assay; IEA, Inferred from Electronic Annotation; 
IPI, Inferred from Physical Interaction.
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The Application of Information Derived From 
Orthologs
Experimental data to support GO annotations are not 
always available for human proteins and especially not 
for miRNAs, but may be obtainable for model organ-
ism orthologs. Inferential assertions about the roles 
of human gene products can be achieved by mapping 
annotations from their orthologous gene products. 
The electronic pipeline Ensembl Compara ensures 
that experimentally supported annotations associ-
ated with those proteins that have a 1-to-1 ortho-
log across human, mouse, and rat are applied to all 
orthologs.10 For example, the predicted 1-to-1 orthol-
ogy between the mouse ACE2 (Q8R0I0) and human 
ACE2 (Q9BYF1) proteins as defined by Compara has 
enabled 3 experimentally supported mouse ACE2 
annotations (including positive regulation of cardiac 
muscle contraction) to be associated with human 
ACE2. The GOC also provides an expert curation tool, 
called Phylogenetic Annotation and Inference Tool,46 
that enables biocurators to infer annotations across 
many species based on phylogenetic relationships 
and protein family membership. In addition, in some 
cases where knowledge from Compara and Phyloge-
netic Annotation and Inference Tool was not available, 
orthology was reviewed on a case-by-case basis and 
used to support transfer of annotations to the ortholo-
gous proteins47 (see next section and Methods in the 
Data Supplement).
Comprehensive Capture of Information About 
Prioritized Gene Products Through Annotation
The manual annotation of the 88 heart-relevant human 
proteins that were prioritized in this effort (Table I in 
the Data Supplement) led to the submission of over 
3100 annotations to the GO database. This represents 
a 4-fold increase in the number of manual annotations 
associated with these proteins. Furthermore, annota-
tion of model organism experimental data has provid-
ed a further 2000 annotations to 82 of these proteins 
through the transfer of experimentally supported anno-
tations to orthologous human proteins via the Ensem-
bl Compara pipeline,10 Phylogenetic Annotation and 
Inference Tool,46 and other expert curation methods.47 
To supplement the orthology-based curation, we man-
ually transferred 50 relevant biological process annota-
tions from mouse or rat to human, using the Inferred 
From Sequence or Structural Similarity evidence code.8 
When annotations provided through other electronic 
pipelines47 (such as mappings between UniProtKB Key-
words and InterPro) are included, the 88 prioritized 
human proteins have a total of 7263 annotations (as of 
March 2017). The number of annotations per protein 
ranges from 20 associated with RNF207 (Q6ZRF8) to 
272 associated with CAV1 (Q03135), with an average 
of 82 annotations per protein. Over 140 annotations 
are associated with the 7 prioritized human miRNAs. 
Therefore, this curation effort allowed bioinformatic 
capture of knowledge of genes that were not repre-
sented before, and it enables more informative data 
analysis, as shown below.
Using GO to Interpret GWAS
GWAS have identified many risk loci associated with 
cardiac disorders.1,31 In some cases, the impact of a 
variant on a protein-coding gene is relatively easy to 
identify because of predicted, and often experimen-
tally verified, deleterious nonsynonymous substitutions. 
However, often risk variants identified in a genomic 
area fall within an intronic, intergenic, or regulatory 
region, making it difficult to identify the true causative 
variant(s) associated with the risk, and which protein-
coding genes or functional RNA genes should be con-
sidered as candidates contributing to a disease.2,31 The 
cost of investigating a candidate gene’s role in a disease 
is considerable. Consequently, before experimental 
investigation, various in silico approaches are generally 
undertaken to try to narrow down the choice of which 
gene in a gene-rich region is involved in a disease. If 
nonsynonymous deleterious gene variants in a gene in 
the same region have already been associated with a 
similar phenotype, this is good supporting evidence for 
candidate gene choice. However, other approaches, 
such as those described by MacArthur et al,48 may also 
be valuable. These include considering whether any of 
the potential candidate genes encode a protein that 
interacts with proteins previously implicated in the dis-
ease (either using in silico network analysis or through 
coimmunoprecipitation experiments), or if the gene is 
expressed in tissues relevant to the disease (eg, by using 
expression quantitative trait loci data31).
MacArthur et al48 also describe selecting candidate 
genes based on a known function or role which is 
shared with other genes established as associated with 
the disease of interest or is consistent with their mutant 
phenotype. This approach can be easily undertaken 
using GO annotation data, and yet it is rarely included 
in the in silico investigations of GWAS results. After our 
focused annotation effort, the ability to use GO anno-
tations to identify candidate genes associated with 
arrhythmia disorders was evaluated. Human proteins 
associated with 9 GO terms that are relevant to normal 
cardiac physiology were downloaded using QuickGO9 
(GO terms are shown in Table IV in the Data Supple-
ment). The corresponding genes were then compared 
with Mendelian genes for arrhythmia disorders (atrial 
fibrillation, long-QT syndrome, short-QT syndrome, 
catecholaminergic polymorphic ventricular tachycardia, 
Brugada syndrome1,31,32) and with GWAS candidate vari-
ants associated with QT interval length and atrial fibril-
lation risk loci, described by Tucker et al2 and Arking 
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et al.31 Of 45 Mendelian arrhythmia-associated genes 
(described in 3 reviews to 20151,31,32), 43 were annotat-
ed with ≥1 of the cardiac-relevant GO terms (Table II in 
the Data Supplement), with SRL and GREM2 being the 
exceptions. The GO annotations associated with the 83 
GWAS-identified candidate genes (associated with 48 
risk loci) suggest that GO data can contribute to pri-
oritization of candidate risk genes. Cardiac physiology-
relevant GO terms suggest the prioritization of 36 of 
the 83 candidate genes. This selection approach com-
pares favorably with that taken by Arking et al.31 In that 
study, authors identified 35 common variant QT interval 
loci and used expression quantitative trait loci, protein 
interaction, and coimmunoprecipitation data to identify 
70 candidate genes associated with these loci (Table II 
in the Data Supplement). Both the GO and the expres-
sion quantitative trait loci approaches suggest 27 QT 
interval candidate genes, whereas coimmunoprecipita-
tion suggests 12 genes and in silico protein interaction 
networks 15 genes. For example, GO annotations hint 
that RNF207, at 1p36, is a good candidate for varia-
tions in QT interval length, with annotations to 6 of the 
key GO terms, and that potassium transport-associated 
KCNAB2 is a good alternative candidate. In contrast, 
in silico protein interaction data support 3 other genes 
at this locus (ACOT7, KCNAB2, and RPL22; Table  2). 
Similarly, GO annotation information narrows the can-
didates at the 3p21 locus to 3 genes (MYL3, SCAP, and 
SETD2; Table 2), with MYL3 having the strongest anno-
tation support, because of its role in muscle contraction 
and heart development; the analysis provided by Arking 
et al31 suggested 5 candidate genes at this locus. Nota-
bly, at the 1q24 risk locus, GO annotations, expression 
quantitative trait loci, and coimmunoprecipitation data 
all suggest ATP1B1 as the candidate gene (Table 2). This 
illustrates that GO annotations can provide additional 
data to either support the choice of candidate genes or 
suggest alternative candidates.
Functional Analysis of Atrial and 
Ventricular High-Throughput Data Sets
To provide a measure of the impact of our cardiac-
focused annotation project on data interpretation, we 
compared the functional analysis of a specific heart 
transcriptomic data set using GO annotations avail-
able in November 2016 to an equivalent analysis using 
GO annotation data available in February 2011. A 
VCM transcriptomic data set3 was used to investigate 
this, as we anticipated that a ventricular-specific tran-
scriptome was likely to include the ion channels, and 
their regulators, required for cardiac repolarization and 
depolarization. Poon et al3 profiled the transcriptome 
of human embryonic stem cells and compared this to 
the transcriptome of adult human VCMs, after filtering 
out the transcripts that were not significantly differen-
tially expressed between the 2 cell types.3 Poon et al3 
found that GO terms describing translation elongation, 
Table 2. Using GO to Support the Identification of the Likely Causative Gene Associated With 3 QT Interval  
Risk Loci31
QT Interval Risk rs846111 rs10919070 rs17784882
Nearest Gene RNF207 ATP1B1 ELP6
GWAS Candidate Gene ACOT7 KCNAB2 RPL22 NME7 KLHL18 MYL3 PTPN23 SCAP SETD2
GO term name
  Cardiac conduction *    *        
  Regulation of membrane potential *    *        
  Actin filament-based process *        *    
  Potassium ion transmembrane transport *  *  *        
  Sodium ion transmembrane transport     *        
  Calcium ion transmembrane transport     *        
  Muscle contraction *    *    *    
  Heart development *        *   *
  Response to oxygen levels     *      *  
Candidate gene predicted by
  GO annotation data RNF207  KCNAB2  ATP1B1    MYL3  SCAP SETD2
  eQTL or protein interaction data  ACOT7 KCNAB2 RPL22 ATP1B1 NME7  KLHL18 MYL3 PTPN23 SCAP SETD2
Gene Ontology (GO) annotation data can be used to provide additional information about candidate genes, located close to the risk loci, and add to the 
information provided by expression quantitative trait loci data (eQTL) or protein interaction data (full list of arrhythmia associated genes in Table II in the Data 
Supplement). Association of these terms with the genes in close proximity to the QT interval risk loci suggests that these are candidate causative genes. At 
the bottom of the table, the candidate gene predicted by either GO annotation, eQTL, or protein interaction data is listed: GO annotation data (based on the 
annotations listed in the table); eQTL or protein interaction data (based on eQTL, in silico QT interval loci protein network analysis or coimmunoprecipitation with 1 
of 5 LQTS Mendelian proteins31).
*The association of 1 of the 9 selected GO terms with a listed gene.
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as well as muscle system, contraction, and energy gen-
eration (their wording), were enriched within the 200 
most abundant transcripts in adult human VCMs. Our 
analysis using the 2011 and 2016 GO annotation data 
sets confirms findings of Poon et al,3 with the majority 
of these proteins annotated to either muscle contrac-
tion, mitochondrion organization, respiratory electron 
transport chain, gene expression, or developmental 
process terms. Notably, our analysis also demonstrates 
that the terms cardiac conduction, regulation of car-
diac conduction, and regulation of the force of heart 
contraction (among others) were significantly enriched 
in the 2016 analysis. Although VCMs are not involved 
in cardiac conduction, it is not unexpected that car-
diac conduction and child terms will be enriched in a 
ventricular data set, because many of the same action 
potential-associated proteins are present in ventricu-
lar, atrial, and conduction tissues.23 The identification 
of the cardiac-specific terms within this data set does, 
however, confirm that the GO terms and annotations 
created by this focused project are sufficient to enable 
the identification of the increased expression of genes 
involved in these processes. In 2011, many of the cardi-
ac physiology GO terms did not exist, and consequent-
ly, these terms are (understandably) not enriched using 
the 2011 annotation data set (Table 3; Table V in the 
Data Supplement).
DISCUSSION
In this article, we describe work to improve the GO 
resource in representing relevant cardiac processes, and 
in capturing roles of gene products from published 
literature through GO annotation. The majority of 
publications describing heart or cardiomyocyte tran-
scriptomic and proteomic data sets use GO annotations 
to investigate the pathways associated with this impor-
tant organ.3,5 We tested whether our recent cardiac-
relevant annotations could be used to support a more 
informative interpretation of high-throughput studies. 
Our reanalysis of the top 200 differentially expressed 
transcripts in adult human VCMs3 (compared with the 
human embryonic stem cells transcriptome; Table V in 
the Data Supplement) confirms the original findings of 
Poon et al3 and, in addition, shows that the transcrip-
tome of these cells is enriched for GO terms referring to 
cardiac physiology, including cardiac conduction, regula-
tion of cardiac conduction, regulation of cardiac muscle 
contraction by calcium ion signaling, and regulation of 
the force of heart contraction. Notably, the enrichment 
of these terms is only possible because of the expansion 
of the GO resource in this area. These cardiac-relevant 
terms are identified despite more than half of these 
highly expressed proteins being associated with protein 
synthesis, mitochondrial respiratory systems, or having 
a structural cellular role. The significance of our work 
lies in the enhanced ability to identify cardiac-relevant 
genes within cardiac tissue; cardiac physiologists can 
now use the GO to test genomic profiles and confirm 
the presence of relevant genes. For example, research-
ers who are using in vitro cardiac cell differentiation 
systems can now test the profiles of gene expression in 
their cells to examine and confirm progression toward 
mature cardiomyocytes. This has potential application 
in the field of heart cell regeneration.
Furthermore, our analysis of QT interval length and 
atrial fibrillation risk loci, described by Tucker et al2 and 
Arking et al,31 demonstrates that our focused GO anno-
tation of cardiac physiological processes provides an 
enhanced GO resource that can be used, in combina-
tion with other experimental and in silico approaches, 
to suggest candidate genes associated with cardiac dis-
Table 3. Comparison of Functional Analysis of Adult Ventricular Cardiomyocyte Data3 Using Gene 
Ontology (Full List of Enriched Terms in Table V in the Data Supplement)




P Value x n
Corrected 
P Value x
GO:0007005 Mitochondrion organization #N/A #N/A #N/A 679 4.56E-12 24
GO:0022904 Respiratory electron transport chain 135 5.48E-34 29 157 1.67E-34 29
GO:0010467 Gene expression 2206 4.58E-11 45 5483 1.09E-13 73
GO:0032502 Developmental process 5680 4.09E-12 80 6093 1.82E-07 64
GO:0061337 Cardiac conduction #N/A #N/A #N/A 126 1.71E-02 4
GO:1903779 Regulation of cardiac conduction #N/A #N/A #N/A 68 1.57E-05 6
GO:0002026 Regulation of the force of heart contraction #N/A #N/A #N/A 31 5.93E-06 5
A selection of Biological Process terms extracted from 2 analyses of the top 200 differentially expressed transcripts in hA-VCMs (adult human 
ventricular cardiomyocytes; compared with the human embryonic stem cells [hESCs] transcriptome3). Terms selected are either cardiac physiology 
relevant or align with terms identified by Poon et al.3 Analyses were conducted using the BinGO plugin33 within the Cytoscape v3.3.0 tool34 using 
either the 2011 or 2016 Gene Ontology (GO) annotation data set. n indicates the number of protein IDs associated with the GO term, and x is 
the number of IDs in both the submitted list and associated with the GO term The inclusion of only the most abundant VCM transcripts probably 
accounts for the low number of genes in this data set associated with the cardiac terms. #N/A indicates term was not significantly enriched in the 
data set.
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ease. In particular, our results suggest that ATP1B1, a 
Na+/K+-ATPase β-subunit, is the most likely candidate 
gene for further study at the 1q24 risk locus because 
it is associated with cardiac-relevant GO annotations. 
Another potential use of cardiac GO annotations is to 
extend protein network analysis. Overlaying proteins 
with relevant annotations (and hence known cardiac 
role) onto an existing network would highlight their 
interacting partners, and these could be explored as 
candidate genes.
With researchers turning to Drosophila and zebrafish 
as model systems for heart disease,49,50 there is a require-
ment for GO to represent cardiac physiology using 
terms that are species independent.6 The Drosophila 
pulsatile heart tube, with its anterior aorta, looks struc-
turally very distinct from the zebrafish 2-chambered 
and the mammalian 4-chambered hearts. However, 
despite this, many of the new GO terms created during 
this project can be applied across all species because 
many orthologous genes have similar functions. The 
major limiting factor to the GO annotation of nonmam-
malian systems is the paucity of research describing the 
roles of individual gene products in the cardiac cycle in 
those species, as the majority of these data relate to 
mammals. Indeed, the curation effort described in this 
article focuses on improving analysis tools for human 
cardiovascular research.
Our results show that collaboration between mem-
bers of relevant model organism databases and focused 
curation groups can improve and extend the capture 
of information about physiological processes in GO, in 
this particular study, cardiac processes. This effort was 
enhanced by the collaboration with experts in the cardi-
ac research field who helped us identify key aspects of 
the process, key genes, and key publications on which 
to focus. As knowledge of the cardiac system contin-
ues to advance, there will be opportunities to capture 
additional cardiac information in GO. We have provided 
a structured framework for the addition of new knowl-
edge to the resource, for example, to better describe 
information about the proteins involved in the mechan-
ical aspect of the heart, and to fully capture roles of gene 
products and hormones in regulating cardiac physiol-
ogy. Our work also shows that collaboration between 
groups developing ontologies and creating biological 
annotations and scientists and clinicians engaged in 
active research can lead to substantial improvements in 
the computational representation of biological knowl-
edge. The GOC welcomes input from researchers about 
any aspect of our work, including changes to the ontol-
ogy and suggestions of papers and gene products to 
annotate (goannotation@ucl.ac.uk, http://geneontology.
org/page/contributing-go). A variety of GitHub reposi-
tories with issue trackers are in place for specific que-
ries: for general inquiries about GO (https://github.
com/geneontology/helpdesk), for specific questions 
about annotations or annotation-related topics (https://
github.com/geneontology/go-annotation/), and for spe-
cific questions or suggestions about the content and 
structure of the ontology (https://github.com/geneon-
tology/go-ontology/). Such collaborations improve the 
value of the GO resource for the benefit of the entire 
cardiovascular research community and facilitate the 
interpretation of high-throughput data sets, toward the 
identification of dysregulated cardiac pathways, as well 
as variants and risk alleles, associated with cardiovas-
cular diseases. This has important implications for car-
diovascular physicians needing to interpret potentially 
pathological variants in their patients as a resource for 
the most up-to-date bioinformatic data to inform diag-
nosis and cascade screening in families.
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GO provides more than a simple flat list of terms. Instead, the terms have defined relations between 
each other, which can be represented in a graphical view (see Figure 1, which is a view of the 
ontology created with the OBO-Edit tool Graph Editor function using the public OBO release of GO 
on April 26, 2017, http://purl.obolibrary.org/obo/go.obo).1 Each GO term can have multiple, more 
general, ‘parent’ terms and multiple, more specific, ‘child’ terms. Different relations are available to 
define the connection between two GO terms2. Five core relations have been applied to the cardiac 
physiology part of the ontology: is_a, part_of, regulates, positively_regulates and 
negatively_regulates. The is_a relation denotes that the child term has all the characteristics of its 
parent but is a more specific term, with differences that distinguish it from other is_a children, for 
example ‘AV node cell to bundle of His cell communication’ is a subtype of ‘cell communication 
involved in cardiac conduction’ and is distinguished by the cells that are communicating. The part_of 
relation denotes that the child term is always a part of the parent term and together with additional 
parts make up the parent. For example, ‘AV node cell action potential’ is part of the process of ‘AV 
node cell to bundle of His cell signaling’ because it is required to propagate the electrical signal along 
the AV node cell. Another example is that GO Molecular Function terms describing channel activities 
required for the changes in membrane potential that are associated with an action potential have 
‘part_of’ relationships with the relevant membrane depolarization and repolarization terms. Coupling 
the channel activities with the processes that regulate membrane potential in these sections of the 
ontology provides a good example of how the Molecular Function and Biological Process branches 
can be integrated. The various types of regulation relations describe when a process has a regulatory 
or controlling effect on another process, for example ‘regulation of cardiac conduction’ describes a 
type of process that has a regulatory effect on ‘cardiac conduction’. The development of the ontology 
to describe cardiac-related processes involved more than placing the new GO terms in the ontology. 
Each GO term was assigned a unique GO identifier (ID), a descriptive definition and synonyms used 
in the literature. Synonyms and definitions facilitate the curation of a gene product’s role by allowing 
easier retrieval of appropriate GO terms when searching the ontology. They also provide a clear, 
human-readable meaning of the term. Additionally, where applicable, GO terms are defined 
computationally by creating necessary and sufficient statements using relationships between GO 
terms and terms from cross-referenced external ontologies3,4. 
 
Expert curation using Gene Ontology 
To create GO annotations supported by experimental data, expert GO curators read publications and 
summarised the data in annotations5. There is a vast number of publications describing the function of 
the gene products we have prioritized, therefore only a fraction of the available literature was curated. 
Because the curators are based at different institutes, different strategies were taken to identify the 
appropriate papers to annotate6,7. Since the focus of this project was to capture the role of specific 
gene products in cardiac physiology, the papers selected usually contained experimental data 
describing the prioritized proteins and their role in cardiac systems.  
Whenever possible, annotations also specify additional contextual information, such as the location of 
a function or process in a ‘regular ventricular cardiac myocyte’ or ‘heart left ventricle’, by using 
 
annotation extensions4 that refer to external ontologies such as the Cell Ontology (CL)8-10 or the 
Uberon multi-species anatomy ontology11,12. For example, human SCN5A is associated with the GO 
term ‘Z disc’ with the annotation extension ‘part_of’ ‘cardiac muscle cell’4. Thus, this annotation 
specifies the cell, as well as the cellular, location of this protein. 
Each annotation includes the gene product identifier, a GO term, an evidence code, and a reference2. 
The QuickGO browser (http://www.ebi.ac.uk/QuickGO/)13 or the AmiGO2 browser 
(http://amigo.geneontology.org/amigo/search/ontology)14 were used to search for the most specific 
GO terms to ‘capture’ the experimental data presented in each paper. Appropriate evidence codes 
were given to each annotation based on the type of experimental data presented in the published 
papers (www.geneontology.org/GO.evidence.shtml)15. The evidence code ‘Inferred by Curator’ (IC) 
was applied when a combination of experimental data from more than one paper supported the 
annotation. To ensure full annotation of the human, mouse and rat proteomes, experimentally 
supported annotations associated with model organism and human gene products are automatically 
transferred to the orthologous mammalian gene products via the Ensembl Compara pipeline16. 
However, 13 of the 88 prioritized proteins are members of highly conserved protein families and 
therefore do not have 1-to-1 orthologs in human, mouse and rat, as defined by Ensembl Compara. In 
these cases, GO annotations with experimental evidence codes were associated to orthologous human, 
mouse and rat proteins, by the expert curators, using the evidence code ISS (Inferred from Sequence 
Similarity), or ISO (Inferred from Orthology) based on confirmation of predicted orthology by the 
HUGO Gene Nomenclature Committee (http://www.genenames.org/) ortholog prediction tool 
(HCOP)17. The procedure for curation of miRNAs is detailed in Huntley et al. 20165. 
 
 
Identifying experimental data to annotate 
The PubMed database18 was used to locate recent papers reviewing the literature for cardiac 
electrophysiology and channelopathies. Gene products with a known role in the cardiac cycle were 
identified from these reviews. PubMed searches, with each individual gene symbol, name or synonym 
and additional filters, were conducted to provide a comprehensive coverage of the role of these 
proteins with respect to the cardiac physiology. These searches included specific filters, in addition to 
the relevant gene-symbol and name: ‘AND cardiac, ‘AND heart, or ‘AND conduction’. The selection 
of papers to curate was then based on whether: 1) they contained experimental data; 2) new 
information would be added to the current GO annotation data associated with the protein; 3) it was 
possible to identify the species the protein or expression construct was derived from. Only papers that 
met all three criteria were curated. The choice of papers curated was, therefore, influenced by the 
information captured previously (i.e. papers already annotated with existing cardiac terms were 
excluded). While human gene products were the main focus of this annotation project, other species 
gene products were also curated where information was available.  
 
Identification of candidate genes associated with arrhythmia risk loci 
The QuickGO browser13, with ‘taxon’ and ‘GO term’ filters applied, was used to download all human 
proteins associated with nine GO terms that are relevant to normal cardiac physiology (these nine GO 
terms are listed in Supplemental Table IV). The Microsoft Excel VLOOKUP function was used to 
identify the Mendelian genes and the candidate genes (listed in Supplemental Table III) that were 
associated with the selected GO terms.  
 
 
GO functional analysis of transcriptomic datasets 
A ventricular cardiomyocyte dataset19 was analysed using the BinGO plugin20 within the Cytoscape 
v3.3.0 tool21, according to the tools recommended procedure. BinGO has the facility to choose which 
GO annotation dataset to include in the analysis, allowing 2011 and 2016 annotation datasets to be 
compared. The ontology go-basic.obo (dated 7/03/2016) was downloaded from the GO Consortium 
website (http://geneontology.org/page/download-ontology), and the gene association files (containing 
the annotation datasets) gene_association.goa_human.104.gz (dated 14/11/2011) and 
gene_association.goa_human.154.gz (dated 16/02/2016), were downloaded from 
ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/old/HUMAN/ and 
ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/HUMAN/ respectively. For the analysis UniProtKB 
accessions were submitted with the following settings: assess overrepresentation; hypergeometric test; 
Benjamini & Hochberg False Discovery Rate correction; p<0.05 significance level; ‘whole 
annotation’ was used as reference set, leading to a comparison of the GO terms associated with the 






Supplemental Table I. 88 Cardiac physiology gene products prioritized for annotation. Human 
proteins with a role in cardiac excitability were compiled based on the description of proteins listed in 
eleven cardiac physiology reviews22-32. This list was then filtered to remove hormones and hormone 
receptors involved in regulating the heart rate (with the exception of AGT, ACE and ACE2) and 
proteins involved in regulating heart development. This enabled us to focus more specifically on ion 
channels and ATPases and the proteins directly regulating their activity.  
Approved symbol Approved name UniProt ID/RNA central ID Link to QuickGO or AmiGO annotation record
ACE angiotensin I converting enzyme P12821 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P12821
ACE2 angiotensin I converting enzyme 2 Q9BYF1 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9BYF1
AGT angiotensinogen P01019 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P01019
AKAP6 A-kinase anchoring protein 6 Q13023 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q13023
AKAP9 A-kinase anchoring protein 9 Q99996 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q99996
ANK2 ankyrin 2 Q01484 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q01484
ANK3 ankyrin 3 Q12955 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q12955
ASPH aspartate beta-hydroxylase Q12797 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q12797
ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 P05023 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P05023
ATP1A2 ATPase Na+/K+ transporting subunit alpha 2 P50993 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P50993
ATP1A3 ATPase Na+/K+ transporting subunit alpha 3 P13637 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P13637
ATP1B1 ATPase Na+/K+ transporting subunit beta 1 P05026 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P05026
ATP2A2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 P16615 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P16615
ATP2B4 ATPase plasma membrane Ca2+ transporting 4 P23634 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P23634
CACNA1C calcium voltage-gated channel subunit alpha1 C Q13936 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q13936
CACNA1D calcium voltage-gated channel subunit alpha1 D Q01668 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q01668
CACNA1G calcium voltage-gated channel subunit alpha1 G O43497 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O43497
CACNA2D1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 P54289 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P54289
CACNB2 calcium voltage-gated channel auxiliary subunit beta 2 Q08289 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q08289
CALM1 calmodulin 1 P62158 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P62158
CAMK2D calcium/calmodulin dependent protein kinase II delta Q13557 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q13557
CASQ2 calsequestrin 2 O14958 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O14958
CAV1 caveolin 1 Q03135 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q03135
CAV2 caveolin 2 P51636 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P51636
CAV3 caveolin 3 P56539 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P56539
CLIC2 chloride intracellular channel 2 O15247 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O15247
CNOT1 CCR4-NOT transcription complex subunit 1 A5YKK6 http://www.ebi.ac.uk/QuickGO/GProtein?ac=A5YKK6
DLG1 discs large MAGUK scaffold protein 1 Q12959 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q12959
DMD dystrophin P11532 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P11532
DSG2 desmoglein 2 Q14126 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q14126
FGF12 fibroblast growth factor 12 P61328 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P61328
FGF13 fibroblast growth factor 13 Q92913 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q92913
FKBP1B FK506 binding protein 1B P68106 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P68106
FLNA filamin A P21333 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P21333
FXYD1 FXYD domain containing ion transport regulator 1 O00168 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O00168
GJA1 gap junction protein alpha 1 P17302 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P17302
GJA5 gap junction protein alpha 5 P36382 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P36382
GPD1L glycerol-3-phosphate dehydrogenase 1 like Q8N335 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q8N335
GSTM2 glutathione S-transferase mu 2 P28161 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P28161
HCN4 hyperpolarization activated cyclic nucleotide gated potassium channel 4 Q9Y3Q4 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9Y3Q4
HRC histidine rich calcium binding protein P23327 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P23327
KCNA5 potassium voltage-gated channel subfamily A member 5 P22460 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P22460
KCND3 potassium voltage-gated channel subfamily D member 3 Q9UK17 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9UK17
KCNE1 potassium voltage-gated channel subfamily E regulatory subunit 1 P15382 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P15382
KCNE2 potassium voltage-gated channel subfamily E regulatory subunit 2 Q9Y6J6 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9Y6J6
KCNE3 potassium voltage-gated channel subfamily E regulatory subunit 3 Q9Y6H6 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9Y6H6
KCNE5 potassium voltage-gated channel subfamily E regulatory subunit 5 Q9UJ90 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9UJ90
KCNH2 potassium voltage-gated channel subfamily H member 2 Q12809 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q12809
KCNJ2 potassium voltage-gated channel subfamily J member 2 P63252 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P63252
KCNJ5 potassium voltage-gated channel subfamily J member 5 P48544 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P48544
KCNJ8 potassium voltage-gated channel subfamily J member 8 Q15842 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q15842
KCNQ1 potassium voltage-gated channel subfamily Q member 1 P51787 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P51787
LIG3 DNA ligase 3 P49916 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P49916
LITAF lipopolysaccharide induced TNF factor Q99732 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q99732
NDRG4 NDRG family member 4 Q9ULP0 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9ULP0
NEDD4L neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase Q96PU5 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q96PU5
NOS1 nitric oxide synthase 1 P29475 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P29475
NOS1AP nitric oxide synthase 1 adaptor protein O75052 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O75052
NPPA natriuretic peptide A P01160 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P01160
NUP155 nucleoporin 155 O75694 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O75694
PDE4B phosphodiesterase 4B Q07343 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q07343
PDE4D phosphodiesterase 4D Q08499 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q08499
PKP2 plakophilin 2 Q99959 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q99959
PLN phospholamban P26678 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P26678
PRKACA protein kinase cAMP-activated catalytic subunit alpha P17612 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P17612
PTPN3 protein tyrosine phosphatase, non-receptor type 3 P26045 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P26045
RANGRF RAN guanine nucleotide release factor Q9HD47 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9HD47
RNF207 ring finger protein 207 Q6ZRF8 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q6ZRF8
RYR2 ryanodine receptor 2 Q92736 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q92736
SCN10A sodium voltage-gated channel alpha subunit 10 Q9Y5Y9 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9Y5Y9
SCN1B sodium voltage-gated channel beta subunit 1 Q07699 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q07699
SCN2B sodium voltage-gated channel beta subunit 2 O60939 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O60939
SCN3B sodium voltage-gated channel beta subunit 3 Q9NY72 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9NY72
SCN4B sodium voltage-gated channel beta subunit 4 Q8IWT1 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q8IWT1
SCN5A sodium voltage-gated channel alpha subunit 5 Q14524 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q14524
SLC8A1 solute carrier family 8 member A1 P32418 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P32418
SLC8B1 solute carrier family 8 member B1 Q6J4K2 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q6J4K2
SLC9A1 solute carrier family 9 member A1 P19634 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P19634
SLMAP sarcolemma associated protein Q14BN4 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q14BN4
SNTA1 syntrophin alpha 1 Q13424 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q13424
SPTBN4 spectrin beta, non-erythrocytic 4 Q9H254 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9H254
SRI sorcin P30626 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P30626
TCAP titin-cap O15273 http://www.ebi.ac.uk/QuickGO/GProtein?ac=O15273
TRDN triadin Q13061 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q13061
TRPM4 transient receptor potential cation channel subfamily M member 4 Q8TD43 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q8TD43
YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon P62258 http://www.ebi.ac.uk/QuickGO/GProtein?ac=P62258
YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta Q04917 http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q04917
hsa-miR-1-3p miR-1 URS00001DC04F_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS00001DC04F_9606
hsa-miR-26a-5p miR-26 URS000019B0F7_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS000019B0F7_9606
hsa-miR-133a-3p miR-133a URS00004C9052_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS00004C9052_9606
hsa-miR-208a-3p miR-208a URS00000E5433_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS00000E5433_9606
hsa-miR-212-3p miR-212 URS00001D6BAE_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS00001D6BAE_9606
hsa-miR-328-3p miR-328 URS00005FDE70_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS00005FDE70_9606
hsa-miR-499-5p miR-499 URS00000C7662_9606 http://amigo.geneontology.org/amigo/gene_product/RNAcentral:URS00000C7662_9606
Supplemental Table II. Using Gene Ontology to support the identification of the likely causative 
gene associated with QT interval length and AF risk loci. 117 genes identified as either a known 
Mendelian gene associated with AF, LQTS, SQTS, CPVT or BrS33,34,  or a candidate gene associated 
with AF risk loci or loci associated with QT interval length, by GWAS33,35,36. Nine GO terms were 
selected based on their potential relevance to cardiac physiology (Supplemental Table III). QuickGO13 
was used to download all human proteins associated with these terms either directly or to a child term 
with one of the following relations: part_of, is_a, regulates, negatively_regulates, positively_regulates 
(11 March 2016). The association of these 9 GO terms with each of the AF or QT interval-associated 
genes was then determined, indicated by solid filled cell. Candidate genes identified by annotation to a 
relevant GO term were then compared with arrhythmia disorder Mendelian genes and candidate genes 
identified using eQTL, in silico QT interval loci protein network analysis (PPI-QT) or co-

























































































































































































































































































































































































































































































































































































RNF207 RNF207 ring	finger	protein	207 Q6ZRF8 rs846111 1p36 x x x x x x RNF207
RNF207 ACOT7 acyl-CoA	thioesterase	7 O00154 rs846111 1p36 PPI-QT	loci ACOT7
RNF207 KCNAB2 potassium	voltage-gated	channel	subfamily	A	regulatory	beta	subunit	2 Q13303 rs846111 1p36 x PPI-QT	loci KCNAB2 KCNAB2
RNF207 RPL22 ribosomal	protein	L22 P35268 rs846111 1p36 PPI-QT	loci RPL22
TCEA3 TCEA3 transcription	elongation	factor	A3 O75764 rs2298632 1p36 eQTL TCEA3
NOS1AP NOS1AP nitric	oxide	synthase	1	adaptor	protein O75052 rs12143842 1q23 x x x x x NOS1AP
ATP1B1 ATP1B1 ATPase	Na+/K+	transporting	subunit	beta	1 P05026 rs10919070 1q24 x x x x x x x eQTL,	5	bait	CoIP ATP1B1 ATP1B1
ATP1B1	 NME7 NME/NM23	family	member	7 Q9Y5B8 rs10919070 1q24 eQTL NME7
SLC8A1 SLC8A1 solute	carrier	family	8	member	A1 P32418 rs12997023 2p22 x x x x x x x PPI-QT	loci (LQTS) SLC8A1
SP3 SP3 Sp3	transcription	factor Q02447 rs938291 2q31.1
TTN-CCDC141 CCDC141 coiled-coil	domain	containing	141 Q6ZP82 rs7561149 2q31.2 5	bait	CoIP CCDC141
TTN-CCDC141 TTN titin Q8WZ42 rs7561149 2q31.2 x x x 5	bait	CoIP TTN TTN
SPATS2L SPATS2L spermatogenesis	associated	serine	rich	2	like Q9NUQ6 rs295140 2q33 eQTL SPATS2L
SPATS2L SGO2 shugoshin	2 Q562F6 rs295140 2q33 PPI-QT	loci SGOL2
ELP6	(C3orf75) ELP6	(C3orf75) elongator	acetyltransferase	complex	subunit	6 Q0PNE2 rs17784882 3p21
ELP6	(C3orf75) KLHL18 kelch	like	family	member	18 O94889 rs17784882 3p21 eQTL KLHL18
ELP6	(C3orf75) MYL3 myosin	light	chain	3 P08590 rs17784882 3p21 x x x 5	bait	CoIP MYL3 MYL3
ELP6	(C3orf75) PTPN23 protein	tyrosine	phosphatase,	non-receptor	type	23 Q9H3S7 rs17784882 3p21 eQTL PTPN23 positive	regulation	of	adherens	junction	organization
ELP6	(C3orf75) SCAP SREBF	chaperone Q12770 rs17784882 3p21 x eQTL SCAP SCAP
ELP6	(C3orf75) SETD2 SET	domain	containing	2 Q9BYW2 rs17784882 3p21 x eQTL SETD2 SETD2
SCN5A-SCN10A SCN5A sodium	voltage-gated	channel	alpha	subunit	5 Q14524 rs6793245 3p22 x x x x x x PPI-QT	loci LQTS AF BrS1 SCN5A SCN5A
SCN5A-SCN10A SCN10A sodium	voltage-gated	channel	alpha	subunit	10 Q9Y5Y9 rs6793245 3p22 x x x x SCN10A
SLC4A4 SLC4A4 solute	carrier	family	4	member	4 Q9Y6R1 rs2363719 4q13 x SLC4A4
SMARCAD1 SMARCAD1 SWI/SNF-related,	matrix-associated	actin-dependent	regulator	of	chromatin,	subfamily	a,	containing	DEAD/H	box	1Q9H4L7 rs3857067 4q22
GFRA3 GFRA3 GDNF	family	receptor	alpha	3 O60609 rs10040989 5q31 sympathetic	nervous	system	development
GFRA3 ETF1 eukaryotic	translation	termination	factor	1 P62495 rs10040989 5q31 PPI-QT	loci ETF1
GFRA3 FAM13B family	with	sequence	similarity	13	member	B Q9NYF5 rs10040989 5q31 eQTL FAM13B
GMPR GMPR guanosine	monophosphate	reductase P36959 rs7765828 6p22
GMPR ATXN1	 ataxin	1 P54253 rs7765828 6p22 x eQTL,	PPI-QT	loci ATXN1	 ATXN1	
SLC35F1-PLN PLN phospholamban P26678 rs11153730 6q22 x x x x x x 5	bait	CoIP PLN PLN
SLC35F1-PLN SLC35F1 solute	carrier	family	35	member	F1 Q5T1Q4 rs11153730 6q22
CAV1 CAV1 caveolin	1 Q03135 rs9920 rs3807989 7q31 x x x x x x PPI-QT	loci,	5	bait	CoIP CAV1 CAV1 caveola	assembly
CAV1 CAV2 caveolin	2 P51636 rs9920 7q31 PPI-QT	loci,	5	bait	CoIP CAV2 caveola	assembly
CAV1 CAV3 caveolin	3 P56539 rs9920 7q31 x x x x x x x not	tested LQTS CAV3 caveola	assembly
KCNH2 KCNH2 potassium	voltage-gated	channel	subfamily	H	member	2 Q12809 rs2072413 7q36 x x x x x PPI-QT	loci LQTS AF SQTS1 KCNH2 KCNH2
NCOA2 NCOA2 nuclear	receptor	coactivator	2 Q15596 rs16936870 8q13 thyroid	hormone	receptor	coactivator	activity
LAPTM4B LAPTM4B lysosomal	protein	transmembrane	4	beta Q86VI4 rs11779860 8q22.1
AZIN1 AZIN1 antizyme	inhibitor	1 O14977 rs1961102 8q22.3
GBF1 GBF1 golgi	brefeldin	A	resistant	guanine	nucleotide	exchange	factor	1 Q92538 rs2485376 10q24 ACTR1A
GBF1 ACTR1A ARP1	actin	related	protein	1	homolog	A P61163 rs2485376 10q24 5	bait	CoIP
KCNQ1 KCNQ1 potassium	voltage-gated	channel	subfamily	Q	member	1 P51787 rs7122937 11p15 x x x x x PPI-QT	loci LQTS AF SQTS2 KCNQ1 KCNQ1
KCNQ1 C11orf21 chromosome	11	open	reading	frame	21 Q9P2W6 rs7122937 11p15 eQTL C11orf21
KCNQ1 TSPAN32 tetraspanin	32 Q96QS1 rs7122937 11p15 eQTL TSPAN32
FEN1-FADS2 FADS1 fatty	acid	desaturase	1 O60427 rs174583 11q12 eQTL FADS1
FEN1-FADS2 FADS2 fatty	acid	desaturase	2 O95864 rs174583 11q12 eQTL FADS2
FEN1-FADS2 FADS3 fatty	acid	desaturase	3 Q9Y5Q0 rs174583 11q12 eQTL FADS3
FEN1-FADS2 FEN1 flap	structure-specific	endonuclease	1 P39748 rs174583 11q12
ATP2A2 ATP2A2 ATPase	sarcoplasmic/endoplasmic	reticulum	Ca2+	transporting	2 P16615 rs3026445 12q24 x x x x PPI-QT	loci,	5	bait	CoIP (LQTS) ATP2A2 ATP2A2
ATP2A2	 ARPC3 actin	related	protein	2/3	complex	subunit	3 O15145 rs3026445 12q24 x eQTL ARPC3 ARPC3
ATP2A2	 FAM216A family	with	sequence	similarity	216	member	A Q8WUB2 rs3026445 12q24 eQTL FAM216A
ATP2A2	 GPN3 GPN-loop	GTPase	3 Q9UHW5 rs3026445 12q24 eQTL GPN3
ATP2A2	 VPS29 VPS29,	retromer	complex	component Q9UBQ0 rs3026445 12q24 eQTL VPS29
KLF12 KLF12 Kruppel	like	factor	12 Q9Y4X4 rs728926 13q22 eQTL KLF12
ANKRD9 ANKRD9 ankyrin	repeat	domain	9 Q96BM1 rs2273905 14q32 eQTL ANKRD9
USP50-TRPM7 TRPM7 transient	receptor	potential	cation	channel	subfamily	M	member	7 Q96QT4 rs3105593 15q21 x x (LQTS) TRPM7
USP50-TRPM7 USP50 ubiquitin	specific	peptidase	50 Q70EL3 rs3105593 15q21
LITAF LITAF lipopolysaccharide	induced	TNF	factor Q99732 rs735951 16p13 eQTL LITAF
MKL2 MKL2 MKL1/myocardin	like	2 Q9ULH7 rs246185 16p13.12 x MKL2
CREBBP CREBBP CREB	binding	protein Q92793 rs1296720 16p13.3 x 5	bait	CoIP CREBBP CREBBP negative	regulation	of	cellular	respiration
CREBBP SRL sarcalumenin Q86TD4 rs1296720 16p13.3 (LQTS) Sarcalumenin	involved	with	Ca2+	handling	of	the	sarcoplasmic	reticulum
CREBBP TRAP1 TNF	receptor-associated	protein	1 Q12931 rs1296720 16p13.3
CNOT1 CNOT1 CCR4-NOT	transcription	complex	subunit	1 A5YKK6 rs246196 16q21 eQTL NDRG4 CNOT1
CNOT1 GOT2 glutamic-oxaloacetic	transaminase	2 P00505 rs246196 16q21 5	bait	CoIP GOT2
CNOT1 NDRG4 NDRG	family	member	4 Q9ULP0 rs246196 16q21 x eQTL NDRG4
LIG3 LIG3 DNA	ligase	3 P49916 rs1052536 17q12 eQTL LIG3
LIG3 CCT6B chaperonin	containing	TCP1	subunit	6B Q92526 rs1052536 17q12 eQTL CCT6B
LIG3 UNC45B unc-45	myosin	chaperone	B Q8IWX7 rs1052536 17q12 5	bait	CoIP UNC45B
KCNJ2 KCNJ2 potassium	voltage-gated	channel	subfamily	J	member	2 P63252 rs1396515 17q24 x x x x x not	tested LQTS AF SQTS3 KCNJ2
PRKCA PRKCA protein	kinase	C	alpha P17252 rs9892651 17q24 x eQTL,	PPI-QT	loci PRKCA PRKCA
KCNE1 KCNE1 potassium	voltage-gated	channel	subfamily	E	regulatory	subunit	1 P15382 rs1805128 21q22 x x x x x PPI-QT	loci LQTS AF KCNE1 KCNE1
KCNN3 potassium	calcium-activated	channel	subfamily	N	member	3 Q9UGI6 rs6666258 1q21 x KCNN3
PRRX1 paired	related	homeobox	1 P54821 rs3903239 1q24
CAND2 cullin	associated	and	neddylation	dissociated	2	(putative) O75155 rs4642101	 3p25
PITX2 paired	like	homeodomain	2 Q99697 rs6817105 4q25 x AF PITX2
GJA1 gap	junction	protein	alpha	1 P17302 rs13216675 6q22 x x x x x GJA1
C9orf3 chromosome	9	open	reading	frame	3 Q8N6M6 rs10821415 9q22
MYOZ1 myozenin	1 Q9NP98 rs10824026 10q22 x MYOZ1
NEURL neuralized	E3	ubiquitin	protein	ligase	1 O76050 rs12415501	 10q24
CUX2 cut	like	homeobox	2 O14529 rs6490029	 12q24 x CUX2
TBX5 T-box	5 Q99593 rs10507248	 12q24 x TBX5
SYNE2 spectrin	repeat	containing	nuclear	envelope	2 Q8WXH0 rs1152591 14q23 x SYNE2
HCN4 hyperpolarization	activated	cyclic	nucleotide	gated	potassium	channel	4 Q9Y3Q4 rs7164883 15q24 x x x x x AF BrS8 HCN4
ZFHX3 zinc	finger	homeobox	3 Q15911 rs2106261 16q22
AKAP9 A-kinase	anchoring	protein	9 Q99996 x x x LQTS
ANK2 ankyrin	2 Q01484 x x x x x x x LQTS
CACNA1C calcium	voltage-gated	channel	subunit	alpha1	C Q13936 x x x x LQTS BrS3
CALM1 calmodulin	1 P62158 x x x LQTS CPVT4
SNTA1 syntrophin	alpha	1 Q13424 x x x x LQTS
KCNE2 potassium	voltage-gated	channel	subfamily	E	regulatory	subunit	2 Q9Y6J6 x x x x x x LQTS AF
KCNJ5 potassium	voltage-gated	channel	subfamily	J	member	5 P48544 x LQTS AF
SCN4B sodium	voltage-gated	channel	beta	subunit	4 Q8IWT1 x x x x x LQTS AF
ABCC9 ATP	binding	cassette	subfamily	C	member	9 O60706 x x AF
GATA4 GATA	binding	protein	4 P43694 x x x AF
GATA5 GATA	binding	protein	5 Q9BWX5 x AF
GATA6 GATA	binding	protein	6 Q92908 x x AF
GJA5 gap	junction	protein	alpha	5 P36382 x x x x x AF
GREM2 gremlin	2,	DAN	family	BMP	antagonist Q9H772 AF
JPH2 junctophilin	2 Q9BR39 x x AF
KCNA5 potassium	voltage-gated	channel	subfamily	A	member	5 P22460 x x x x x x AF
KCND3 potassium	voltage-gated	channel	subfamily	D	member	3 Q9UK17 x x x AF
KCNE3 potassium	voltage-gated	channel	subfamily	E	regulatory	subunit	3 Q9Y6H6 x x x AF BrS6
KCNE5 potassium	voltage-gated	channel	subfamily	E	regulatory	subunit	5 Q9UJ90 x x x x x AF
KCNJ8 potassium	voltage-gated	channel	subfamily	J	member	8 Q15842 x x AF
LMNA lamin	A/C P02545 x x AF
NKX2-5 NK2	homeobox	5 P52952 x x x x AF
NPPA natriuretic	peptide	A P01160 x x x x x x x AF
NUP155 nucleoporin	155 O75694 x x x x AF
RYR2 ryanodine	receptor	2 Q92736 x x x x x x x AF CPVT1	
SCN1B sodium	voltage-gated	channel	beta	subunit	1 Q07699 x x x x x AF BrS5
SCN2B sodium	voltage-gated	channel	beta	subunit	2 O60939 x x x x x AF
SCN3B sodium	voltage-gated	channel	beta	subunit	3 Q9NY72 x x x x x AF BrS7
CACNB2	 calcium	voltage-gated	channel	auxiliary	subunit	beta	2 Q08289 x x BrS4
CASQ2 calsequestrin	2 O14958 x x x x x x CPVT2
GPD1L	 glycerol-3-phosphate	dehydrogenase	1	like Q8N335 x x x x BrS2
TRDN	 triadin Q13061 x x x x CPVT5
Supplemental Table III. Cardiac physiology relevant Biological Process GO terms. Nine GO terms 
were selected based on their potential relevance to cardiac physiology.  
 
GO identifier GO term name 
GO:0061337 cardiac conduction 
GO:0042391 regulation of membrane potential 
GO:0030029 actin filament-based process 
GO:0071805 potassium ion transmembrane transport 
GO:0035725 sodium ion transmembrane transport 
GO:0070588 calcium ion transmembrane transport 
GO:0006936 muscle contraction 
GO:0007507 heart development 
GO:0070482 response to oxygen levels 
 







































Biological Process GO:0086014 atrial cardiac muscle cell action potential 215
Biological Process GO:0099624 atrial cardiac muscle cell membrane repolarization 0 226
Biological Process GO:0086066 atrial cardiac muscle cell to AV node cell communication 13
Biological Process GO:0086044 atrial cardiac muscle cell to AV node cell communication by electrical coupling 76
Biological Process GO:0086026 atrial cardiac muscle cell to AV node cell signaling 0 604
Biological Process GO:0086071 atrial cardiac muscle cell-AV node cell adhesion involved in cell communication 0 0
Biological Process GO:0086016 AV node cell action potential 112
Biological Process GO:0086067 AV node cell to bundle of His cell communication 52
Biological Process GO:0086053 AV node cell to bundle of His cell communication by electrical coupling 121
Biological Process GO:0086027 AV node cell to bundle of His cell signaling 44
Biological Process GO:0086072 AV node cell-bundle of His cell adhesion involved in cell communication 4
Biological Process GO:0086043 bundle of His cell action potential 32
Biological Process GO:0086069 bundle of His cell to Purkinje myocyte communication 4
Biological Process GO:0086054 bundle of His cell to Purkinje myocyte communication by electrical coupling 35
Biological Process GO:0086028 bundle of His cell to Purkinje myocyte signaling 0 285
Biological Process GO:0086073 bundle of His cell-Purkinje myocyte adhesion involved in cell communication 181
Biological Process GO:0086064 cell communication by electrical coupling involved in cardiac conduction 91
Biological Process GO:0086065 cell communication involved in cardiac conduction 39
Biological Process GO:0086019 cell-cell signaling involved in cardiac conduction 40
Biological Process GO:0098912 membrane depolarization during atrial cardiac muscle cell action potential* 71
Biological Process GO:0086045 membrane depolarization during AV node cell action potential 140
Biological Process GO:0086048 membrane depolarization during bundle of His cell action potential 62
Biological Process GO:0086047 membrane depolarization during Purkinje myocyte cell action potential 60
Biological Process GO:0086046 membrane depolarization during SA node cell action potential 138
Biological Process GO:0098914 membrane repolarization during atrial cardiac muscle cell action potential* 93
Biological Process GO:0086049 membrane repolarization during AV node cell action potential 0 0
Biological Process GO:0086050 membrane repolarization during bundle of His cell action potential 27
Biological Process GO:0086051 membrane repolarization during Purkinje myocyte action potential 0 0
Biological Process GO:0086052 membrane repolarization during SA node cell action potential 29
Biological Process GO:1903948 negative regulation of atrial cardiac muscle cell action potential 0 0
Biological Process GO:1903950 negative regulation of AV node cell action potential 0 0
Biological Process GO:1903780 negative regulation of cardiac conduction 0 0
Biological Process GO:1901845 negative regulation of cell communication by electrical coupling involved in cardiac conduction 0 0
Biological Process GO:1905028 negative regulation of membrane depolarization during AV node cell action potential 0 0
Biological Process GO:1905001 negative regulation of membrane repolarization during atrial cardiac muscle cell action potential
0 0
Biological Process GO:1903953 negative regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle 
cell action potential repolarization 0 0
Biological Process GO:1903949 positive regulation of atrial cardiac muscle cell action potential 3
Biological Process GO:1903951 positive regulation of AV node cell action potential 0 0
Biological Process GO:1903781 positive regulation of cardiac conduction 0 8
Biological Process GO:1901846 positive regulation of cell communication by electrical coupling involved in cardiac conduction 2
Biological Process GO:1905029 positive regulation of membrane depolarization during AV node cell action potential 0 0
Biological Process GO:1905002 positive regulation of membrane repolarization during atrial cardiac muscle cell action potential
0 0
Biological Process GO:1903954 positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle 
cell action potential repolarization 3
Biological Process GO:0086017 Purkinje myocyte action potential 0 131
Biological Process GO:0086068 Purkinje myocyte to ventricular cardiac muscle cell communication 0 160
Biological Process GO:0086055 Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling 1
Biological Process GO:0086029 Purkinje myocyte to ventricular cardiac muscle cell signaling 27
Biological Process GO:0086074 Purkinje myocyte-ventricular cardiac muscle cell adhesion involved in cell communication 0 0
Biological Process GO:0098910 regulation of atrial cardiac muscle cell action potential 127
Biological Process GO:0098904 regulation of AV node cell action potential 113
Biological Process GO:0098905 regulation of bundle of His cell action potential 99
Biological Process GO:1903779 regulation of cardiac conduction 447
Child terms of GO term cardiac conduction*, GO:0061337
Supplemental Table IV. List of new cardiac physiology relevant GO terms. 
197 new GO terms were created to support the annotation of 88 prioritized proteins and 7 miRNAs and their role in cardiac processes. These were created by the GO 
editors following an ontology development meeting in November 2011 and individual requests by GO curators. Table IV lists 200 GO terms as it includes 3 terms, 
‘membrane depolarization during atrial cardiac muscle cell action potential’ and ‘membrane repolarization during atrial cardiac muscle cell action potential’, as well 
as ‘cardiac conduction’, indicated by *, that were already in the ontology). The column header ‘Aspect’ lists the ontology to which the GO term belongs, either 
Molecular Function or Biological Process. Information about the number of annotations associated with each GO term is provided (based on data available 18 October 
2017) in two ways: as the number of direct annotations (number of times each GO term has been associated with a gene product from any species) and number of 
annotations to child term/s (number of times a child term for each GO term has been associated with a gene product from any species). Terms were considered as 
child terms if they had an is_a, part_of, occurs_in, regulates, positively_regulates or negatively_regulates relation to the parent term. The graph nature of the 
ontology means that some annotations will be represented more than once in this table. 
Of the 197 new GO terms created, 136 have been directly associated with a gene product. Of the 63 terms without direct annotations, 22 provide a parent GO term 
that will facilitate gene grouping during functional analyses using GO datasets. For example, ‘atrial cardiac muscle cell membrane repolarization’ has no direct 
annotations, but its child terms have been used in 226 annotations. 41 terms, mostly leaf nodes, have not yet been associated with any gene product either directly or 
via child terms; many of these refer either to processes occurring in specific cell types, such as ‘negative regulation of AV node cell action potential’, or describe very 
specific functions, e.g. ‘stretch-activated, cation-selective, calcium channel activity involved in regulation of action potential’. Some of these areas of study did not fall 
under the focus of this project, and relevant literature was not examined in detail. Future annotation projects, for example looking at signaling pathways that regulate 
both the rate and strength of heart contractions, may lead to the association of proteins or RNAs with these terms.
Biological Process GO:1901844 regulation of cell communication by electrical coupling involved in cardiac conduction 106
Biological Process GO:0086091 regulation of heart rate by cardiac conduction 1171
Biological Process GO:1905027 regulation of membrane depolarization during AV node cell action potential 0 0
Biological Process GO:1905000 regulation of membrane repolarization during atrial cardiac muscle cell action potential 2
Biological Process GO:0098906 regulation of Purkinje myocyte action potential 35
Biological Process GO:0098907 regulation of SA node cell action potential 84
Biological Process GO:0086092 regulation of the force of heart contraction by cardiac conduction 68
Biological Process GO:1903952 regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action 
potential repolarization 0 3
Biological Process GO:0086015 SA node cell action potential 165
Biological Process GO:0086070 SA node cell to atrial cardiac muscle cell communication 70
Biological Process GO:0086021 SA node cell to atrial cardiac muscle cell communication by electrical coupling 3
Biological Process GO:0086018 SA node cell to atrial cardiac muscle cell signalling 44
Biological Process GO:0086022 SA node cell-atrial cardiac muscle cell adhesion involved in cell communication 0 0
Molecular Function GO:0086082 cell adhesive protein binding involved in AV node cell-bundle of His cell communication 2
Molecular Function GO:0086083 cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication 17
Molecular Function GO:0086076 gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling
40
Molecular Function GO:0086077 gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling 85
Molecular Function GO:0086078 gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling 35
Molecular Function GO:0086075 gap junction channel activity involved in cardiac conduction electrical coupling 40
Molecular Function GO:0086079 gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical 
coupling 1
Molecular Function GO:0086020 gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling
3
Molecular Function GO:0086056 voltage-gated calcium channel activity involved in AV node cell action potential 112
Molecular Function GO:0086057 voltage-gated calcium channel activity involved in bundle of His cell action potential 34
Molecular Function GO:0086058 voltage-gated calcium channel activity involved in Purkinje myocyte cell action potential 0 0
Molecular Function GO:0086059 voltage-gated calcium channel activity involved SA node cell action potential 104
Molecular Function GO:0086089 voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential 
repolarization 90
Molecular Function GO:0086086 voltage-gated potassium channel activity involved in AV node cell action potential repolarization
0 0
Molecular Function GO:0086087 voltage-gated potassium channel activity involved in bundle of His cell action potential 
repolarization 27
Molecular Function GO:0086088 voltage-gated potassium channel activity involved in Purkinje myocyte action potential 
repolarization 0 0
Molecular Function GO:0086041 voltage-gated potassium channel activity involved in SA node cell action potential depolarization
29
Molecular Function GO:0086090 voltage-gated potassium channel activity involved in SA node cell action potential repolarization
29
Molecular Function GO:0086060 voltage-gated sodium channel activity involved in AV node cell action potential 4
Molecular Function GO:0086061 voltage-gated sodium channel activity involved in bundle of His cell action potential 4
Molecular Function GO:0086062 voltage-gated sodium channel activity involved in Purkinje myocyte action potential 36
Molecular Function GO:0086063 voltage-gated sodium channel activity involved in SA node cell action potential 6
Biological Process GO:0086096 adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process 0 0
Biological Process GO:0086102 adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway involved 
in negative regulation of heart rate 0 0
Biological Process GO:0086030 adrenergic receptor signaling pathway involved in cardiac muscle relaxation 3
Biological Process GO:0086023 adrenergic receptor signaling pathway involved in heart process 62
Biological Process GO:0086024 adrenergic receptor signaling pathway involved in positive regulation of heart rate 2
Biological Process GO:0038166 angiotensin-activated signaling pathway 784
Biological Process GO:0086098 angiotensin-activated signaling pathway involved in heart process 73
Biological Process GO:0090662 ATP hydrolysis coupled transmembrane transport 2577
Biological Process GO:1903515 calcium ion transport from cytosol to endoplasmic reticulum 56
Biological Process GO:1903514 calcium ion transport from endoplasmic reticulum to cytosol 36
Biological Process GO:0086001 cardiac muscle cell action potential 65
Biological Process GO:0086002 cardiac muscle cell action potential involved in contraction 436
Biological Process GO:0086003 cardiac muscle cell contraction 12
Biological Process GO:0086042 cardiac muscle cell-cardiac muscle cell adhesion 63
Biological Process GO:0014898 cardiac muscle hypertrophy in response to stress 440
Biological Process GO:0060926 cardiac pacemaker cell development 0 100
Biological Process GO:0060920 cardiac pacemaker cell differentiation 0 150
Biological Process GO:0060927 cardiac pacemaker cell fate commitment 0 33
Biological Process GO:1903513 endoplasmic reticulum to cytosol transport 0 1787
Biological Process GO:0086100 endothelin receptor signaling pathway 561
Biological Process GO:0086101 endothelin receptor signaling pathway involved in heart process 0 0
Biological Process GO:0086093 G-protein coupled acetylcholine receptor signaling pathway involved in involved in heart process
0 0
Biological Process GO:0086033 G-protein coupled acetylcholine receptor signaling pathway involved in negative regulation of 
heart rate 0 0
Biological Process GO:0086103 G-protein coupled receptor signaling pathway involved in heart process 35
Biological Process GO:0086010 membrane depolarization during action potential 757
Biological Process GO:0086012 membrane depolarization during cardiac muscle cell action potential 183
Biological Process GO:0098913 membrane depolarization during ventricular cardiac muscle cell action potential 0 0
Biological Process GO:0086009 membrane repolarization 310
Biological Process GO:0086011 membrane repolarization during action potential 142
Biological Process GO:0086013 membrane repolarization during cardiac muscle cell action potential 143
Other cardiac-relevant GO terms
Biological Process GO:0098915 membrane repolarization during ventricular cardiac muscle cell action potential 156
Biological Process GO:1901205 negative regulation of adrenergic receptor signaling pathway involved in heart process 32
Biological Process GO:1903246 negative regulation of adrenergic receptor signaling pathway involved in positive regulation of 
heart rate 0 0
Biological Process GO:1903280 negative regulation of calcium:sodium antiporter activity 6
Biological Process GO:1902260 negative regulation of delayed rectifier potassium channel activity 182
Biological Process GO:1903597 negative regulation of gap junction assembly 36
Biological Process GO:1903609 negative regulation of inward rectifier potassium channel activity 36
Biological Process GO:1900826 negative regulation of membrane depolarization during cardiac muscle cell action potential 34
Biological Process GO:1905032 negative regulation of membrane repolarization during cardiac muscle cell action potential 0 36
Biological Process GO:1905025 negative regulation of membrane repolarization during ventricular cardiac muscle cell action 
potential 36
Biological Process GO:1902309 negative regulation of peptidyl-serine dephosphorylation 102
Biological Process GO:1902303 negative regulation of potassium ion export 28
Biological Process GO:1903765 negative regulation of potassium ion export across plasma membrane 36
Biological Process GO:1903287 negative regulation of potassium ion import 0 0
Biological Process GO:1903783 negative regulation of sodium ion import across plasma membrane 0 0
Biological Process GO:1902306 negative regulation of sodium ion transmembrane transport 95
Biological Process GO:0098736 negative regulation of the force of heart contraction 31
Biological Process GO:1903946 negative regulation of ventricular cardiac muscle cell action potential 0 36
Biological Process GO:1903761 negative regulation of voltage-gated potassium channel activity involved in ventricular cardiac 
muscle cell action potential repolarization 0 0
Biological Process GO:0086097 phospholipase C-activating angiotensin-activated signaling pathway 44
Biological Process GO:0086099 phospholipase C-activating angiotensin-activated signaling pathway involved in heart process 0 0
Biological Process GO:0003301 physiological cardiac muscle hypertrophy 13
Biological Process GO:1901206 positive regulation of adrenergic receptor signaling pathway involved in heart process 29
Biological Process GO:1903247 positive regulation of adrenergic receptor signaling pathway involved in positive regulation of 
heart rate 0 0
Biological Process GO:1903281 positive regulation of calcium:sodium antiporter activity 75
Biological Process GO:1903598 positive regulation of gap junction assembly 114
Biological Process GO:0086095 positive regulation of IKACh channel activity by G-protein coupled acetylcholine receptor signaling 
pathway involved in negative regulation of heart rate 0 0
Biological Process GO:1900827 positive regulation of membrane depolarization during cardiac muscle cell action potential 3
Biological Process GO:1905033 positive regulation of membrane repolarization during cardiac muscle cell action potential 0 40
Biological Process GO:1905026 positive regulation of membrane repolarization during ventricular cardiac muscle cell action 
potential 0 37
Biological Process GO:1902310 positive regulation of peptidyl-serine dephosphorylation 85
Biological Process GO:1902304 positive regulation of potassium ion export 6
Biological Process GO:1903766 positive regulation of potassium ion export across plasma membrane 34
Biological Process GO:1903288 positive regulation of potassium ion import 138
Biological Process GO:0086094 positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor 
signaling pathway involved in positive regulation of cardiac muscle contraction 0 0
Biological Process GO:1903784 positive regulation of sodium ion import across plasma membrane 0 0
Biological Process GO:1902307 positive regulation of sodium ion transmembrane transport 6
Biological Process GO:0098735 positive regulation of the force of heart contraction 161
Biological Process GO:1903947 positive regulation of ventricular cardiac muscle cell action potential 0 37
Biological Process GO:1903762 positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac 
muscle cell action potential repolarization 37
Biological Process GO:0003165 Purkinje myocyte development 34
Biological Process GO:0003168 Purkinje myocyte differentiation 33
Biological Process GO:1901204 regulation of adrenergic receptor signaling pathway involved in heart process 0 61
Biological Process GO:1903245 regulation of adrenergic receptor signaling pathway involved in positive regulation of heart rate
0 0
Biological Process GO:1903279 regulation of calcium:sodium antiporter activity 0 81
Biological Process GO:0098901 regulation of cardiac muscle cell action potential 20
Biological Process GO:0098909 regulation of cardiac muscle cell action potential involved in regulation of contraction 163
Biological Process GO:0086004 regulation of cardiac muscle cell contraction 262
Biological Process GO:0086036 regulation of cardiac muscle cell membrane potential 200
Biological Process GO:1903596 regulation of gap junction assembly 0 150
Biological Process GO:1900825 regulation of membrane depolarization during cardiac muscle cell action potential 133
Biological Process GO:0060306 regulation of membrane repolarization 341
Biological Process GO:1905031 regulation of membrane repolarization during cardiac muscle cell action potential 3
Biological Process GO:1905024 regulation of membrane repolarization during ventricular cardiac muscle cell action potential 0 104
Biological Process GO:1902308 regulation of peptidyl-serine dephosphorylation 0 187
Biological Process GO:1902302 regulation of potassium ion export 0 135
Biological Process GO:1903764 regulation of potassium ion export across plasma membrane 31
Biological Process GO:1903286 regulation of potassium ion import 31
Biological Process GO:0014861 regulation of skeletal muscle contraction via regulation of action potential 43
Biological Process GO:1903782 regulation of sodium ion import across plasma membrane 0 0
Biological Process GO:1902305 regulation of sodium ion transmembrane transport 167
Biological Process GO:0098911 regulation of ventricular cardiac muscle cell action potential 337
Biological Process GO:0060307 regulation of ventricular cardiac muscle cell membrane repolarization 461
Biological Process GO:1903760 regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell 
action potential repolarization 31
Biological Process GO:1903416 response to glycoside 78
Biological Process GO:0086005 ventricular cardiac muscle cell action potential 392
Biological Process GO:0099625 ventricular cardiac muscle cell membrane repolarization 34
Molecular Function GO:0086039 calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane 
potential 10
Molecular Function GO:0086038 calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane 
potential 42
Molecular Function GO:0086081 cell adhesive protein binding involved in atrial cardiac muscle cell-AV node cell communication 0 0
Molecular Function GO:0086084 cell adhesive protein binding involved in Purkinje myocyte-ventricular cardiac muscle cell 
communication 0 0
Molecular Function GO:0086085 cell adhesive protein binding involved in SA cardiac muscle cell-atrial cardiac muscle cell 
communication 0 0
Molecular Function GO:1903763 gap junction channel activity involved in cell communication by electrical coupling 150
Molecular Function GO:0086080 protein binding involved in heterotypic cell-cell adhesion 123
Molecular Function GO:0086037 sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell 
membrane potential 26
Molecular Function GO:0086040 sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane 
potential 1
Molecular Function GO:0097364 stretch-activated, cation-selective, calcium channel activity involved in regulation of action 
potential 0 0
Molecular Function GO:0097365 stretch-activated, cation-selective, calcium channel activity involved in regulation of cardiac 
muscle cell action potential 0 0
Molecular Function GO:0086007 voltage-gated calcium channel activity involved in cardiac muscle cell action potential 76
Molecular Function GO:0086008 voltage-gated potassium channel activity involved in cardiac muscle cell action potential 
repolarization 89
Molecular Function GO:1902282 voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action 
potential repolarization 157
Molecular Function GO:0086006 voltage-gated sodium channel activity involved in cardiac muscle cell action potential 225
Total direct annotations 16,935
Supplemental Table Vi. hA-VCMs protein list. The 200 most abundant transcripts in hA-VCMs, as 
compared to hESCs transcripts, as listed by Poon et al.19   
 









































































































































































































Supplemental Table Vii. hA-VCMs BinGO 2016. BinGO analysis of the adult ventricular 
cardiomyocyte (hA-VCMs) data19 using the 2016 GO annotation dataset. x is the number of IDs in both 
the submitted list and associated with the GO term, n indicates the number of protein IDs associated 
with the GO term, X is the number of protein IDs submitted for analysis, N is the number of protein 
IDs used as the background set. 
 
GO-ID GO term p-value corr p-value x n X N Proteins submitted in analysis that are associated with the GO term
GO:0000027 ribosomal large subunit assembly 2.49E-09 3.37E-08 6 24 190 35980 Q02878|P63173|P39023|P83731|P62913|P46777
GO:0000028 ribosomal small subunit assembly 5.13E-10 7.26E-09 6 19 190 35980 P42677|P63173|P08708|P62263|P46783|P39019
GO:0000075 cell cycle checkpoint 1.57E-02 4.33E-02 5 275 190 35980 P0CG47|P62987|P83731|P62979|P0CG48
GO:0000077 DNA damage checkpoint 1.28E-02 3.77E-02 4 170 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0000082 G1/S transition of mitotic cell cycle 2.50E-03 1.02E-02 5 176 190 35980 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0000086 G2/M transition of mitotic cell cycle 6.95E-03 2.33E-02 4 142 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0000165 MAPK cascade 1.39E-03 6.35E-03 8 401 190 35980 P0CG47|P51452|Q14116|P62987|P62979|P02511|P62158|P0CG48





GO:0000186 activation of MAPKK activity 1.96E-03 8.37E-03 6 244 190 35980 P0CG47|P62987|P62979|P62158|P25116|P0CG48
GO:0000187 activation of MAPK activity 1.32E-04 8.21E-04 6 146 190 35980 P0CG47|P60033|P62987|P62979|P00441|P0CG48
GO:0000271 polysaccharide biosynthetic process 1.13E-04 7.13E-04 4 47 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0000302 response to reactive oxygen species 1.97E-07 2.07E-06 10 210 190 35980 P02144|P05090|P13639|P68871|P09493|P22352|P02511|P69905|P00441|P01034
GO:0000422 mitophagy 6.34E-06 5.43E-05 8 183 190 35980 P0CG47|P52179|Q9P0U1|P40925|P62987|P62979|P10176|P0CG48
GO:0000423 macromitophagy 1.68E-06 1.57E-05 8 153 190 35980 P0CG47|P52179|Q9P0U1|P40925|P62987|P62979|P10176|P0CG48
GO:0000462 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 3.45E-04 1.91E-03 3 26 190 35980 P62263|P62249|P39019
GO:0000715 nucleotide-excision repair, DNA damage recognition 5.12E-06 4.49E-05 4 22 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0000724 double-strand break repair via homologous recombination 8.20E-03 2.68E-02 4 149 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0000725 recombinational repair 8.39E-03 2.72E-02 4 150 190 35980 P0CG47|P62987|P62979|P0CG48






GO:0001503 ossification 5.25E-04 2.73E-03 7 263 190 35980 P63244|P63173|P08493|Q14192|P62280|P17535|P06576
GO:0001649 osteoblast differentiation 6.10E-04 3.10E-03 5 128 190 35980 P63244|Q14192|P62280|P17535|P06576
GO:0001666 response to hypoxia 5.41E-06 4.72E-05 10 303 190 35980 P0CG47|P02144|P01160|P19021|P62987|P62979|P02511|Q6P6C2|P0CG48|P01034
GO:0001775 cell activation 5.90E-04 3.01E-03 12 737 190 35980 P07602|P01033|Q14116|P09382|P68871|P04275|P62158|P04792|P19105|P25116|P00441|P01034
GO:0001817 regulation of cytokine production 4.56E-04 2.43E-03 11 614 190 35980 P0CG47|Q14116|P05090|P0DMV8|P0DMV9|P62987|P62979|P04792|P25116|P00441|P0CG48
GO:0001818 negative regulation of cytokine production 7.43E-03 2.45E-02 5 228 190 35980 P0CG47|P05090|P62987|P62979|P0CG48
GO:0001819 positive regulation of cytokine production 5.02E-05 3.54E-04 10 393 190 35980 P0CG47|Q14116|P0DMV8|P0DMV9|P62987|P62979|P04792|P25116|P00441|P0CG48





GO:0001932 regulation of protein phosphorylation 2.73E-03 1.09E-02 17 1505 190 35980 P07602|P0CG47|P51452|Q14116|O75116|P19022|P0CG48|P63244|P60033|P62987|P23327|P62979|P62158|P04792|P25116|Q8N335|P00441
GO:0001934 positive regulation of protein phosphorylation 4.24E-03 1.61E-02 13 1057 190 35980 P07602|P0CG47|Q14116|O75116|P19022|P0CG48|P63244|P60033|P62987|P62979|P62158|P25116|P00441
GO:0001959 regulation of cytokine-mediated signaling pathway 1.12E-05 9.10E-05 7 142 190 35980 P0CG47|P63244|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0002026 regulation of the force of heart contraction 5.92E-07 5.93E-06 5 31 190 35980 P10916|P08590|P16615|P13533|P12883
GO:0002027 regulation of heart rate 5.27E-11 7.84E-10 10 90 190 35980 Q14896|O14958|P01160|P09493|P16615|P23327|P62158|P13533|Q8N335|P12883
GO:0002218 activation of innate immune response 2.58E-03 1.05E-02 6 258 190 35980 P0CG47|P51452|P62987|P62979|P62158|P0CG48
GO:0002220 innate immune response activating cell surface receptor 5.09E-04 2.65E-03 5 123 190 35980 P0CG47|P62987|P62979|P62158|P0CG48
GO:0002221 pattern recognition receptor signaling pathway 1.48E-03 6.64E-03 5 156 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002223 stimulatory C-type lectin receptor signaling pathway 4.54E-04 2.43E-03 5 120 190 35980 P0CG47|P62987|P62979|P62158|P0CG48
GO:0002224 toll-like receptor signaling pathway 8.29E-04 4.08E-03 5 137 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002230 positive regulation of defense response to virus by host 3.67E-05 2.69E-04 6 116 190 35980 P52179|P40925|P62987|Q16654|Q6P6C2|P10176
GO:0002262 myeloid cell homeostasis 2.14E-04 1.26E-03 5 102 190 35980 P02144|P08708|P62263|P00441|P39019
GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent 6.95E-03 2.33E-02 4 142 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0002576 platelet degranulation 9.07E-05 5.88E-04 5 85 190 35980 P07602|P01033|P04275|P62158|P00441




GO:0002684 positive regulation of immune system process 5.84E-03 2.01E-02 13 1099 190 35980 P0CG47|P51452|Q14116|P51684|P0DMV8|P0DMV9|P0CG48|P39019|P60033|P09382|P62987|P62979|P62158
GO:0002697 regulation of immune effector process 8.55E-03 2.76E-02 7 434 190 35980 P52179|P40925|P62987|Q16654|Q6P6C2|P10176|P39019
GO:0002753 cytoplasmic pattern recognition receptor signaling 3.09E-05 2.32E-04 4 34 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0002755 MyD88-dependent toll-like receptor signaling pathway 1.46E-04 9.01E-04 5 94 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002756 MyD88-independent toll-like receptor signaling pathway 9.07E-05 5.88E-04 5 85 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002758 innate immune response-activating signal transduction 2.17E-03 9.08E-03 6 249 190 35980 P0CG47|P51452|P62987|P62979|P62158|P0CG48
GO:0002831 regulation of response to biotic stimulus 1.55E-03 6.90E-03 6 233 190 35980 P52179|P40925|P62987|Q16654|Q6P6C2|P10176
GO:0003007 heart morphogenesis 4.59E-09 5.96E-08 12 232 190 35980 O15273|Q14896|P10916|P19429|Q14192|P08590|P09493|P68032|P45379|P13533|P12883|P63316





GO:0003009 skeletal muscle contraction 1.07E-08 1.33E-07 6 30 190 35980 P02144|O15273|P19429|P13639|P12883|P63316





GO:0003013 circulatory system process 6.73E-12 1.06E-10 18 404 190 35980 O15273|Q14896|P10916|P01160|P68032|P13533|P12883|P16860|O14958|P19429|P68871|P08590|P09493|P45379|P25116|Q8N335|P00441|P63316
GO:0003015 heart process 2.21E-17 4.73E-16 14 85 190 35980 O15273|Q14896|P10916|P68032|P13533|P12883|O14958|P19429|P08590|P09493|P45379|Q8N335|P00441|P63316
GO:0003018 vascular process in circulatory system 3.47E-03 1.35E-02 5 190 190 35980 P16860|P01160|P68871|P25116|P00441
GO:0003073 regulation of systemic arterial blood pressure 1.53E-03 6.79E-03 4 93 190 35980 P19429|P01160|P09493|P25116
GO:0003205 cardiac chamber development 7.43E-10 1.03E-08 11 155 190 35980 Q13765|Q14896|P10916|P19429|Q14192|P08590|P09493|P45379|P13533|P12883|P63316
GO:0003206 cardiac chamber morphogenesis 3.29E-10 4.70E-09 10 108 190 35980 Q14896|P10916|P19429|Q14192|P08590|P09493|P45379|P13533|P12883|P63316
GO:0003208 cardiac ventricle morphogenesis 4.89E-11 7.34E-10 9 63 190 35980 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0003229 ventricular cardiac muscle tissue development 4.52E-12 7.42E-11 9 49 190 35980 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0003231 cardiac ventricle development 5.15E-10 7.26E-09 10 113 190 35980 Q13765|Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0005975 carbohydrate metabolic process 4.55E-03 1.71E-02 16 1451 190 35980 P0CG47|P13929|P40926|P04406|P40925|P0CG48|P05090|P00505|P07195|P17174|P62987|Q16654|P62979|P62158|Q8N335|P48735
GO:0005976 polysaccharide metabolic process 1.19E-04 7.48E-04 5 90 190 35980 P0CG47|P62987|P62979|P62158|P0CG48
GO:0005977 glycogen metabolic process 2.68E-05 2.05E-04 5 66 190 35980 P0CG47|P62987|P62979|P62158|P0CG48
GO:0005978 glycogen biosynthetic process 1.85E-05 1.45E-04 4 30 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0005996 monosaccharide metabolic process 1.01E-08 1.27E-07 13 304 190 35980 P0CG47|P13929|P40926|P04406|P40925|P0CG48|P05090|P00505|P17174|P62987|Q16654|P62979|P62158
GO:0006006 glucose metabolic process 1.42E-11 2.20E-10 13 178 190 35980 P0CG47|P13929|P40926|P04406|P40925|P0CG48|P05090|P00505|P17174|P62987|Q16654|P62979|P62158
GO:0006073 cellular glucan metabolic process 2.88E-05 2.17E-04 5 67 190 35980 P0CG47|P62987|P62979|P62158|P0CG48








GO:0006090 pyruvate metabolic process 2.26E-03 9.40E-03 5 172 190 35980 P13929|P04406|P07195|Q16654|P35613






GO:0006094 gluconeogenesis 2.75E-06 2.52E-05 6 74 190 35980 P13929|P00505|P40926|P04406|P40925|P17174
GO:0006099 tricarboxylic acid cycle 2.65E-03 1.06E-02 3 52 190 35980 P40926|P40925|P48735
GO:0006101 citrate metabolic process 3.27E-03 1.28E-02 3 56 190 35980 P40926|P40925|P48735
GO:0006103 2-oxoglutarate metabolic process 1.55E-04 9.48E-04 3 20 190 35980 P00505|P17174|P48735
GO:0006107 oxaloacetate metabolic process 2.42E-07 2.51E-06 4 11 190 35980 P00505|P40926|P40925|P17174
GO:0006112 energy reserve metabolic process 2.82E-04 1.60E-03 6 168 190 35980 P0CG47|P62987|P62979|P62158|P12235|P0CG48
GO:0006119 oxidative phosphorylation 5.13E-20 1.27E-18 16 93 190 35980 O00217|O95169|P51970|O43674|O14561|O00483|O43920|P36542|O95167|P10176|O95178|O96000|P13073|Q8WYQ3|O15239|P20674
GO:0006120 mitochondrial electron transport, NADH to ubiquinone 2.08E-15 4.14E-14 11 50 190 35980 O00217|O95169|P51970|O43674|O14561|O00483|O43920|O95167|O95178|O96000|O15239
GO:0006123 mitochondrial electron transport, cytochrome c to oxygen 1.69E-05 1.33E-04 3 10 190 35980 P13073|P10176|P20674

















GO:0006164 purine nucleotide biosynthetic process 3.16E-07 3.24E-06 10 221 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|P36542|P56381|Q8WYQ3|P06576
GO:0006283 transcription-coupled nucleotide-excision repair 6.17E-04 3.14E-03 4 73 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0006289 nucleotide-excision repair 7.12E-03 2.37E-02 4 143 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0006297 nucleotide-excision repair, DNA gap filling 6.17E-06 5.31E-05 4 23 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0006301 postreplication repair 2.31E-05 1.79E-04 5 64 190 35980 P0CG47|P62987|P62979|Q15004|P0CG48
GO:0006352 DNA-templated transcription, initiation 8.68E-09 1.10E-07 14 359 190 35980 P0CG47|P10606|P09669|P01160|O00483|P14854|P15954|P10176|P0CG48|P13073|P62987|P62979|P24311|P20674
GO:0006364 rRNA processing 4.67E-08 5.28E-07 10 180 190 35980 P42766|P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019
GO:0006366 transcription from RNA polymerase II promoter 4.03E-05 2.90E-04 15 833 190 35980 P0CG47|P10606|P09669|P01160|O00483|P14854|P15954|P10176|P17535|P0CG48|P13073|P62987|P62979|P24311|P20674
GO:0006367 transcription initiation from RNA polymerase II promoter 3.10E-10 4.46E-09 14 277 190 35980 P0CG47|P10606|P09669|P01160|O00483|P14854|P15954|P10176|P0CG48|P13073|P62987|P62979|P24311|P20674
GO:0006396 RNA processing 1.58E-02 4.33E-02 12 1115 190 35980 P42766|P08708|P62263|P18077|P62857|P62913|P46777|Q6P6C2|P62753|P62249|P39019|Q8N8D1




































GO:0006417 regulation of translation 5.45E-04 2.82E-03 9 435 190 35980 P63244|P13639|P63173|P04406|P62263|Q14240|P16989|P04792|P60228























GO:0006595 polyamine metabolic process 1.71E-03 7.50E-03 4 96 190 35980 P54368|P06732|P17540|P17174


































GO:0006732 coenzyme metabolic process 1.40E-02 4.02E-02 7 478 190 35980 P13929|P40926|P04406|Q9NPI5|P07195|P40925|Q8N335
GO:0006733 oxidoreduction coenzyme metabolic process 4.47E-04 2.39E-03 7 256 190 35980 P13929|P40926|P04406|Q9NPI5|P07195|P40925|Q8N335
GO:0006734 NADH metabolic process 1.48E-06 1.41E-05 5 37 190 35980 P13929|P40926|P04406|P40925|Q8N335






GO:0006754 ATP biosynthetic process 5.96E-10 8.36E-09 8 56 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576




















































GO:0006839 mitochondrial transport 2.45E-07 2.54E-06 10 215 190 35980 O75947|P0DMV8|P25705|Q9P0U1|P48047|P18859|P36542|Q9Y6H1|P56381|P06576
GO:0006873 cellular ion homeostasis 5.79E-04 2.96E-03 10 533 190 35980 P13693|P02792|P51684|O14958|P19429|P16615|P23327|P25116|P00441|P06576
GO:0006874 cellular calcium ion homeostasis 1.67E-03 7.33E-03 7 321 190 35980 P13693|P51684|O14958|P19429|P16615|P23327|P25116
GO:0006875 cellular metal ion homeostasis 9.41E-04 4.57E-03 9 470 190 35980 P13693|P02792|P51684|O14958|P19429|P16615|P23327|P25116|P00441






GO:0006914 autophagy 1.02E-04 6.52E-04 10 428 190 35980 P0CG47|P52179|Q9P0U1|P40925|P62987|Q16654|P62979|Q6P6C2|P10176|P0CG48
GO:0006915 apoptotic process 4.33E-03 1.64E-02 14 1185 190 35980 P0CG47|P04406|Q9H3K2|P68032|P12235|P0CG48|Q8N8D1|P63244|P09382|P62987|P62979|P02511|P25116|P01034





GO:0006935 chemotaxis 7.38E-03 2.44E-02 11 880 190 35980 P0CG47|P51684|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P0CG48|P39019




GO:0006937 regulation of muscle contraction 2.42E-15 4.80E-14 16 179 190 35980 Q14896|P10916|P01160|P16615|P12883|O14958|P19429|P08590|P09493|P23327|P62158|P45379|P25116|O14558|P00441|P63316
GO:0006940 regulation of smooth muscle contraction 6.62E-03 2.24E-02 3 72 190 35980 P19429|P25116|P00441
GO:0006941 striated muscle contraction 7.91E-18 1.74E-16 15 101 190 35980 P02144|O15273|Q14896|P10916|P13639|P68032|P13533|P12883|O14958|P19429|P08590|P09493|P45379|Q8N335|P63316
GO:0006942 regulation of striated muscle contraction 6.20E-10 8.65E-09 9 83 190 35980 Q14896|P10916|O14958|P01160|P08590|P16615|P23327|P62158|P12883







GO:0006952 defense response 1.52E-02 4.33E-02 18 1947 190 35980 P0CG47|P51452|P52179|Q14116|P51684|P04406|P40925|Q6P6C2|P10176|P0CG48|P62891|P62987|Q16654|P62979|P62158|Q01628|P25116|P01034
GO:0006977 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest 4.20E-04 2.27E-03 4 66 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0006979 response to oxidative stress 2.80E-08 3.27E-07 15 461 190 35980 O00217|P02144|P0DMV8|P13639|P0DMV9|P16615|P05090|Q9Y3D2|P68871|P09493|P22352|P02511|P69905|P00441|P01034












GO:0007009 plasma membrane organization 1.28E-02 3.76E-02 5 261 190 35980 O75116|P19022|P16615|P35613|P00441




GO:0007015 actin filament organization 1.28E-02 3.77E-02 6 362 190 35980 O15273|Q9Y3D2|P68133|P68032|P63313|P45379
GO:0007093 mitotic cell cycle checkpoint 3.47E-03 1.35E-02 5 190 190 35980 P0CG47|P62987|P83731|P62979|P0CG48
GO:0007167 enzyme linked receptor protein signaling pathway 7.18E-04 3.62E-03 16 1207 190 35980 P0CG47|P51452|P01160|O75116|P13533|P19105|P0CG48|P16860|P60660|P62987|Q16654|P62979|P62158|P17081|P04792|P62753
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway 1.33E-03 6.10E-03 13 923 190 35980
P0CG47|P51452|O75116|P19105|P0CG48|P60660|P62987|Q16654|P62979|
P62158|P17081|P04792|P62753
GO:0007179 transforming growth factor beta receptor signaling 1.31E-02 3.82E-02 4 171 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0007219 Notch signaling pathway 3.61E-04 1.99E-03 6 176 190 35980 P0CG47|P17174|P62987|P62979|P0CG48|P39019
GO:0007220 Notch receptor processing 6.17E-06 5.31E-05 4 23 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0007249 I-kappaB kinase/NF-kappaB signaling 4.37E-05 3.12E-04 5 73 190 35980 P0CG47|O75116|P62987|P62979|P0CG48
GO:0007254 JNK cascade 1.30E-03 6.00E-03 4 89 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0007265 Ras protein signal transduction 1.18E-02 3.48E-02 6 355 190 35980 P0CG47|O75116|P62987|P62979|P62158|P0CG48











GO:0007409 axonogenesis 1.30E-02 3.82E-02 9 705 190 35980 P0CG47|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P0CG48
GO:0007411 axon guidance 4.48E-03 1.68E-02 9 593 190 35980 P0CG47|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P0CG48
GO:0007417 central nervous system development 5.11E-03 1.85E-02 12 957 190 35980 P0CG47|P05090|P84243|P18859|O14949|P19021|P19022|P14854|P62158|P24311|P24752|P01034
GO:0007420 brain development 6.06E-03 2.07E-02 10 737 190 35980 P0CG47|P05090|P84243|P18859|O14949|P19022|P14854|P62158|P24752|P01034
GO:0007507 heart development 3.22E-08 3.74E-07 16 537 190 35980 Q13765|P02144|O15273|Q14896|P10916|P01160|P19021|P68032|P13533|P12883|P19429|Q14192|P08590|P09493|P45379|P63316
GO:0007512 adult heart development 7.72E-05 5.20E-04 3 16 190 35980 O15273|P13533|P12883
GO:0007517 muscle organ development 8.22E-11 1.22E-09 15 300 190 35980 O15273|Q14896|P10916|P13639|P68133|P68032|P13533|P12883|P19429|P60660|P08590|P09493|P02511|P45379|P63316
GO:0007519 skeletal muscle tissue development 5.83E-03 2.01E-02 4 135 190 35980 P13639|P60660|P08590|P68133
GO:0007565 female pregnancy 4.40E-03 1.66E-02 5 201 190 35980 P01160|P19021|P35613|P00441|P01034
GO:0007566 embryo implantation 1.86E-03 8.00E-03 3 46 190 35980 P35613|P00441|P01034
GO:0007568 aging 7.91E-04 3.92E-03 7 282 190 35980 P01033|P13929|P05090|P13639|P02511|P17535|P00441
GO:0007596 blood coagulation 3.41E-05 2.54E-04 12 541 190 35980 P07602|P01033|P84243|P68871|P16615|P04275|P62158|P04792|P35613|P19105|P25116|P00441
GO:0007599 hemostasis 3.73E-05 2.73E-04 12 546 190 35980 P07602|P01033|P84243|P68871|P16615|P04275|P62158|P04792|P35613|P19105|P25116|P00441
GO:0007623 circadian rhythm 2.24E-04 1.30E-03 6 161 190 35980 P0CG47|P62987|P62979|P17535|P0CG48|P01034
GO:0008015 blood circulation 5.95E-12 9.50E-11 18 401 190 35980 O15273|Q14896|P10916|P01160|P68032|P13533|P12883|P16860|O14958|P19429|P68871|P08590|P09493|P45379|P25116|Q8N335|P00441|P63316
GO:0008016 regulation of heart contraction 2.90E-13 5.04E-12 16 243 190 35980 Q14896|P10916|P01160|P16615|P17661|P13533|P12883|O14958|P19429|Q9UBY9|P08590|P09493|P23327|P62158|P45379|Q8N335
























GO:0008217 regulation of blood pressure 7.43E-06 6.20E-05 8 187 190 35980 P16860|P19429|P01160|P68871|P09493|P13533|P25116|P00441
GO:0008219 cell death 7.25E-03 2.41E-02 14 1259 190 35980 P0CG47|P04406|Q9H3K2|P68032|P12235|P0CG48|Q8N8D1|P63244|P09382|P62987|P62979|P02511|P25116|P01034
GO:0008286 insulin receptor signaling pathway 2.33E-04 1.35E-03 8 305 190 35980 P0CG47|P62987|Q16654|P62979|P62158|P17081|P62753|P0CG48
GO:0008406 gonad development 7.84E-03 2.57E-02 5 231 190 35980 P0CG47|P16989|Q13772|P00441|P01034
GO:0008584 male gonad development 6.29E-03 2.14E-02 4 138 190 35980 P0CG47|P16989|Q13772|P01034



































GO:0009060 aerobic respiration 8.71E-04 4.27E-03 4 80 190 35980 P13073|P40926|P40925|P48735


























GO:0009124 nucleoside monophosphate biosynthetic process 4.61E-07 4.65E-06 8 129 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576





GO:0009127 purine nucleoside monophosphate biosynthetic process 6.41E-08 7.07E-07 8 100 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576





GO:0009142 nucleoside triphosphate biosynthetic process 1.55E-07 1.65E-06 8 112 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576





GO:0009145 purine nucleoside triphosphate biosynthetic process 3.94E-08 4.50E-07 8 94 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576





GO:0009152 purine ribonucleotide biosynthetic process 1.73E-07 1.82E-06 10 207 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|P36542|P56381|Q8WYQ3|P06576
GO:0009156 ribonucleoside monophosphate biosynthetic process 2.18E-07 2.27E-06 8 117 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576





GO:0009163 nucleoside biosynthetic process 7.43E-06 6.20E-05 8 187 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576
GO:0009165 nucleotide biosynthetic process 2.47E-06 2.28E-05 11 344 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|Q9NPI5|P36542|P56381|Q8WYQ3|P06576





GO:0009168 purine ribonucleoside monophosphate biosynthetic 6.41E-08 7.07E-07 8 100 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576
GO:0009187 cyclic nucleotide metabolic process 1.29E-02 3.78E-02 3 92 190 35980 P16860|Q08493|P01160





GO:0009201 ribonucleoside triphosphate biosynthetic process 5.92E-08 6.60E-07 8 99 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576





GO:0009206 purine ribonucleoside triphosphate biosynthetic process 3.62E-08 4.17E-07 8 93 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576
GO:0009250 glucan biosynthetic process 1.85E-05 1.45E-04 4 30 190 35980 P0CG47|P62987|P62979|P0CG48





GO:0009260 ribonucleotide biosynthetic process 3.30E-07 3.37E-06 10 222 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|P36542|P56381|Q8WYQ3|P06576
GO:0009266 response to temperature stimulus 2.58E-03 1.05E-02 6 258 190 35980 P0DMV8|P0DMV9|Q9UBY9|P16989|P02511|P00441
GO:0009408 response to heat 2.63E-03 1.06E-02 5 178 190 35980 P0DMV8|P0DMV9|Q9UBY9|P02511|P00441





GO:0009607 response to biotic stimulus 2.11E-03 8.89E-03 13 973 190 35980 P52179|Q14116|P40925|Q6P6C2|P10176|P17535|P13693|P62891|P62987|Q16654|P04792|Q01628|P25116








GO:0009636 response to toxic substance 1.76E-03 7.66E-03 7 324 190 35980 P68871|O14880|P47985|P22352|P69905|P00441|P01034









































GO:0009894 regulation of catabolic process 1.70E-03 7.46E-03 11 723 190 35980 P0CG47|P54368|P01033|P63244|Q05639|P68104|P60033|P62987|P62979|P0CG48|P01034
GO:0009896 positive regulation of catabolic process 5.01E-03 1.85E-02 7 392 190 35980 P0CG47|P54368|P63244|P60033|P62987|P62979|P0CG48




GO:0009967 positive regulation of signal transduction 8.56E-03 2.76E-02 16 1554 190 35980 P07602|P0CG47|Q14116|P0DMV8|P0DMV9|P19022|P0CG48|Q8N8D1|P63244|P60033|P09382|P62987|P62979|P62158|P25116|P00441
GO:0009968 negative regulation of signal transduction 2.12E-04 1.25E-03 17 1192 190 35980 P0CG47|P51452|P0DMV8|P0DMV9|P19022|P16989|Q8N3K9|P0CG48|P13693|P63244|P05090|O14958|P62987|P62979|P62158|P04792|Q8N335





















GO:0009991 response to extracellular stimulus 3.73E-03 1.43E-02 8 471 190 35980 P13073|P13639|P68133|Q16654|P24752|P00441|P39019|P01034








GO:0010035 response to inorganic substance 2.74E-09 3.68E-08 17 517 190 35980 P02144|P13639|P80297|P19021|P68133|P35613|P17535|O14958|Q05639|P68871|P02511|P69905|P62158|P45379|P00441|P63316|P01034
GO:0010038 response to metal ion 2.03E-05 1.58E-04 10 353 190 35980 O14958|P80297|P19021|P68133|P62158|P45379|P35613|P17535|P00441|P63316




GO:0010257 NADH dehydrogenase complex assembly 1.13E-12 1.88E-11 10 62 190 35980 O00217|O95169|P51970|O43674|O14561|O43920|O95167|O95178|O96000|O15239
GO:0010460 positive regulation of heart rate 8.74E-06 7.22E-05 4 25 190 35980 P01160|P09493|P16615|P23327









GO:0010522 regulation of calcium ion transport into cytosol 1.65E-03 7.26E-03 4 95 190 35980 O14958|P23327|P62158|P25116




GO:0010562 positive regulation of phosphorus metabolic process 5.72E-03 1.98E-02 14 1224 190 35980 P07602|P0CG47|Q14116|O75116|P19022|P0CG48|P63244|Q05639|P60033|P62987|P62979|P62158|P25116|P00441










GO:0010608 posttranscriptional regulation of gene expression 2.08E-06 1.93E-05 14 564 190 35980 P0CG47|P0DMV8|P13639|P04406|P16989|P0CG48|P63244|P63173|P62263|P62987|Q14240|P62979|P04792|P60228




GO:0010634 positive regulation of epithelial cell migration 1.79E-02 4.86E-02 3 104 190 35980 P51684|O75116|P04792









GO:0010649 regulation of cell communication by electrical coupling 1.69E-05 1.33E-04 3 10 190 35980 O14958|P23327|P62158
GO:0010803 regulation of tumor necrosis factor-mediated signaling 8.45E-09 1.07E-07 7 50 190 35980 P0CG47|P63244|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0010880 regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum 3.45E-04 1.91E-03 3 26 190 35980 O14958|P23327|P62158
GO:0010881 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion 1.55E-04 9.48E-04 3 20 190 35980 O14958|P23327|P62158
GO:0010882 regulation of cardiac muscle contraction by calcium ion 7.37E-06 6.19E-05 4 24 190 35980 O14958|P16615|P23327|P62158
GO:0010927 cellular component assembly involved in morphogenesis 4.27E-05 3.07E-04 9 309 190 35980 O15273|Q14896|P10916|O14958|P09493|P68133|P68032|P45379|P13533
GO:0010939 regulation of necrotic cell death 7.72E-08 8.36E-07 6 41 190 35980 P0CG47|P62987|P16989|P62979|P12235|P0CG48





GO:0010942 positive regulation of cell death 3.84E-04 2.11E-03 12 702 190 35980 P0CG47|P63244|Q05639|P68871|P62987|P62979|P69905|P62753|P25116|P00441|P0CG48|Q8N8D1
GO:0010959 regulation of metal ion transport 1.18E-02 3.48E-02 6 355 190 35980 O14958|P01160|P23327|P62158|P25116|Q8N335
GO:0012501 programmed cell death 4.97E-03 1.83E-02 14 1204 190 35980 P0CG47|P04406|Q9H3K2|P68032|P12235|P0CG48|Q8N8D1|P63244|P09382|P62987|P62979|P02511|P25116|P01034




GO:0014074 response to purine-containing compound 1.61E-02 4.41E-02 4 182 190 35980 O14958|P35613|P17535|P00441
GO:0014706 striated muscle tissue development 5.02E-12 8.07E-11 16 293 190 35980 O15273|Q14896|P10916|P13639|P01160|P68133|P68032|P13533|P12883|P19429|Q14192|P60660|P08590|P09493|P45379|P63316
GO:0014733 regulation of skeletal muscle adaptation 1.30E-06 1.27E-05 4 16 190 35980 P16615|Q8N3K9|P12883|P63316
GO:0014866 skeletal myofibril assembly 4.99E-06 4.39E-05 3 7 190 35980 O15273|P68133|P68032
GO:0014883 transition between fast and slow fiber 1.19E-05 9.64E-05 3 9 190 35980 P16615|P12883|P63316
GO:0014888 striated muscle adaptation 3.45E-04 1.91E-03 3 26 190 35980 O15273|P01160|P68133






GO:0015669 gas transport 1.24E-03 5.79E-03 3 40 190 35980 P02144|P68871|P69905
GO:0015671 oxygen transport 9.10E-04 4.44E-03 3 36 190 35980 P02144|P68871|P69905










GO:0015985 energy coupled proton transport, down electrochemical 3.33E-09 4.40E-08 7 44 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0015986 ATP synthesis coupled proton transport 3.33E-09 4.40E-08 7 44 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|P06576






















GO:0016051 carbohydrate biosynthetic process 4.20E-08 4.78E-07 10 178 190 35980 P0CG47|P13929|P00505|P40926|P04406|P40925|P17174|P62987|P62979|P0CG48
GO:0016054 organic acid catabolic process 2.39E-03 9.85E-03 6 254 190 35980 P00505|P17174|Q16698|P51857|P24752|Q13011














GO:0016072 rRNA metabolic process 7.76E-08 8.36E-07 10 190 190 35980 P42766|P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019
GO:0016236 macroautophagy 1.82E-06 1.70E-05 10 268 190 35980 P0CG47|P52179|Q9P0U1|P40925|P62987|Q16654|P62979|Q6P6C2|P10176|P0CG48





GO:0016265 death 7.25E-03 2.41E-02 14 1259 190 35980 P0CG47|P04406|Q9H3K2|P68032|P12235|P0CG48|Q8N8D1|P63244|P09382|P62987|P62979|P02511|P25116|P01034











GO:0016485 protein processing 5.21E-03 1.85E-02 6 298 190 35980 P0CG47|P63244|P62987|P62979|P25116|P0CG48
GO:0017015 regulation of transforming growth factor beta receptor 3.30E-03 1.29E-02 4 115 190 35980 P0CG47|P62987|P62979|P0CG48















GO:0019068 virion assembly 4.83E-05 3.41E-04 4 38 190 35980 P0CG47|P62987|P62979|P0CG48






GO:0019082 viral protein processing 3.61E-07 3.67E-06 4 12 190 35980 P0CG47|P62987|P62979|P0CG48





GO:0019216 regulation of lipid metabolic process 1.50E-03 6.70E-03 7 315 190 35980 P07602|P63244|P05090|Q05639|P60033|Q16654|P00441




GO:0019318 hexose metabolic process 1.11E-09 1.53E-08 13 253 190 35980 P0CG47|P13929|P40926|P04406|P40925|P0CG48|P05090|P00505|P17174|P62987|Q16654|P62979|P62158
GO:0019319 hexose biosynthetic process 3.48E-06 3.11E-05 6 77 190 35980 P13929|P00505|P40926|P04406|P40925|P17174
GO:0019362 pyridine nucleotide metabolic process 2.23E-04 1.30E-03 7 228 190 35980 P13929|P40926|P04406|Q9NPI5|P07195|P40925|Q8N335






























GO:0019674 NAD metabolic process 3.03E-07 3.12E-06 7 83 190 35980 P13929|P40926|P04406|Q9NPI5|P07195|P40925|Q8N335





GO:0019722 calcium-mediated signaling 1.99E-03 8.47E-03 4 100 190 35980 O14958|P16615|P23327|P62158
GO:0019725 cellular homeostasis 1.47E-04 9.03E-04 14 831 190 35980 P0CG47|P02792|P51684|P16615|P0CG48|P13693|P63244|O14958|P19429|P09382|P23327|P25116|P00441|P06576








GO:0019932 second-messenger-mediated signaling 1.41E-02 4.06E-02 4 175 190 35980 O14958|P16615|P23327|P62158
GO:0019985 translesion synthesis 7.51E-06 6.26E-05 5 51 190 35980 P0CG47|P62987|P62979|Q15004|P0CG48
GO:0021762 substantia nigra development 1.86E-03 8.00E-03 3 46 190 35980 P18859|P14854|P62158













GO:0022613 ribonucleoprotein complex biogenesis 8.20E-10 1.13E-08 17 477 190 35980 P08708|P18077|P39019|P42677|P42766|Q02878|P63173|P39023|P62263|P46783|P83731|P62857|P62913|P46777|P62753|P60228|P62249
GO:0022618 ribonucleoprotein complex assembly 1.06E-08 1.33E-07 12 250 190 35980 P42677|Q02878|P63173|P08708|P39023|P62263|P46783|P83731|P62913|P46777|P60228|P39019
GO:0022898 regulation of transmembrane transporter activity 5.08E-03 1.85E-02 5 208 190 35980 O14958|P01160|P23327|P62158|Q8N335










GO:0023014 signal transduction by protein phosphorylation 3.68E-03 1.41E-02 8 470 190 35980 P0CG47|P51452|Q14116|P62987|P62979|P02511|P62158|P0CG48





GO:0023056 positive regulation of signaling 1.83E-02 4.94E-02 16 1696 190 35980 P07602|P0CG47|Q14116|P0DMV8|P0DMV9|P19022|P0CG48|Q8N8D1|P63244|P60033|P09382|P62987|P62979|P62158|P25116|P00441




GO:0030003 cellular cation homeostasis 4.72E-04 2.49E-03 10 519 190 35980 P13693|P02792|P51684|O14958|P19429|P16615|P23327|P25116|P00441|P06576




GO:0030036 actin cytoskeleton organization 1.95E-04 1.16E-03 13 751 190 35980 O15273|Q14896|P10916|O75116|P68133|P68032|P13533|O14958|Q9Y3D2|P09493|P63313|P17081|P45379
GO:0030048 actin filament-based movement 3.01E-18 6.74E-17 15 95 190 35980 O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|P19429|P60660|P08590|P09493|P45379|Q8N335|P63316
GO:0030049 muscle filament sliding 1.08E-22 3.13E-21 14 39 190 35980 O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|P19429|P60660|P08590|P09493|P45379|P63316
GO:0030111 regulation of Wnt signaling pathway 1.01E-02 3.16E-02 6 343 190 35980 P0CG47|P63244|P19022|P62987|P62979|P0CG48






GO:0030162 regulation of proteolysis 1.37E-02 3.97E-02 10 835 190 35980 P0CG47|P01033|P63244|Q9NWT8|P62987|P62979|P02511|P25116|P0CG48|P01034
GO:0030168 platelet activation 8.58E-06 7.11E-05 9 252 190 35980 P07602|P01033|P68871|P04275|P62158|P04792|P19105|P25116|P00441
GO:0030177 positive regulation of Wnt signaling pathway 1.33E-02 3.87E-02 4 172 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0030178 negative regulation of Wnt signaling pathway 1.03E-03 4.92E-03 6 215 190 35980 P0CG47|P63244|P19022|P62987|P62979|P0CG48
GO:0030218 erythrocyte differentiation 7.41E-03 2.45E-02 3 75 190 35980 P02144|P62263|P39019
GO:0030239 myofibril assembly 2.25E-11 3.46E-10 9 58 190 35980 O15273|Q14896|P10916|O14958|P09493|P68133|P68032|P45379|P13533
GO:0030240 skeletal muscle thin filament assembly 1.44E-06 1.38E-05 3 5 190 35980 O15273|P68133|P68032
GO:0030260 entry into host cell 1.11E-02 3.31E-02 3 87 190 35980 P0DMV8|P0DMV9|P60033
GO:0030308 negative regulation of cell growth 2.32E-03 9.60E-03 5 173 190 35980 P63244|P16860|P10916|P01160|P02511
GO:0030330 DNA damage response, signal transduction by p53 class 1.53E-03 6.79E-03 4 93 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0030490 maturation of SSU-rRNA 6.42E-04 3.25E-03 3 32 190 35980 P62263|P62249|P39019
GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway 9.13E-04 4.44E-03 4 81 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0030522 intracellular receptor signaling pathway 1.52E-03 6.78E-03 6 232 190 35980 P0CG47|Q14192|P62987|P62979|Q13772|P0CG48
GO:0030901 midbrain development 1.30E-03 6.00E-03 4 89 190 35980 P18859|O14949|P14854|P62158
GO:0031032 actomyosin structure organization 2.77E-09 3.70E-08 9 98 190 35980 O15273|Q14896|P10916|O14958|P09493|P68133|P68032|P45379|P13533
GO:0031098 stress-activated protein kinase signaling cascade 2.39E-04 1.38E-03 6 163 190 35980 P0CG47|P51452|P62987|P62979|P02511|P0CG48
GO:0031145 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process 1.14E-03 5.40E-03 4 86 190 35980 P0CG47|P62987|P62979|P0CG48














GO:0031329 regulation of cellular catabolic process 1.60E-03 7.06E-03 10 610 190 35980 P0CG47|P01033|P63244|Q05639|P68104|P60033|P62987|P62979|P0CG48|P01034
GO:0031331 positive regulation of cellular catabolic process 8.42E-03 2.72E-02 6 330 190 35980 P0CG47|P63244|P60033|P62987|P62979|P0CG48
GO:0031347 regulation of defense response 1.04E-05 8.52E-05 16 835 190 35980 P0CG47|P51452|P52179|Q14116|P0DMV8|P0DMV9|P40925|Q6P6C2|P10176|P0CG48|P39019|P05090|P62987|Q16654|P62979|P62158
GO:0031349 positive regulation of defense response 1.97E-03 8.40E-03 8 424 190 35980 P0CG47|P51452|Q14116|P62987|P62979|P62158|P0CG48|P39019
GO:0031396 regulation of protein ubiquitination 5.13E-03 1.85E-02 6 297 190 35980 P0CG47|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0031397 negative regulation of protein ubiquitination 1.82E-04 1.09E-03 6 155 190 35980 P0CG47|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0031398 positive regulation of protein ubiquitination 1.55E-02 4.33E-02 4 180 190 35980 P0CG47|P62987|P62979|P0CG48




GO:0031400 negative regulation of protein modification process 6.92E-05 4.74E-04 13 676 190 35980 P0CG47|P51452|P0DMV8|P0DMV9|O75116|Q8N3K9|P0CG48|P63244|P62987|P62979|P62158|P04792|Q8N335
GO:0031401 positive regulation of protein modification process 8.05E-03 2.64E-02 14 1275 190 35980 P07602|P0CG47|Q14116|Q969T9|O75116|P19022|P0CG48|P63244|P60033|P62987|P62979|P62158|P25116|P00441
GO:0031570 DNA integrity checkpoint 1.58E-02 4.33E-02 4 181 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0031571 mitotic G1 DNA damage checkpoint 7.92E-04 3.92E-03 4 78 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0031647 regulation of protein stability 5.95E-03 2.04E-02 5 216 190 35980 P0DMV8|P0DMV9|Q9P0U1|P60033|P04406
GO:0031960 response to corticosteroid 2.75E-03 1.10E-02 5 180 190 35980 P41222|P19021|P17174|P62158|Q8N8D1
GO:0032101 regulation of response to external stimulus 1.43E-03 6.49E-03 13 931 190 35980 P52179|Q14116|P51684|P40925|Q6P6C2|P10176|P39019|P05090|P62987|Q16654|P62158|P04792|P25116
GO:0032147 activation of protein kinase activity 4.89E-03 1.81E-02 8 493 190 35980 P0CG47|P60033|P62987|P62979|P62158|P25116|P00441|P0CG48





GO:0032269 negative regulation of cellular protein metabolic process 1.01E-04 6.52E-04 18 1231 190 35980 P0CG47|P51452|P01033|P0DMV8|P0DMV9|P04406|O75116|Q8N3K9|P0CG48|P63244|P62987|P62979|P02511|P62158|P04792|P60228|Q8N335|P01034
GO:0032270 positive regulation of cellular protein metabolic process 3.84E-03 1.47E-02 17 1557 190 35980 P07602|P0CG47|Q14116|P13639|Q969T9|O75116|P19022|P16989|P0CG48|P63244|Q9NWT8|P60033|P62987|P62979|P62158|P25116|P00441
GO:0032355 response to estradiol 8.20E-03 2.68E-02 4 149 190 35980 P13639|P19021|P02511|P01034
GO:0032386 regulation of intracellular transport 2.52E-07 2.60E-06 16 625 190 35980 P54368|Q14116|Q14896|P0DMV8|Q9P0U1|P16615|P63244|P05090|O14958|Q02818|P23327|P02511|P62158|P45379|P25116|P63316
GO:0032387 negative regulation of intracellular transport 1.10E-03 5.23E-03 5 146 190 35980 P05090|O14958|P0DMV8|P02511|P62158
GO:0032388 positive regulation of intracellular transport 1.32E-02 3.83E-02 6 364 190 35980 P54368|Q14116|P63244|Q9P0U1|P62158|P25116
GO:0032409 regulation of transporter activity 6.66E-03 2.25E-02 5 222 190 35980 O14958|P01160|P23327|P62158|Q8N335
GO:0032412 regulation of ion transmembrane transporter activity 4.69E-03 1.75E-02 5 204 190 35980 O14958|P01160|P23327|P62158|Q8N335
GO:0032479 regulation of type I interferon production 4.57E-03 1.71E-02 4 126 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0032480 negative regulation of type I interferon production 1.03E-04 6.61E-04 4 46 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0032481 positive regulation of type I interferon production 1.30E-03 6.00E-03 4 89 190 35980 P0CG47|P62987|P62979|P0CG48

















GO:0032677 regulation of interleukin-8 production 4.17E-03 1.58E-02 3 61 190 35980 P0DMV8|P0DMV9|P25116
GO:0032757 positive regulation of interleukin-8 production 1.75E-03 7.63E-03 3 45 190 35980 P0DMV8|P0DMV9|P25116








GO:0032781 positive regulation of ATPase activity 7.91E-05 5.31E-04 4 43 190 35980 Q14896|P08590|P09493|P45379
GO:0032787 monocarboxylic acid metabolic process 9.66E-05 6.24E-04 13 699 190 35980 P13929|P04406|O14561|P19021|P51857|P35613|P41222|P00505|P07195|Q16654|Q16698|Q13011|P48735
GO:0032844 regulation of homeostatic process 3.97E-03 1.51E-02 8 476 190 35980 P63244|P16860|O14958|Q16654|P23327|P62158|P25116|Q8N335
GO:0032868 response to insulin 1.10E-04 6.99E-04 10 432 190 35980 P0CG47|P01160|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P0CG48
GO:0032869 cellular response to insulin stimulus 1.74E-04 1.05E-03 9 372 190 35980 P0CG47|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P0CG48
GO:0032870 cellular response to hormone stimulus 1.85E-04 1.10E-03 14 850 190 35980 P0CG47|Q969T9|O75116|P17535|P0CG48|Q14192|P17174|P62987|Q16654|P62979|Q13772|P62158|P17081|P62753





GO:0032880 regulation of protein localization 3.39E-03 1.33E-02 13 1029 190 35980 P54368|Q14116|Q08493|Q9P0U1|P19021|P19022|P12235|P63244|P05090|Q02818|P17081|P25116|Q8N335
GO:0032970 regulation of actin filament-based process 3.15E-03 1.24E-02 8 458 190 35980 Q14896|P09493|O75116|P19021|P16615|P17081|P45379|P63316
GO:0032971 regulation of muscle filament sliding 5.78E-07 5.80E-06 3 4 190 35980 Q14896|P45379|P63316
GO:0032981 mitochondrial respiratory chain complex I assembly 1.13E-12 1.88E-11 10 62 190 35980 O00217|O95169|P51970|O43674|O14561|O43920|O95167|O95178|O96000|O15239
















GO:0033108 mitochondrial respiratory chain complex assembly 4.71E-11 7.10E-10 10 89 190 35980 O00217|O95169|P51970|O43674|O14561|O43920|O95167|O95178|O96000|O15239
GO:0033157 regulation of intracellular protein transport 1.63E-02 4.46E-02 6 382 190 35980 P54368|Q14116|P63244|P05090|Q9P0U1|Q02818
GO:0033209 tumor necrosis factor-mediated signaling pathway 1.44E-03 6.49E-03 5 155 190 35980 P0CG47|P63244|P62987|P62979|P0CG48
GO:0033275 actin-myosin filament sliding 1.08E-22 3.13E-21 14 39 190 35980 O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|P19429|P60660|P08590|P09493|P45379|P63316










GO:0033674 positive regulation of kinase activity 1.00E-02 3.16E-02 9 675 190 35980 P0CG47|Q05639|P60033|P62987|P62979|P62158|P25116|P00441|P0CG48
GO:0033683 nucleotide-excision repair, DNA incision 5.36E-05 3.72E-04 4 39 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0033692 cellular polysaccharide biosynthetic process 8.67E-05 5.65E-04 4 44 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0033993 response to lipid 5.80E-06 5.02E-05 18 989 190 35980 Q14116|P13639|Q969T9|O75116|P19021|P68133|Q08431|P17535|Q8N8D1|P41222|Q14192|P17174|Q16654|P02511|Q13772|P62158|P25116|P01034
GO:0034097 response to cytokine 2.25E-04 1.31E-03 15 974 190 35980 P0CG47|P01033|P51684|P04406|P80297|P68363|P16989|P17535|P0CG48|P63244|P39023|P62987|Q14240|P62979|Q01628
GO:0034101 erythrocyte homeostasis 1.00E-03 4.79E-03 4 83 190 35980 P02144|P08708|P62263|P39019
GO:0034103 regulation of tissue remodeling 5.65E-03 1.96E-02 3 68 190 35980 Q14116|Q16654|P01034
GO:0034134 toll-like receptor 2 signaling pathway 5.66E-05 3.91E-04 5 77 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034138 toll-like receptor 3 signaling pathway 1.01E-04 6.52E-04 5 87 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034142 toll-like receptor 4 signaling pathway 2.35E-04 1.35E-03 5 104 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034146 toll-like receptor 5 signaling pathway 3.33E-05 2.48E-04 5 69 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034162 toll-like receptor 9 signaling pathway 5.31E-05 3.71E-04 5 76 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034166 toll-like receptor 10 signaling pathway 3.57E-05 2.63E-04 5 70 190 35980 P0CG47|P51452|P62987|P62979|P0CG48





GO:0034248 regulation of cellular amide metabolic process 8.35E-04 4.09E-03 9 462 190 35980 P63244|P13639|P63173|P04406|P62263|Q14240|P16989|P04792|P60228
GO:0034470 ncRNA processing 1.99E-04 1.18E-03 10 465 190 35980 P42766|P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019
GO:0034599 cellular response to oxidative stress 1.21E-03 5.67E-03 6 222 190 35980 P0DMV8|P0DMV9|P09493|P16615|P00441|P01034
GO:0034612 response to tumor necrosis factor 3.41E-03 1.33E-02 6 273 190 35980 P0CG47|P63244|P62987|P16989|P62979|P0CG48











GO:0034637 cellular carbohydrate biosynthetic process 1.97E-05 1.54E-04 5 62 190 35980 P0CG47|P17174|P62987|P62979|P0CG48






































GO:0034660 ncRNA metabolic process 1.70E-03 7.46E-03 11 723 190 35980 P42766|Q9NSD9|P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019
GO:0034762 regulation of transmembrane transport 9.86E-03 3.11E-02 8 557 190 35980 P54368|O14958|Q9Y277|P01160|P23327|P62158|P25116|Q8N335
GO:0034763 negative regulation of transmembrane transport 1.22E-02 3.60E-02 3 90 190 35980 P54368|O14958|P62158
GO:0035051 cardiocyte differentiation 3.85E-05 2.81E-04 6 117 190 35980 O15273|P10916|Q14192|P01160|P68032|P13533
GO:0035150 regulation of tube size 1.99E-03 8.47E-03 5 167 190 35980 P16860|P01160|P68871|P25116|P00441
GO:0035637 multicellular organismal signaling 2.26E-03 9.40E-03 5 172 190 35980 O14958|P19429|P01160|P16615|P00441
GO:0035666 TRIF-dependent toll-like receptor signaling pathway 7.21E-05 4.89E-04 5 81 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0035872 nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway 1.03E-04 6.61E-04 4 46 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0036293 response to decreased oxygen levels 6.99E-06 5.91E-05 10 312 190 35980 P0CG47|P02144|P01160|P19021|P62987|P62979|P02511|Q6P6C2|P0CG48|P01034
GO:0036294 cellular response to decreased oxygen levels 6.78E-03 2.28E-02 4 141 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0036297 interstrand cross-link repair 7.21E-05 4.89E-04 4 42 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0038061 NIK/NF-kappaB signaling 1.92E-03 8.23E-03 4 99 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0038123 toll-like receptor TLR1:TLR2 signaling pathway 5.31E-05 3.71E-04 5 76 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0038124 toll-like receptor TLR6:TLR2 signaling pathway 5.31E-05 3.71E-04 5 76 190 35980 P0CG47|P51452|P62987|P62979|P0CG48
GO:0040008 regulation of growth 3.51E-04 1.94E-03 12 695 190 35980 Q13765|P63244|P16860|P10916|P84243|P60033|P01160|P80297|P16989|P02511|P13533|P00441
GO:0040011 locomotion 4.58E-03 1.71E-02 17 1585 190 35980 P0CG47|P51684|P0DMV8|P0DMV9|O75116|P19022|P35613|P19105|P0CG48|P39019|P60033|P60660|P62987|P83731|P62979|P62158|P06576
GO:0040012 regulation of locomotion 4.51E-03 1.69E-02 11 822 190 35980 P01033|P63244|P05090|P51684|P60033|P09382|P09493|O75116|P04792|Q01628|P25116
GO:0042058 regulation of epidermal growth factor receptor signaling 9.56E-04 4.63E-03 4 82 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0042059 negative regulation of epidermal growth factor receptor 7.21E-05 4.89E-04 4 42 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0042060 wound healing 1.32E-06 1.28E-05 16 709 190 35980 P07602|Q13765|P01033|P13929|P16615|P35613|P19105|P05090|P84243|P68871|P09493|P04275|P62158|P04792|P25116|P00441
GO:0042176 regulation of protein catabolic process 4.17E-04 2.26E-03 9 419 190 35980 P0CG47|P54368|P01033|P63244|P60033|P62987|P62979|P0CG48|P01034










GO:0042246 tissue regeneration 3.98E-03 1.51E-02 3 60 190 35980 Q13765|P13929|P05090
GO:0042254 ribosome biogenesis 5.02E-12 8.07E-11 16 293 190 35980 P08708|P18077|P39019|P42677|P42766|Q02878|P63173|P39023|P62263|P46783|P83731|P62857|P62913|P46777|P62753|P62249
GO:0042255 ribosome assembly 3.22E-14 6.07E-13 11 63 190 35980 P42677|Q02878|P63173|P08708|P39023|P62263|P46783|P83731|P62913|P46777|P39019
GO:0042273 ribosomal large subunit biogenesis 2.32E-10 3.34E-09 8 50 190 35980 P42766|Q02878|P63173|P39023|P18077|P83731|P62913|P46777
GO:0042274 ribosomal small subunit biogenesis 6.63E-12 1.05E-10 9 51 190 35980 P42677|P63173|P08708|P62263|P46783|P62857|P62753|P62249|P39019
GO:0042276 error-prone translesion synthesis 2.74E-06 2.52E-05 4 19 190 35980 P0CG47|P62987|P62979|P0CG48





GO:0042325 regulation of phosphorylation 2.58E-03 1.05E-02 18 1628 190 35980 P07602|P0CG47|P51452|Q14116|O75116|P19022|P0CG48|P63244|Q05639|P60033|P62987|P23327|P62979|P62158|P04792|P25116|Q8N335|P00441
GO:0042327 positive regulation of phosphorylation 2.24E-03 9.31E-03 14 1100 190 35980 P07602|P0CG47|Q14116|O75116|P19022|P0CG48|P63244|Q05639|P60033|P62987|P62979|P62158|P25116|P00441
GO:0042330 taxis 7.38E-03 2.44E-02 11 880 190 35980 P0CG47|P51684|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P0CG48|P39019
GO:0042391 regulation of membrane potential 3.72E-03 1.43E-02 7 371 190 35980 P0CG47|P63244|O14958|P01160|P16615|Q8N335|P00441
GO:0042451 purine nucleoside biosynthetic process 1.45E-06 1.38E-05 8 150 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576
GO:0042455 ribonucleoside biosynthetic process 4.96E-06 4.38E-05 8 177 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576
GO:0042493 response to drug 3.57E-05 2.63E-04 11 458 190 35980 P13929|P05090|P13639|P09382|P19021|P47985|P37108|P68032|P17535|P00441|P01034
GO:0042542 response to hydrogen peroxide 2.78E-06 2.53E-05 7 115 190 35980 P02144|P13639|P68871|P02511|P69905|P00441|P01034
GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I 7.65E-03 2.52E-02 4 146 190 35980 P0CG47|P62987|P62979|P0CG48




GO:0042692 muscle cell differentiation 5.11E-11 7.63E-10 15 290 190 35980 Q14315|O15273|Q14896|P10916|P01160|P19022|P68133|P16615|P68032|P13533|O14958|Q14192|P09382|P09493|P45379
GO:0042743 hydrogen peroxide metabolic process 2.41E-05 1.85E-04 4 32 190 35980 P68871|P22352|P69905|P00441
GO:0042744 hydrogen peroxide catabolic process 1.32E-04 8.21E-04 3 19 190 35980 P68871|P22352|P69905
GO:0042769 DNA damage response, detection of DNA damage 3.89E-05 2.81E-04 4 36 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0042770 signal transduction in response to DNA damage 2.63E-03 1.06E-02 4 108 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0042773 ATP synthesis coupled electron transport 1.55E-17 3.37E-16 14 83 190 35980 O00217|O95169|P51970|O43674|O14561|O00483|O43920|O95167|P10176|O95178|O96000|P13073|O15239|P20674
GO:0042775 mitochondrial ATP synthesis coupled electron transport 5.07E-18 1.12E-16 14 77 190 35980 O00217|O95169|P51970|O43674|O14561|O00483|O43920|O95167|P10176|O95178|O96000|P13073|O15239|P20674
GO:0042776 mitochondrial ATP synthesis coupled proton transport 4.89E-12 7.99E-11 7 19 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|P06576











GO:0043065 positive regulation of apoptotic process 2.73E-03 1.09E-02 10 657 190 35980 P0CG47|P63244|Q05639|P62987|P62979|P62753|P25116|P00441|P0CG48|Q8N8D1
GO:0043066 negative regulation of apoptotic process 2.93E-06 2.66E-05 18 941 190 35980 P0CG47|Q13765|P01033|P0DMV8|P0DMV9|P16989|P68032|P0CG48|P13693|Q14192|P62987|P61247|Q16654|P62979|P02511|P04792|P25116|P00441




GO:0043068 positive regulation of programmed cell death 2.88E-03 1.14E-02 10 662 190 35980 P0CG47|P63244|Q05639|P62987|P62979|P62753|P25116|P00441|P0CG48|Q8N8D1




GO:0043086 negative regulation of catalytic activity 4.54E-05 3.23E-04 17 1048 190 35980 P0CG47|P51452|P54368|P01033|O75116|Q8N3K9|P0CG48|P63244|P19429|P62987|Q14240|P62979|P02511|P04792|P45379|Q8WYQ3|P01034
GO:0043122 regulation of I-kappaB kinase/NF-kappaB signaling 5.62E-05 3.89E-04 8 248 190 35980 P0CG47|Q14116|P09382|P62987|P62979|P04792|P25116|P0CG48
GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB 7.95E-05 5.33E-04 7 193 190 35980 P0CG47|Q14116|P09382|P62987|P62979|P25116|P0CG48












GO:0043207 response to external biotic stimulus 1.43E-03 6.49E-03 13 931 190 35980 P52179|Q14116|P40925|Q6P6C2|P10176|P17535|P13693|P62891|P62987|Q16654|P04792|Q01628|P25116





GO:0043405 regulation of MAP kinase activity 1.31E-03 6.05E-03 9 493 190 35980 P0CG47|P51452|P60033|P62987|P62979|P62158|P25116|P00441|P0CG48
GO:0043406 positive regulation of MAP kinase activity 1.05E-03 5.03E-03 6 216 190 35980 P0CG47|P60033|P62987|P62979|P00441|P0CG48
GO:0043408 regulation of MAPK cascade 5.56E-03 1.93E-02 11 846 190 35980 P07602|P0CG47|P51452|P60033|P19022|P62987|P62979|P62158|P25116|P00441|P0CG48
GO:0043410 positive regulation of MAPK cascade 2.31E-03 9.57E-03 10 642 190 35980 P07602|P0CG47|P60033|P19022|P62987|P62979|P62158|P25116|P00441|P0CG48
GO:0043434 response to peptide hormone 6.75E-07 6.71E-06 15 591 190 35980 P0CG47|P01033|P01160|P16615|P35613|P17535|P0CG48|P17174|P08574|P62987|Q16654|P62979|P62158|P17081|P62753








GO:0043462 regulation of ATPase activity 5.51E-08 6.20E-07 7 65 190 35980 Q14896|P19429|P08590|P09493|P45379|P13533|P63316
GO:0043487 regulation of RNA stability 1.22E-05 9.89E-05 7 144 190 35980 P0CG47|P0DMV8|P62987|P16989|P62979|P04792|P0CG48
GO:0043488 regulation of mRNA stability 1.02E-05 8.39E-05 7 140 190 35980 P0CG47|P0DMV8|P62987|P16989|P62979|P04792|P0CG48
GO:0043500 muscle adaptation 6.42E-04 3.25E-03 3 32 190 35980 O15273|P01160|P68133
GO:0043502 regulation of muscle adaptation 5.55E-04 2.86E-03 4 71 190 35980 P16615|Q8N3K9|P12883|P63316
GO:0043549 regulation of kinase activity 8.60E-03 2.76E-02 12 1025 190 35980 P0CG47|P51452|P63244|Q05639|P60033|P62987|P62979|P62158|P04792|P25116|P00441|P0CG48














GO:0043618 regulation of transcription from RNA polymerase II promoter in response to stress 3.31E-04 1.86E-03 4 62 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0043620 regulation of DNA-templated transcription in response to 4.45E-04 2.39E-03 4 67 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0043623 cellular protein complex assembly 1.61E-08 1.99E-07 15 442 190 35980 O00217|O15273|Q14896|O95169|P51970|O43674|O14561|O43920|O95167|O95178|O96000|O14958|Q9Y3D2|P02511|O15239





GO:0043627 response to estrogen 1.39E-03 6.35E-03 6 228 190 35980 P13639|Q969T9|P19021|P02511|Q08431|P01034
GO:0043648 dicarboxylic acid metabolic process 3.45E-04 1.91E-03 5 113 190 35980 P00505|P40926|P40925|P17174|P48735
GO:0043666 regulation of phosphoprotein phosphatase activity 1.37E-02 3.96E-02 3 94 190 35980 O75116|Q8N3K9|P62158
GO:0043900 regulation of multi-organism process 3.47E-04 1.92E-03 10 499 190 35980 P52179|P01033|P41222|P09382|P40925|P62987|Q16654|Q6P6C2|P10176|Q01628















GO:0044042 glucan metabolic process 2.88E-05 2.17E-04 5 67 190 35980 P0CG47|P62987|P62979|P62158|P0CG48













































































GO:0044262 cellular carbohydrate metabolic process 1.19E-04 7.49E-04 7 206 190 35980 P0CG47|P17174|P62987|P62979|P62158|P0CG48|P48735
GO:0044264 cellular polysaccharide metabolic process 8.10E-05 5.40E-04 5 83 190 35980 P0CG47|P62987|P62979|P62158|P0CG48












































GO:0044282 small molecule catabolic process 1.02E-03 4.89E-03 8 382 190 35980 P13929|P00505|P04406|P17174|Q16698|P51857|P24752|Q13011
GO:0044283 small molecule biosynthetic process 1.58E-03 6.98E-03 10 609 190 35980 P13929|P41222|P00505|P40926|P04406|O14561|P40925|P17174|P51857|P24752






GO:0044409 entry into host 1.11E-02 3.31E-02 3 87 190 35980 P0DMV8|P0DMV9|P60033



























GO:0044706 multi-multicellular organism process 1.10E-02 3.29E-02 5 251 190 35980 P01160|P19021|P35613|P00441|P01034
































GO:0044723 single-organism carbohydrate metabolic process 1.26E-03 5.88E-03 14 1034 190 35980 P0CG47|P13929|P40926|P04406|P40925|P0CG48|P05090|P00505|P17174|P62987|Q16654|P62979|P62158|P48735





































GO:0044766 multi-organism transport 3.89E-05 2.81E-04 4 36 190 35980 P0CG47|P62987|P62979|P0CG48








GO:0044770 cell cycle phase transition 6.77E-03 2.28E-02 6 315 190 35980 P0CG47|P62987|Q9Y5N6|P83731|P62979|P0CG48
GO:0044772 mitotic cell cycle phase transition 6.38E-03 2.17E-02 6 311 190 35980 P0CG47|P62987|Q9Y5N6|P83731|P62979|P0CG48
GO:0044773 mitotic DNA damage checkpoint 2.22E-03 9.26E-03 4 103 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0044774 mitotic DNA integrity checkpoint 2.81E-03 1.12E-02 4 110 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0044783 G1 DNA damage checkpoint 8.31E-04 4.08E-03 4 79 190 35980 P0CG47|P62987|P62979|P0CG48






GO:0044819 mitotic G1/S transition checkpoint 8.31E-04 4.08E-03 4 79 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0044839 cell cycle G2/M phase transition 6.95E-03 2.33E-02 4 142 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0044843 cell cycle G1/S phase transition 2.50E-03 1.02E-02 5 176 190 35980 P0CG47|P62987|Q9Y5N6|P62979|P0CG48





GO:0045088 regulation of innate immune response 5.02E-04 2.62E-03 9 430 190 35980 P0CG47|P51452|P0DMV8|P0DMV9|P62987|P62979|P62158|P0CG48|P39019
GO:0045089 positive regulation of innate immune response 1.34E-03 6.17E-03 7 309 190 35980 P0CG47|P51452|P62987|P62979|P62158|P0CG48|P39019
GO:0045137 development of primary sexual characteristics 8.55E-03 2.76E-02 5 236 190 35980 P0CG47|P16989|Q13772|P00441|P01034






GO:0045214 sarcomere organization 3.42E-08 3.96E-07 6 36 190 35980 O15273|Q14896|O14958|P09493|P45379|P13533





GO:0045471 response to ethanol 6.95E-03 2.33E-02 4 142 190 35980 P13639|P00505|P68032|P00441
GO:0045732 positive regulation of protein catabolic process 4.90E-04 2.57E-03 7 260 190 35980 P0CG47|P54368|P63244|P60033|P62987|P62979|P0CG48
GO:0045787 positive regulation of cell cycle 1.40E-02 4.02E-02 6 369 190 35980 P0CG47|P51452|O75116|P62987|P62979|P0CG48
GO:0045823 positive regulation of heart contraction 3.89E-05 2.81E-04 4 36 190 35980 P01160|P09493|P16615|P23327
GO:0045859 regulation of protein kinase activity 1.29E-02 3.79E-02 11 954 190 35980 P0CG47|P51452|P63244|P60033|P62987|P62979|P62158|P04792|P25116|P00441|P0CG48
GO:0045862 positive regulation of proteolysis 3.72E-03 1.43E-02 7 371 190 35980 P0CG47|P63244|Q9NWT8|P62987|P62979|P25116|P0CG48
GO:0045893 positive regulation of transcription, DNA-templated 9.65E-03 3.05E-02 16 1575 190 35980 P0CG47|Q13765|P0DMV8|P0DMV9|Q969T9|Q8TAK5|Q9Y6H1|P17535|P0CG48|P60033|Q14192|P62987|P62979|Q13772|P17081|P25116
GO:0045926 negative regulation of growth 2.04E-03 8.66E-03 6 246 190 35980 P63244|P16860|P10916|P01160|P80297|P02511
GO:0045930 negative regulation of mitotic cell cycle 3.17E-03 1.25E-02 6 269 190 35980 P0CG47|Q9NWT8|P62987|P83731|P62979|P0CG48




GO:0045937 positive regulation of phosphate metabolic process 5.72E-03 1.98E-02 14 1224 190 35980 P07602|P0CG47|Q14116|O75116|P19022|P0CG48|P63244|Q05639|P60033|P62987|P62979|P62158|P25116|P00441










GO:0046129 purine ribonucleoside biosynthetic process 1.45E-06 1.38E-05 8 150 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576
GO:0046364 monosaccharide biosynthetic process 5.79E-06 5.02E-05 6 84 190 35980 P13929|P00505|P40926|P04406|P40925|P17174
GO:0046390 ribose phosphate biosynthetic process 3.73E-07 3.78E-06 10 225 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|P36542|P56381|Q8WYQ3|P06576
GO:0046395 carboxylic acid catabolic process 2.39E-03 9.85E-03 6 254 190 35980 P00505|P17174|Q16698|P51857|P24752|Q13011












GO:0046496 nicotinamide nucleotide metabolic process 2.23E-04 1.30E-03 7 228 190 35980 P13929|P40926|P04406|Q9NPI5|P07195|P40925|Q8N335
GO:0046546 development of primary male sexual characteristics 6.29E-03 2.14E-02 4 138 190 35980 P0CG47|P16989|Q13772|P01034
GO:0046620 regulation of organ growth 1.01E-02 3.17E-02 3 84 190 35980 P16989|P13533|P00441
GO:0046661 male sex differentiation 1.11E-02 3.32E-02 4 163 190 35980 P0CG47|P16989|Q13772|P01034






GO:0046718 viral entry into host cell 1.08E-02 3.25E-02 3 86 190 35980 P0DMV8|P0DMV9|P60033
GO:0046794 transport of virus 3.47E-05 2.57E-04 4 35 190 35980 P0CG47|P62987|P62979|P0CG48








GO:0048010 vascular endothelial growth factor receptor signaling 9.88E-04 4.75E-03 7 293 190 35980 P0CG47|O75116|P62987|P62979|P62158|P04792|P0CG48





GO:0048511 rhythmic process 1.02E-05 8.41E-05 10 326 190 35980 P0CG47|P63244|O75116|P19021|P62987|P62979|P17535|P00441|P0CG48|P01034



































GO:0048545 response to steroid hormone 2.99E-06 2.71E-05 14 582 190 35980 P13639|Q969T9|O75116|P19021|P68133|Q08431|Q8N8D1|P41222|Q14192|P17174|P02511|Q13772|P62158|P01034










GO:0048608 reproductive structure development 2.61E-03 1.06E-02 8 444 190 35980 P07602|P0CG47|P16989|P04275|Q13772|P35613|P00441|P01034
GO:0048644 muscle organ morphogenesis 2.83E-13 4.94E-12 11 76 190 35980 O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P45379|P13533|P12883|P63316
GO:0048646 anatomical structure formation involved in morphogenesis 2.47E-03 1.01E-02 14 1112 190 35980 Q14116|O15273|Q14896|P10916|P68133|P68032|P13533|Q08431|P05090|O14958|Q14192|P09493|P45379|P06576
GO:0048666 neuron development 1.55E-02 4.33E-02 12 1112 190 35980 P0CG47|P05090|O14949|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P00441|P0CG48
GO:0048667 cell morphogenesis involved in neuron differentiation 7.06E-03 2.36E-02 10 754 190 35980 P0CG47|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P00441|P0CG48
GO:0048678 response to axon injury 2.08E-04 1.23E-03 4 55 190 35980 P05090|P09382|P00441|P01034
GO:0048729 tissue morphogenesis 1.17E-04 7.37E-04 12 616 190 35980 O15273|Q14896|P10916|P19429|P08590|P09493|P68133|P68032|P45379|P13533|P12883|P63316







GO:0048738 cardiac muscle tissue development 5.01E-12 8.07E-11 13 164 190 35980 O15273|Q14896|P10916|P01160|P68032|P13533|P12883|P19429|Q14192|P08590|P09493|P45379|P63316
GO:0048747 muscle fiber development 6.81E-06 5.80E-05 5 50 190 35980 Q14315|O15273|P10916|P68133|P13533








GO:0048857 neural nucleus development 5.88E-03 2.02E-02 3 69 190 35980 P18859|P14854|P62158






GO:0048872 homeostasis of number of cells 1.16E-04 7.31E-04 7 205 190 35980 P02144|P08708|P62263|P19022|P25116|P00441|P39019
GO:0048878 chemical homeostasis 2.40E-04 1.38E-03 15 980 190 35980 P02792|P51684|P16615|P13693|P63244|O14958|P19429|P09382|P17174|Q16654|P23327|P62753|P25116|P00441|P06576
GO:0050688 regulation of defense response to virus 4.98E-04 2.61E-03 6 187 190 35980 P52179|P40925|P62987|Q16654|Q6P6C2|P10176
GO:0050691 regulation of defense response to virus by host 6.10E-05 4.20E-04 6 127 190 35980 P52179|P40925|P62987|Q16654|Q6P6C2|P10176


















GO:0050801 ion homeostasis 1.79E-04 1.07E-03 12 645 190 35980 P13693|P02792|P51684|O14958|P19429|P17174|P16615|Q16654|P23327|P25116|P00441|P06576
GO:0050817 coagulation 3.54E-05 2.62E-04 12 543 190 35980 P07602|P01033|P84243|P68871|P16615|P04275|P62158|P04792|P35613|P19105|P25116|P00441
GO:0050848 regulation of calcium-mediated signaling 9.13E-04 4.44E-03 4 81 190 35980 O14958|P23327|Q8N3K9|P62158
GO:0050849 negative regulation of calcium-mediated signaling 1.32E-04 8.21E-04 3 19 190 35980 O14958|Q8N3K9|P62158
GO:0050852 T cell receptor signaling pathway 1.52E-02 4.33E-02 4 179 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0050878 regulation of body fluid levels 4.33E-05 3.10E-04 14 740 190 35980 P07602|P01033|P19021|P16615|P35613|P19105|P16860|P84243|P68871|P04275|P62158|P04792|P25116|P00441
GO:0050879 multicellular organismal movement 7.72E-08 8.36E-07 6 41 190 35980 P02144|O15273|P19429|P13639|P12883|P63316
GO:0050880 regulation of blood vessel size 1.94E-03 8.31E-03 5 166 190 35980 P16860|P01160|P68871|P25116|P00441
GO:0050881 musculoskeletal movement 7.72E-08 8.36E-07 6 41 190 35980 P02144|O15273|P19429|P13639|P12883|P63316
















GO:0051050 positive regulation of transport 1.31E-02 3.83E-02 11 956 190 35980 P54368|Q14116|P63244|P16860|Q9P0U1|P01160|P62158|P17081|Q08431|P25116|Q8N335
GO:0051051 negative regulation of transport 1.15E-03 5.45E-03 9 484 190 35980 P54368|P63244|Q08493|P05090|O14958|P0DMV8|P02511|P62158|P25116
GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity 2.49E-03 1.02E-02 6 256 190 35980 P0CG47|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0051092 positive regulation of NF-kappaB transcription factor 1.58E-04 9.68E-04 6 151 190 35980 P0CG47|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0051129 negative regulation of cellular component organization 1.37E-02 3.97E-02 9 711 190 35980 P63244|P05090|P0DMV8|P0DMV9|Q9NWT8|P09382|O75116|P17081|P01034
GO:0051146 striated muscle cell differentiation 1.19E-10 1.74E-09 13 211 190 35980 Q14315|O15273|Q14896|P10916|P01160|P19022|P68133|P68032|P13533|O14958|Q14192|P09493|P45379
GO:0051147 regulation of muscle cell differentiation 1.16E-02 3.45E-02 4 165 190 35980 Q13765|Q14116|Q9NPI5|P19022




















GO:0051223 regulation of protein transport 1.07E-02 3.23E-02 10 803 190 35980 P54368|Q14116|P63244|Q08493|P05090|Q9P0U1|P19021|Q02818|P12235|P25116






















GO:0051241 negative regulation of multicellular organismal process 4.59E-05 3.26E-04 17 1049 190 35980 P0CG47|P01033|P01160|O75116|P16615|P16989|P0CG48|P39019|P16860|P41222|P05090|P09382|P62987|P62979|P25116|P00441|P01034













GO:0051254 positive regulation of RNA metabolic process 1.40E-02 4.03E-02 16 1644 190 35980 P0CG47|Q13765|P0DMV8|P0DMV9|Q969T9|Q8TAK5|Q9Y6H1|P17535|P0CG48|P60033|Q14192|P62987|P62979|Q13772|P17081|P25116
GO:0051259 protein oligomerization 6.08E-05 4.19E-04 11 486 190 35980 P68871|P19021|P19022|P22352|Q16698|P02511|P04275|P69905|P45379|P24752|P39019
GO:0051260 protein homooligomerization 5.55E-03 1.93E-02 6 302 190 35980 P19021|P22352|Q16698|P02511|P04275|P24752
GO:0051270 regulation of cellular component movement 1.26E-04 7.90E-04 14 819 190 35980 P01033|Q14896|P51684|O75116|P16615|P39019|P63244|P05090|P60033|P09493|P04792|P45379|P25116|P63316
GO:0051279 regulation of release of sequestered calcium ion into 7.92E-04 3.92E-03 4 78 190 35980 O14958|P23327|P62158|P25116
GO:0051282 regulation of sequestering of calcium ion 3.51E-03 1.36E-02 4 117 190 35980 O14958|P23327|P62158|P25116
GO:0051291 protein heterooligomerization 1.41E-03 6.42E-03 4 91 190 35980 P68871|P19022|P69905|P45379
GO:0051336 regulation of hydrolase activity 8.67E-03 2.78E-02 18 1834 190 35980 P01033|Q14896|P0DMV8|O75116|Q8N3K9|P13533|P63244|P19429|P08590|P09493|P02511|P62158|P45379|P25116|P20585|P00441|P63316|P01034
GO:0051338 regulation of transferase activity 1.49E-03 6.66E-03 15 1172 190 35980 P0CG47|P51452|P0CG48|P63244|P15880|Q05639|P60033|P62987|Q14240|P62979|P62158|P04792|Q8WYQ3|P25116|P00441
GO:0051340 regulation of ligase activity 1.00E-02 3.16E-02 4 158 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051346 negative regulation of hydrolase activity 1.63E-02 4.45E-02 7 493 190 35980 P01033|P19429|O75116|Q8N3K9|P02511|P45379|P01034
GO:0051347 positive regulation of transferase activity 6.94E-03 2.33E-02 10 752 190 35980 P0CG47|P15880|Q05639|P60033|P62987|P62979|P62158|P25116|P00441|P0CG48
GO:0051348 negative regulation of transferase activity 2.77E-04 1.58E-03 9 396 190 35980 P0CG47|P51452|P63244|P62987|Q14240|P62979|P04792|Q8WYQ3|P0CG48
GO:0051351 positive regulation of ligase activity 2.22E-03 9.26E-03 4 103 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051352 negative regulation of ligase activity 2.55E-03 1.04E-02 4 107 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051384 response to glucocorticoid 1.99E-03 8.47E-03 5 167 190 35980 P41222|P19021|P17174|P62158|Q8N8D1
GO:0051403 stress-activated MAPK cascade 7.56E-05 5.12E-04 6 132 190 35980 P0CG47|P51452|P62987|P62979|P02511|P0CG48
GO:0051436 negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle 1.85E-03 7.97E-03 4 98 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051437 positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition 6.50E-04 3.28E-03 4 74 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051438 regulation of ubiquitin-protein transferase activity 9.81E-03 3.10E-02 4 157 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051439 regulation of ubiquitin-protein ligase activity involved in 2.63E-03 1.06E-02 4 108 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051443 positive regulation of ubiquitin-protein transferase activity 1.85E-03 7.97E-03 4 98 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051444 negative regulation of ubiquitin-protein transferase activity 2.38E-03 9.82E-03 4 105 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0051592 response to calcium ion 3.62E-03 1.39E-02 4 118 190 35980 O14958|P62158|P45379|P17535
GO:0051604 protein maturation 7.62E-03 2.51E-02 6 323 190 35980 P0CG47|P63244|P62987|P62979|P25116|P0CG48
























GO:0051707 response to other organism 1.43E-03 6.49E-03 13 931 190 35980 P52179|Q14116|P40925|Q6P6C2|P10176|P17535|P13693|P62891|P62987|Q16654|P04792|Q01628|P25116
GO:0051726 regulation of cell cycle 1.68E-02 4.58E-02 13 1260 190 35980 P0CG47|P51452|O75116|P17535|P0CG48|P63244|Q14094|Q9NWT8|P62987|P83731|P62979|Q15004|P62158
GO:0051806 entry into cell of other organism involved in symbiotic 1.11E-02 3.31E-02 3 87 190 35980 P0DMV8|P0DMV9|P60033
GO:0051828 entry into other organism involved in symbiotic interaction 1.11E-02 3.31E-02 3 87 190 35980 P0DMV8|P0DMV9|P60033
GO:0051881 regulation of mitochondrial membrane potential 3.61E-03 1.39E-02 3 58 190 35980 P0CG47|P63244|P00441
GO:0051924 regulation of calcium ion transport 8.55E-03 2.76E-02 5 236 190 35980 O14958|P01160|P23327|P62158|P25116
GO:0052126 movement in host environment 1.11E-02 3.31E-02 3 87 190 35980 P0DMV8|P0DMV9|P60033
GO:0052192 movement in environment of other organism involved in 1.11E-02 3.31E-02 3 87 190 35980 P0DMV8|P0DMV9|P60033
GO:0055001 muscle cell development 2.06E-12 3.42E-11 13 153 190 35980 Q14315|O15273|Q14896|P10916|P01160|P68133|P16615|P68032|P13533|O14958|Q14192|P09493|P45379
GO:0055002 striated muscle cell development 1.34E-11 2.09E-10 12 140 190 35980 Q14315|O15273|Q14896|P10916|O14958|Q14192|P01160|P09493|P68133|P68032|P45379|P13533
GO:0055003 cardiac myofibril assembly 7.72E-05 5.20E-04 3 16 190 35980 O15273|P10916|P68032
GO:0055006 cardiac cell development 1.16E-06 1.14E-05 6 64 190 35980 O15273|P10916|Q14192|P01160|P68032|P13533
GO:0055007 cardiac muscle cell differentiation 1.04E-05 8.52E-05 6 93 190 35980 O15273|P10916|Q14192|P01160|P68032|P13533
GO:0055008 cardiac muscle tissue morphogenesis 9.93E-15 1.92E-13 11 57 190 35980 O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P45379|P13533|P12883|P63316
GO:0055010 ventricular cardiac muscle tissue morphogenesis 7.99E-13 1.36E-11 9 41 190 35980 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0055013 cardiac muscle cell development 8.74E-07 8.60E-06 6 61 190 35980 O15273|P10916|Q14192|P01160|P68032|P13533
GO:0055065 metal ion homeostasis 2.28E-03 9.45E-03 9 535 190 35980 P13693|P02792|P51684|O14958|P19429|P16615|P23327|P25116|P00441
GO:0055074 calcium ion homeostasis 2.15E-03 9.05E-03 7 336 190 35980 P13693|P51684|O14958|P19429|P16615|P23327|P25116
GO:0055080 cation homeostasis 3.81E-04 2.10E-03 11 601 190 35980 P13693|P02792|P51684|O14958|P19429|P16615|Q16654|P23327|P25116|P00441|P06576
GO:0055082 cellular chemical homeostasis 1.36E-04 8.43E-04 12 626 190 35980 P13693|P02792|P63244|P51684|O14958|P19429|P09382|P16615|P23327|P25116|P00441|P06576


















GO:0055117 regulation of cardiac muscle contraction 2.68E-05 2.05E-04 5 66 190 35980 O14958|P01160|P16615|P23327|P62158
GO:0060047 heart contraction 8.97E-18 1.96E-16 14 80 190 35980 O15273|Q14896|P10916|P68032|P13533|P12883|O14958|P19429|P08590|P09493|P45379|Q8N335|P00441|P63316
GO:0060048 cardiac muscle contraction 4.89E-17 1.03E-15 13 69 190 35980 O15273|Q14896|P10916|P68032|P13533|P12883|O14958|P19429|P08590|P09493|P45379|Q8N335|P63316
GO:0060314 regulation of ryanodine-sensitive calcium-release channel 3.45E-04 1.91E-03 3 26 190 35980 O14958|P23327|P62158
GO:0060322 head development 8.84E-03 2.83E-02 10 780 190 35980 P0CG47|P05090|P84243|P18859|O14949|P19022|P14854|P62158|P24752|P01034




GO:0060415 muscle tissue morphogenesis 9.29E-14 1.69E-12 11 69 190 35980 O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P45379|P13533|P12883|P63316
GO:0060537 muscle tissue development 1.12E-11 1.76E-10 16 309 190 35980 O15273|Q14896|P10916|P13639|P01160|P68133|P68032|P13533|P12883|P19429|Q14192|P60660|P08590|P09493|P45379|P63316
GO:0060538 skeletal muscle organ development 8.39E-03 2.72E-02 4 150 190 35980 P13639|P60660|P08590|P68133




GO:0060759 regulation of response to cytokine stimulus 1.46E-05 1.17E-04 7 148 190 35980 P0CG47|P63244|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:0060828 regulation of canonical Wnt signaling pathway 1.17E-02 3.46E-02 5 255 190 35980 P0CG47|P19022|P62987|P62979|P0CG48











GO:0061337 cardiac conduction 4.57E-03 1.71E-02 4 126 190 35980 O14958|P19429|P01160|P16615
GO:0061418 regulation of transcription from RNA polymerase II promoter in response to hypoxia 2.73E-05 2.08E-04 4 33 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0061458 reproductive system development 2.80E-03 1.11E-02 8 449 190 35980 P07602|P0CG47|P16989|P04275|Q13772|P35613|P00441|P01034
GO:0061564 axon development 5.84E-03 2.01E-02 10 733 190 35980 P0CG47|P05090|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P0CG48
GO:0061726 mitochondrion disassembly 6.34E-06 5.43E-05 8 183 190 35980 P0CG47|P52179|Q9P0U1|P40925|P62987|P62979|P10176|P0CG48
































GO:0070201 regulation of establishment of protein localization 7.26E-03 2.41E-02 11 878 190 35980 P54368|Q14116|P63244|Q08493|P05090|Q9P0U1|P19021|Q02818|P17081|P12235|P25116
GO:0070252 actin-mediated cell contraction 8.46E-20 2.08E-18 15 76 190 35980 O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|P19429|P60660|P08590|P09493|P45379|Q8N335|P63316
GO:0070265 necrotic cell death 4.83E-05 3.41E-04 4 38 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0070266 necroptotic process 1.61E-05 1.28E-04 4 29 190 35980 P0CG47|P62987|P62979|P0CG48




GO:0070423 nucleotide-binding oligomerization domain containing 1.40E-05 1.12E-04 4 28 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0070482 response to oxygen levels 1.14E-05 9.25E-05 10 330 190 35980 P0CG47|P02144|P01160|P19021|P62987|P62979|P02511|Q6P6C2|P0CG48|P01034
GO:0070527 platelet aggregation 1.43E-03 6.49E-03 3 42 190 35980 P68871|P04792|P19105






GO:0070848 response to growth factor 8.00E-03 2.62E-02 11 890 190 35980 P0CG47|P51452|P63244|P13639|P68104|P62987|P62979|P62158|P04792|P13533|P0CG48






GO:0070911 global genome nucleotide-excision repair 3.31E-04 1.86E-03 4 62 190 35980 P0CG47|P62987|P62979|P0CG48









GO:0070987 error-free translesion synthesis 2.74E-06 2.52E-05 4 19 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0071156 regulation of cell cycle arrest 4.57E-03 1.71E-02 4 126 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0071158 positive regulation of cell cycle arrest 1.35E-03 6.20E-03 4 90 190 35980 P0CG47|P62987|P62979|P0CG48





GO:0071345 cellular response to cytokine stimulus 7.78E-04 3.88E-03 13 870 190 35980 P0CG47|P51684|P04406|P80297|P68363|P16989|P0CG48|P63244|P39023|P62987|Q14240|P62979|Q01628
GO:0071356 cellular response to tumor necrosis factor 2.21E-03 9.25E-03 6 250 190 35980 P0CG47|P63244|P62987|P16989|P62979|P0CG48
GO:0071363 cellular response to growth factor stimulus 6.53E-03 2.21E-02 11 865 190 35980 P0CG47|P51452|P63244|P13639|P68104|P62987|P62979|P62158|P04792|P13533|P0CG48
GO:0071375 cellular response to peptide hormone stimulus 1.06E-03 5.04E-03 9 478 190 35980 P0CG47|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P0CG48
GO:0071407 cellular response to organic cyclic compound 1.17E-02 3.46E-02 8 574 190 35980 Q14116|O14958|Q969T9|Q14192|P09382|O75116|Q13772|P00441
GO:0071417 cellular response to organonitrogen compound 7.94E-04 3.92E-03 11 657 190 35980 P0CG47|O14958|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P00441|P0CG48
GO:0071453 cellular response to oxygen levels 8.39E-03 2.72E-02 4 150 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0071456 cellular response to hypoxia 5.68E-03 1.97E-02 4 134 190 35980 P0CG47|P62987|P62979|P0CG48





































GO:0071826 ribonucleoprotein complex subunit organization 1.64E-08 2.01E-07 12 260 190 35980 P42677|Q02878|P63173|P08708|P39023|P62263|P46783|P83731|P62913|P46777|P60228|P39019












GO:0071897 DNA biosynthetic process 7.01E-04 3.54E-03 5 132 190 35980 P0CG47|P62987|P62979|Q15004|P0CG48
GO:0071900 regulation of protein serine/threonine kinase activity 3.07E-03 1.21E-02 10 668 190 35980 P0CG47|P51452|P60033|P62987|P62979|P62158|P04792|P25116|P00441|P0CG48
GO:0071902 positive regulation of protein serine/threonine kinase 1.47E-03 6.62E-03 7 314 190 35980 P0CG47|P60033|P62987|P62979|P62158|P00441|P0CG48
GO:0072329 monocarboxylic acid catabolic process 2.72E-03 1.09E-02 4 109 190 35980 P00505|Q16698|P51857|Q13011
GO:0072331 signal transduction by p53 class mediator 6.45E-03 2.19E-02 4 139 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0072350 tricarboxylic acid metabolic process 4.77E-03 1.77E-02 3 64 190 35980 P40926|P40925|P48735








GO:0072395 signal transduction involved in cell cycle checkpoint 5.55E-04 2.86E-03 4 71 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0072401 signal transduction involved in DNA integrity checkpoint 5.26E-04 2.73E-03 4 70 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0072413 signal transduction involved in mitotic cell cycle 4.71E-04 2.49E-03 4 68 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0072422 signal transduction involved in DNA damage checkpoint 5.26E-04 2.73E-03 4 70 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0072431 signal transduction involved in mitotic G1 DNA damage 4.45E-04 2.39E-03 4 67 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0072503 cellular divalent inorganic cation homeostasis 2.23E-03 9.29E-03 7 338 190 35980 P13693|P51684|O14958|P19429|P16615|P23327|P25116
GO:0072507 divalent inorganic cation homeostasis 3.21E-03 1.26E-02 7 361 190 35980 P13693|P51684|O14958|P19429|P16615|P23327|P25116





GO:0072522 purine-containing compound biosynthetic process 7.26E-07 7.19E-06 10 242 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|P36542|P56381|Q8WYQ3|P06576
GO:0072524 pyridine-containing compound metabolic process 2.89E-04 1.64E-03 7 238 190 35980 P13929|P40926|P04406|Q9NPI5|P07195|P40925|Q8N335
GO:0072593 reactive oxygen species metabolic process 8.92E-05 5.80E-04 6 136 190 35980 P68871|Q16654|P22352|P69905|P62158|P00441

















GO:0075733 intracellular transport of virus 2.41E-05 1.85E-04 4 32 190 35980 P0CG47|P62987|P62979|P0CG48




GO:0080135 regulation of cellular response to stress 1.14E-03 5.39E-03 11 687 190 35980 P07602|P51452|P13693|P63244|P0DMV8|P0DMV9|P16989|Q9Y6H1|P02511|P04792|P00441
GO:0090002 establishment of protein localization to plasma membrane 1.33E-02 3.86E-02 3 93 190 35980 O75116|P19022|P35613
GO:0090068 positive regulation of cell cycle process 1.44E-02 4.13E-02 5 269 190 35980 P0CG47|O75116|P62987|P62979|P0CG48
GO:0090090 negative regulation of canonical Wnt signaling pathway 2.15E-03 9.05E-03 5 170 190 35980 P0CG47|P19022|P62987|P62979|P0CG48
GO:0090101 negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway 4.08E-03 1.55E-02 4 122 190 35980 P0CG47|P62987|P62979|P0CG48






GO:0090257 regulation of muscle system process 7.59E-15 1.48E-13 17 230 190 35980 Q14896|P10916|P01160|P16615|Q8N3K9|P12883|O14958|P19429|P08590|P09493|P23327|P62158|P45379|P25116|O14558|P00441|P63316
GO:0090263 positive regulation of canonical Wnt signaling pathway 6.29E-03 2.14E-02 4 138 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0090279 regulation of calcium ion import 2.63E-03 1.06E-02 4 108 190 35980 O14958|P23327|P62158|P25116
GO:0090288 negative regulation of cellular response to growth factor 8.59E-03 2.76E-02 4 151 190 35980 P0CG47|P62987|P62979|P0CG48









GO:0090407 organophosphate biosynthetic process 8.01E-05 5.35E-04 13 686 190 35980 O75947|P06732|P48047|P01160|P36542|P16860|P25705|P18859|Q9NPI5|P56381|Q8WYQ3|Q8N335|P06576
GO:0097031 mitochondrial respiratory chain complex I biogenesis 1.13E-12 1.88E-11 10 62 190 35980 O00217|O95169|P51970|O43674|O14561|O43920|O95167|O95178|O96000|O15239
GO:0097300 programmed necrotic cell death 4.34E-05 3.10E-04 4 37 190 35980 P0CG47|P62987|P62979|P0CG48
GO:0097305 response to alcohol 1.96E-04 1.17E-03 9 378 190 35980 P13639|P00505|O75116|P19021|P68032|P02511|P62158|P00441|P01034
GO:0097485 neuron projection guidance 4.57E-03 1.71E-02 9 595 190 35980 P0CG47|P60660|O75116|P62987|P83731|P62979|P62158|P19105|P0CG48
GO:0098542 defense response to other organism 8.90E-03 2.84E-02 8 547 190 35980 P52179|P62891|P40925|P62987|Q16654|Q6P6C2|P10176|Q01628












GO:0098754 detoxification 1.44E-03 6.49E-03 5 155 190 35980 P68871|O14880|P22352|P69905|P00441
GO:0098771 inorganic ion homeostasis 4.62E-04 2.46E-03 11 615 190 35980 P13693|P02792|P51684|O14958|P19429|P16615|Q16654|P23327|P25116|P00441|P06576
GO:0098779 mitophagy in response to mitochondrial depolarization 5.83E-03 2.01E-02 4 135 190 35980 P52179|Q9P0U1|P40925|P10176
GO:0098780 response to mitochondrial depolarisation 5.83E-03 2.01E-02 4 135 190 35980 P52179|Q9P0U1|P40925|P10176
GO:0098792 xenophagy 1.33E-05 1.06E-04 6 97 190 35980 P52179|P40925|P62987|Q16654|Q6P6C2|P10176
GO:0098869 cellular oxidant detoxification 1.21E-03 5.67E-03 5 149 190 35980 P68871|O14880|P22352|P69905|P00441
GO:1900034 regulation of cellular response to heat 7.68E-03 2.52E-02 3 76 190 35980 P0DMV8|P0DMV9|P02511
GO:1900407 regulation of cellular response to oxidative stress 2.92E-04 1.65E-03 4 60 190 35980 P07602|P63244|P04792|P00441
GO:1900408 negative regulation of cellular response to oxidative 9.87E-04 4.75E-03 3 37 190 35980 P07602|P63244|P04792
GO:1901019 regulation of calcium ion transmembrane transporter 9.13E-04 4.44E-03 4 81 190 35980 O14958|P01160|P23327|P62158





GO:1901184 regulation of ERBB signaling pathway 1.09E-03 5.20E-03 4 85 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1901185 negative regulation of ERBB signaling pathway 7.91E-05 5.31E-04 4 43 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1901293 nucleoside phosphate biosynthetic process 3.25E-06 2.92E-05 11 354 190 35980 O75947|P16860|P25705|P48047|P18859|P01160|Q9NPI5|P36542|P56381|Q8WYQ3|P06576








































































GO:1901652 response to peptide 1.40E-06 1.35E-05 15 627 190 35980 P0CG47|P01033|P01160|P16615|P35613|P17535|P0CG48|P17174|P08574|P62987|Q16654|P62979|P62158|P17081|P62753
GO:1901653 cellular response to peptide 1.37E-03 6.26E-03 9 496 190 35980 P0CG47|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P0CG48





GO:1901659 glycosyl compound biosynthetic process 8.35E-06 6.93E-05 8 190 190 35980 O75947|P25705|P48047|P18859|P36542|P56381|Q8WYQ3|P06576




GO:1901699 cellular response to nitrogen compound 1.72E-03 7.52E-03 11 724 190 35980 P0CG47|O14958|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P00441|P0CG48





GO:1901701 cellular response to oxygen-containing compound 1.15E-04 7.28E-04 16 1022 190 35980 P0CG47|Q14116|O75116|P0CG48|P63244|P09382|P09493|P17174|P62987|Q16654|P62979|P62158|P17081|P62753|P00441|P01034
GO:1902400 intracellular signal transduction involved in G1 DNA 4.45E-04 2.39E-03 4 67 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1902402 signal transduction involved in mitotic DNA damage 4.71E-04 2.49E-03 4 68 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1902403 signal transduction involved in mitotic DNA integrity 4.71E-04 2.49E-03 4 68 190 35980 P0CG47|P62987|P62979|P0CG48




GO:1902532 negative regulation of intracellular signal transduction 2.24E-04 1.30E-03 10 472 190 35980 P51452|P13693|P63244|O14958|P0DMV8|P16989|Q8N3K9|P62158|P04792|Q8N335
GO:1902533 positive regulation of intracellular signal transduction 5.14E-04 2.67E-03 15 1054 190 35980 P07602|P0CG47|Q14116|P0DMV8|P0DMV9|P19022|P0CG48|P63244|P60033|P09382|P62987|P62979|P62158|P25116|P00441











GO:1902579 multi-organism localization 3.89E-05 2.81E-04 4 36 190 35980 P0CG47|P62987|P62979|P0CG48














GO:1902583 multi-organism intracellular transport 2.41E-05 1.85E-04 4 32 190 35980 P0CG47|P62987|P62979|P0CG48









GO:1902680 positive regulation of RNA biosynthetic process 1.13E-02 3.36E-02 16 1603 190 35980 P0CG47|Q13765|P0DMV8|P0DMV9|Q969T9|Q8TAK5|Q9Y6H1|P17535|P0CG48|P60033|Q14192|P62987|P62979|Q13772|P17081|P25116
GO:1902806 regulation of cell cycle G1/S phase transition 1.31E-02 3.82E-02 4 171 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1902807 negative regulation of cell cycle G1/S phase transition 3.96E-03 1.51E-02 4 121 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1902882 regulation of response to oxidative stress 4.20E-04 2.27E-03 4 66 190 35980 P07602|P63244|P04792|P00441
GO:1902883 negative regulation of response to oxidative stress 9.87E-04 4.75E-03 3 37 190 35980 P07602|P63244|P04792
GO:1903008 organelle disassembly 1.26E-05 1.01E-04 8 201 190 35980 P0CG47|P52179|Q9P0U1|P40925|P62987|P62979|P10176|P0CG48
GO:1903050 regulation of proteolysis involved in cellular protein 1.50E-02 4.29E-02 5 272 190 35980 P0CG47|P63244|P62987|P62979|P0CG48
GO:1903052 positive regulation of proteolysis involved in cellular 2.15E-03 9.05E-03 5 170 190 35980 P0CG47|P63244|P62987|P62979|P0CG48
GO:1903115 regulation of actin filament-based movement 2.12E-05 1.65E-04 4 31 190 35980 Q14896|P16615|P45379|P63316
GO:1903169 regulation of calcium ion transmembrane transport 7.25E-04 3.65E-03 5 133 190 35980 O14958|P01160|P23327|P62158|P25116
GO:1903201 regulation of oxidative stress-induced cell death 1.13E-04 7.13E-04 4 47 190 35980 P07602|P63244|P04792|P00441
GO:1903202 negative regulation of oxidative stress-induced cell death 7.69E-04 3.84E-03 3 34 190 35980 P07602|P63244|P04792
GO:1903320 regulation of protein modification by small protein 7.19E-03 2.39E-02 6 319 190 35980 P0CG47|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:1903321 negative regulation of protein modification by small protein conjugation or removal 2.47E-04 1.42E-03 6 164 190 35980 P0CG47|P0DMV8|P0DMV9|P62987|P62979|P0CG48
GO:1903362 regulation of cellular protein catabolic process 4.80E-03 1.79E-02 6 293 190 35980 P0CG47|P63244|P60033|P62987|P62979|P0CG48
GO:1903364 positive regulation of cellular protein catabolic process 4.70E-04 2.49E-03 6 185 190 35980 P0CG47|P63244|P60033|P62987|P62979|P0CG48
GO:1903508 positive regulation of nucleic acid-templated transcription 9.65E-03 3.05E-02 16 1575 190 35980 P0CG47|Q13765|P0DMV8|P0DMV9|Q969T9|Q8TAK5|Q9Y6H1|P17535|P0CG48|P60033|Q14192|P62987|P62979|Q13772|P17081|P25116
GO:1903522 regulation of blood circulation 1.84E-13 3.31E-12 18 326 190 35980 Q14896|P10916|P01160|P16615|P17661|P13533|P12883|P16860|O14958|P19429|Q9UBY9|P08590|P09493|P23327|P62158|P45379|P25116|Q8N335
GO:1903524 positive regulation of blood circulation 1.69E-04 1.02E-03 5 97 190 35980 P01160|P09493|P16615|P23327|P25116
GO:1903649 regulation of cytoplasmic transport 3.32E-03 1.30E-02 8 462 190 35980 Q14116|P63244|P05090|O14958|Q9P0U1|P23327|P62158|P25116
GO:1903651 positive regulation of cytoplasmic transport 1.50E-02 4.29E-02 5 272 190 35980 Q14116|P63244|Q9P0U1|P62158|P25116
GO:1903779 regulation of cardiac conduction 1.67E-06 1.57E-05 6 68 190 35980 O14958|P19429|P01160|P16615|P23327|P62158
GO:1903827 regulation of cellular protein localization 3.12E-03 1.23E-02 9 561 190 35980 P54368|Q14116|P63244|P05090|Q9P0U1|Q02818|P19022|P17081|Q8N335
GO:1903844 regulation of cellular response to transforming growth 3.41E-03 1.33E-02 4 116 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1903845 negative regulation of cellular response to transforming growth factor beta stimulus 9.56E-04 4.63E-03 4 82 190 35980 P0CG47|P62987|P62979|P0CG48
GO:1904062 regulation of cation transmembrane transport 1.45E-03 6.56E-03 6 230 190 35980 O14958|P01160|P23327|P62158|P25116|Q8N335
GO:1990267 response to transition metal nanoparticle 1.61E-03 7.10E-03 5 159 190 35980 P80297|P19021|Q02818|P35613|P00441
GO:1990542 mitochondrial transmembrane transport 1.79E-09 2.44E-08 8 64 190 35980 O75947|P25705|Q9P0U1|P48047|P18859|P36542|P56381|P06576
GO:1990748 cellular detoxification 1.32E-03 6.07E-03 5 152 190 35980 P68871|O14880|P22352|P69905|P00441
GO:2000021 regulation of ion homeostasis 1.38E-04 8.56E-04 7 211 190 35980 P63244|P16860|O14958|P23327|P62158|P25116|Q8N335
GO:2000045 regulation of G1/S transition of mitotic cell cycle 1.07E-02 3.23E-02 4 161 190 35980 P0CG47|P62987|P62979|P0CG48
GO:2000058 regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process 1.78E-03 7.70E-03 4 97 190 35980 P0CG47|P62987|P62979|P0CG48
GO:2000060 positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process 1.24E-03 5.79E-03 4 88 190 35980 P0CG47|P62987|P62979|P0CG48
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle 3.51E-03 1.36E-02 4 117 190 35980 P0CG47|P62987|P62979|P0CG48
GO:2001233 regulation of apoptotic signaling pathway 3.09E-04 1.74E-03 9 402 190 35980 P0CG47|P13693|P63244|P0DMV8|P0DMV9|P16989|P04792|P00441|Q8N8D1
GO:2001234 negative regulation of apoptotic signaling pathway 5.83E-03 2.01E-02 5 215 190 35980 P13693|P0DMV8|P0DMV9|P16989|P04792
GO:2001242 regulation of intrinsic apoptotic signaling pathway 1.97E-05 1.54E-04 7 155 190 35980 P0CG47|P13693|P63244|P0DMV8|P16989|P04792|P00441
GO:2001243 negative regulation of intrinsic apoptotic signaling 1.65E-03 7.26E-03 4 95 190 35980 P13693|P0DMV8|P16989|P04792
GO:2001244 positive regulation of intrinsic apoptotic signaling pathway 3.79E-03 1.45E-02 3 59 190 35980 P0CG47|P63244|P00441
GO:2001257 regulation of cation channel activity 2.14E-03 9.02E-03 4 102 190 35980 O14958|P01160|P23327|P62158
Supplemental Table Viii. hA-VCMs BinGO 2011. BinGO analysis of the adult ventricular 
cardiomyocyte (hA-VCMs) data19 using the 2011 GO annotation dataset. x is the number of IDs in both 
the submitted list and associated with the GO term, n indicates the number of protein IDs associated 
with the GO term, X is the number of protein IDs submitted for analysis, N is the number of protein 
IDs used as the background set.  
 
GO-ID Description p-value corr	p-value x n X N Proteins submitted in analysis that are associated with the GO term
GO:0000028 ribosomal	small	subunit	assembly 5.69E-08 8.67E-07 4 7 178 27688 P08708|P62263|P62851|P62753
GO:0000075 cell	cycle	checkpoint 5.93E-03 2.83E-02 6 252 178 27688 P0CG47|P62987|Q9Y5N6|P83731|P62979|P0CG48
GO:0000082 G1/S	transition	of	mitotic	cell	cycle 4.58E-03 2.28E-02 5 167 178 27688 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0000084 mitotic	S	phase 1.13E-03 7.77E-03 5 121 178 27688 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0000165 MAPK	cascade 9.25E-03 3.89E-02 5 198 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0000187 activation	of	MAPK	activity 3.35E-04 2.84E-03 6 143 178 27688 P0CG47|P60033|P62987|P62979|P00441|P0CG48
GO:0000302 response	to	reactive	oxygen	species 7.31E-05 7.33E-04 7 157 178 27688 P02144|Q14116|P68871|P09493|P69905|P00441|P12883
GO:0001817 regulation	of	cytokine	production 4.05E-03 2.09E-02 8 393 178 27688 P0CG47|Q14116|P62987|P62979|P04792|P25116|P00441|P0CG48
GO:0002027 regulation	of	heart	rate 2.01E-03 1.19E-02 3 39 178 27688 P09493|P13533|P12883
GO:0002218 activation	of	innate	immune	response 1.66E-03 1.03E-02 5 132 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002221 pattern	recognition	receptor	signaling	pathway 5.71E-04 4.50E-03 5 104 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002224 toll-like	receptor	signaling	pathway 3.59E-04 3.02E-03 5 94 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002262 myeloid	cell	homeostasis 3.31E-05 3.53E-04 6 94 178 27688 P01033|P02144|P08708|P62263|P00441|P39019
GO:0002576 platelet	degranulation 1.79E-04 1.61E-03 5 81 178 27688 P07602|P01033|P04275|P62158|P00441
GO:0002753 cytoplasmic	pattern	recognition	receptor	signaling	 2.58E-05 2.84E-04 4 27 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0002755 MyD88-dependent	toll-like	receptor	signaling	 1.09E-04 1.06E-03 5 73 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002756 MyD88-independent	toll-like	receptor	signaling	 6.27E-05 6.35E-04 5 65 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0002758 innate	immune	response-activating	signal	 7.37E-04 5.59E-03 5 110 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0003007 heart	morphogenesis 2.38E-09 4.02E-08 12 181 178 27688
O15273|Q14896|P10916|P19429|Q14192|P08590|P09493|P68032|P45379
|P13533|P12883|P63316









GO:0003013 circulatory	system	process 2.76E-09 4.59E-08 15 320 178 27688
Q14116|O15273|Q14896|P10916|P01160|P68032|P13533|P16860|P19429
|P68871|P08590|P09493|P25116|P00441|P63316
GO:0003015 heart	process 2.75E-12 5.64E-11 9 39 178 27688 O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P00441|P63316
GO:0003018 vascular	process	in	circulatory	system 6.07E-04 4.74E-03 6 160 178 27688 Q14116|P16860|P01160|P68871|P25116|P00441
GO:0003205 cardiac	chamber	development 1.08E-09 1.94E-08 10 101 178 27688
Q14896|P10916|P19429|Q14192|P08590|P09493|P45379|P13533|P12883|
P63316
GO:0003206 cardiac	chamber	morphogenesis 4.77E-10 8.79E-09 10 93 178 27688
Q14896|P10916|P19429|Q14192|P08590|P09493|P45379|P13533|P12883|
P63316
GO:0003208 cardiac	ventricle	morphogenesis 1.99E-10 3.80E-09 9 61 178 27688 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0003229 ventricular	cardiac	muscle	tissue	development 1.11E-11 2.22E-10 9 45 178 27688 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0003231 cardiac	ventricle	development 3.34E-09 5.52E-08 9 83 178 27688 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0005996 monosaccharide	metabolic	process 3.09E-04 2.63E-03 8 262 178 27688 P13929|P00505|P40926|P04406|P40925|P17174|Q16654|P62158
GO:0006006 glucose	metabolic	process 1.38E-05 1.58E-04 8 168 178 27688 P13929|P00505|P40926|P04406|P40925|P17174|Q16654|P62158




GO:0006090 pyruvate	metabolic	process 2.29E-03 1.31E-02 5 142 178 27688 P13929|P04406|P07195|Q16654|P35613






GO:0006094 gluconeogenesis 1.79E-06 2.40E-05 6 57 178 27688 P13929|P00505|P40926|P04406|P40925|P17174
GO:0006099 tricarboxylic	acid	cycle 6.52E-03 2.87E-02 3 59 178 27688 P40926|P40925|P48735
GO:0006101 citrate	metabolic	process 8.17E-03 3.49E-02 3 64 178 27688 P40926|P40925|P48735
GO:0006103 2-oxoglutarate	metabolic	process 4.79E-04 3.87E-03 3 24 178 27688 P00505|P17174|P48735
GO:0006107 oxaloacetate	metabolic	process 1.12E-04 1.08E-03 3 15 178 27688 P00505|P40926|P40925


























GO:0006164 purine	nucleotide	biosynthetic	process 2.80E-06 3.61E-05 10 232 178 27688
O75947|P16860|P25705|P48047|P18859|P01160|P16615|P36542|P56381|
P06576
GO:0006364 rRNA	processing 9.33E-08 1.36E-06 9 121 178 27688 P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019






GO:0006413 translational	initiation 2.58E-04 2.23E-03 4 48 178 27688 P08708|Q14240|P61247|P60228











GO:0006417 regulation	of	translation 3.36E-03 1.79E-02 6 224 178 27688 P63244|P62263|Q14240|P37108|P04792|P60228
GO:0006446 regulation	of	translational	initiation 4.83E-03 2.38E-02 3 53 178 27688 Q14240|P04792|P60228

















GO:0006733 oxidoreduction	coenzyme	metabolic	process 2.17E-03 1.26E-02 6 205 178 27688 P13929|P40926|P04406|Q9NPI5|P07195|P40925





GO:0006754 ATP	biosynthetic	process 5.08E-07 7.08E-06 8 108 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576

































GO:0006818 hydrogen	transport 4.23E-05 4.44E-04 7 144 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0006839 mitochondrial	transport 1.74E-06 2.34E-05 8 127 178 27688 O75947|P25705|Q9P0U1|P48047|P18859|P36542|P56381|P06576








GO:0006937 regulation	of	muscle	contraction 1.47E-08 2.31E-07 9 98 178 27688 Q14896|P10916|P19429|P08590|P09493|P25116|O14558|P00441|P63316
GO:0006940 regulation	of	smooth	muscle	contraction 3.87E-03 2.02E-02 3 49 178 27688 P19429|P25116|P00441
GO:0006941 striated	muscle	contraction 6.35E-12 1.28E-10 10 61 178 27688
P02144|O15273|Q14896|O14958|P19429|P08590|P09493|P68032|P13533
|P63316
GO:0006942 regulation	of	striated	muscle	contraction 1.87E-03 1.14E-02 3 38 178 27688 Q14896|P10916|P08590









8.72E-04 6.35E-03 4 66 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0006979 response	to	oxidative	stress 5.01E-04 4.02E-03 9 354 178 27688 O00217|P02144|Q14116|P68871|P09493|P22352|P69905|P00441|P12883
GO:0006986 response	to	unfolded	protein 1.30E-02 4.95E-02 3 76 178 27688 Q12988|Q9UBY9|P04792
GO:0007093 mitotic	cell	cycle	checkpoint 2.74E-03 1.52E-02 5 148 178 27688 P0CG47|P62987|P83731|P62979|P0CG48
GO:0007167 enzyme	linked	receptor	protein	signaling	pathway 9.64E-03 4.01E-02 11 752 178 27688
P0CG47|P51452|P16860|P01160|P62987|P62979|P62158|P17081|P13533|
P62753|P0CG48
GO:0007173 epidermal	growth	factor	receptor	signaling	 2.04E-03 1.20E-02 4 83 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0007249 I-kappaB	kinase/NF-kappaB	signaling 4.67E-04 3.80E-03 4 56 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0007254 JNK	cascade 3.09E-03 1.66E-02 4 93 178 27688 P0CG47|P62987|P62979|P0CG48










GO:0007346 regulation	of	mitotic	cell	cycle 4.19E-03 2.12E-02 7 312 178 27688 P0CG47|P51452|Q9NWT8|P62987|P83731|P62979|P0CG48
GO:0007507 heart	development 1.24E-07 1.78E-06 16 489 178 27688
P02144|O15273|Q14896|P10916|P19021|P68032|P13533|P12883|P16860|
O14958|P19429|Q14192|P08590|P09493|P45379|P63316
GO:0007512 adult	heart	development 1.38E-04 1.28E-03 3 16 178 27688 O15273|P13533|P12883
GO:0007517 muscle	organ	development 2.19E-08 3.40E-07 13 268 178 27688
O15273|Q14896|P10916|P68133|P68032|P13533|P12883|P19429|P60660|
P08590|P09493|P45379|P63316
GO:0007596 blood	coagulation 2.00E-03 1.19E-02 10 518 178 27688
P07602|P01033|P84243|P68871|P16615|P04275|P62158|P35613|P25116|
P00441
GO:0007599 hemostasis 2.18E-03 1.26E-02 10 524 178 27688
P07602|P01033|P84243|P68871|P16615|P04275|P62158|P35613|P25116|
P00441
GO:0008015 blood	circulation 2.65E-09 4.44E-08 15 319 178 27688
Q14116|O15273|Q14896|P10916|P01160|P68032|P13533|P16860|P19429
|P68871|P08590|P09493|P25116|P00441|P63316
GO:0008016 regulation	of	heart	contraction 1.04E-05 1.22E-04 7 116 178 27688 Q9UBY9|P08590|P09493|P17661|P45379|P13533|P12883
GO:0008063 Toll	signaling	pathway 1.41E-04 1.30E-03 5 77 178 27688 P0CG47|P51452|P62987|P62979|P0CG48















GO:0008217 regulation	of	blood	pressure 5.48E-05 5.65E-04 7 150 178 27688 P16860|P19429|P01160|P68871|P09493|P13533|P00441
GO:0008219 cell	death 1.13E-02 4.59E-02 15 1206 178 27688
P0CG47|P02792|Q12988|P04406|Q9H3K2|P68032|P0CG48|Q8N8D1|P0938
2|P62987|P61247|P62979|P04792|P25116|P00441



















GO:0009060 aerobic	respiration 1.21E-02 4.83E-02 3 74 178 27688 P40926|P40925|P48735

























GO:0009127 purine	nucleoside	monophosphate	biosynthetic	 6.33E-06 7.74E-05 8 151 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576
GO:0009132 nucleoside	diphosphate	metabolic	process 2.51E-03 1.41E-02 5 145 178 27688 P13929|P25705|P04406|P07195|P06576
GO:0009135 purine	nucleoside	diphosphate	metabolic	process 1.55E-03 9.84E-03 5 130 178 27688 P13929|P25705|P04406|P07195|P06576




GO:0009142 nucleoside	triphosphate	biosynthetic	process 5.46E-06 6.75E-05 8 148 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576




GO:0009145 purine	nucleoside	triphosphate	biosynthetic	 4.23E-06 5.30E-05 8 143 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576




GO:0009152 purine	ribonucleotide	biosynthetic	process 1.36E-06 1.83E-05 10 214 178 27688
O75947|P16860|P25705|P48047|P18859|P01160|P16615|P36542|P56381|
P06576








GO:0009163 nucleoside	biosynthetic	process 7.49E-05 7.48E-04 8 213 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576










GO:0009168 purine	ribonucleoside	monophosphate	 6.33E-06 7.74E-05 8 151 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576
GO:0009179 purine	ribonucleoside	diphosphate	metabolic	 1.55E-03 9.84E-03 5 130 178 27688 P13929|P25705|P04406|P07195|P06576
GO:0009185 ribonucleoside	diphosphate	metabolic	process 1.66E-03 1.03E-02 5 132 178 27688 P13929|P25705|P04406|P07195|P06576
GO:0009187 cyclic	nucleotide	metabolic	process 1.30E-02 4.95E-02 3 76 178 27688 P16860|Q08493|P01160












GO:0009206 purine	ribonucleoside	triphosphate	biosynthetic	 4.02E-06 5.09E-05 8 142 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576




GO:0009260 ribonucleotide	biosynthetic	process 1.89E-06 2.51E-05 10 222 178 27688
O75947|P16860|P25705|P48047|P18859|P01160|P16615|P36542|P56381|
P06576
GO:0009611 response	to	wounding 1.05E-03 7.37E-03 14 835 178 27688
P07602|P01033|P13929|P16615|P35613|P84243|P60033|P09382|P68871|
P09493|P04275|P62158|P25116|P00441












GO:0009887 organ	morphogenesis 1.78E-03 1.10E-02 15 983 178 27688
O15273|Q14896|P10916|P68032|P13533|P35613|P12883|P19429|P08493|
Q14192|P08590|P09493|P45379|P00441|P63316




GO:0009894 regulation	of	catabolic	process 7.82E-03 3.38E-02 7 351 178 27688 P0CG47|P01033|P63244|P62987|P62979|P0CG48|P01034
GO:0009896 positive	regulation	of	catabolic	process 9.63E-03 4.01E-02 5 200 178 27688 P0CG47|P63244|P62987|P62979|P0CG48


























GO:0010035 response	to	inorganic	substance 6.06E-08 9.16E-07 16 464 178 27688
P02144|Q14116|P80297|P19021|P68133|P35613|P17535|P16860|Q05639|
P08493|P68871|P22352|P69905|P62158|P45379|P00441
GO:0010038 response	to	metal	ion 3.57E-05 3.80E-04 10 311 178 27688
P16860|P08493|P80297|P19021|P68133|P62158|P45379|P35613|P17535|
P00441







GO:0010564 regulation	of	cell	cycle	process 7.94E-03 3.42E-02 7 352 178 27688 P0CG47|Q9NWT8|O75116|P62987|P62979|P62158|P0CG48
GO:0010608 posttranscriptional	regulation	of	gene	expression 7.12E-03 3.11E-02 6 262 178 27688 P63244|P62263|Q14240|P37108|P04792|P60228
GO:0010712 regulation	of	collagen	metabolic	process 1.99E-04 1.76E-03 3 18 178 27688 Q14116|P25116|P01034
GO:0010927 cellular	component	assembly	involved	in	 4.47E-04 3.65E-03 6 151 178 27688 O15273|P10916|P09493|P68133|P68032|P13533




GO:0010948 negative	regulation	of	cell	cycle	process 5.70E-03 2.73E-02 5 176 178 27688 P0CG47|Q9NWT8|P62987|P62979|P0CG48
GO:0014070 response	to	organic	cyclic	compound 3.88E-03 2.02E-02 14 963 178 27688
Q14116|P19021|P68133|P35613|Q08431|Q8N8D1|P16860|P41222|Q1419
2|P09382|P17174|P22352|Q13772|P24752
GO:0014706 striated	muscle	tissue	development 5.13E-10 9.38E-09 14 238 178 27688
O15273|Q14896|P10916|P68133|P68032|P13533|P12883|P19429|Q14192
|P60660|P08590|P09493|P45379|P63316
GO:0014866 skeletal	myofibril	assembly 1.43E-05 1.62E-04 3 8 178 27688 O15273|P68133|P68032









GO:0015985 energy	coupled	proton	transport,	down	 1.50E-09 2.63E-08 7 33 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0015986 ATP	synthesis	coupled	proton	transport 1.50E-09 2.63E-08 7 33 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0015992 proton	transport 3.87E-05 4.08E-04 7 142 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
















GO:0016051 carbohydrate	biosynthetic	process 1.06E-03 7.37E-03 6 178 178 27688 P13929|P00505|P40926|P04406|P40925|P17174
GO:0016053 organic	acid	biosynthetic	process 9.71E-03 4.03E-02 7 366 178 27688 P41222|P00505|O14561|O14880|P17174|P51857|P24752
GO:0016054 organic	acid	catabolic	process 4.16E-03 2.11E-02 6 234 178 27688 P00505|P17174|Q16698|P51857|P24752|Q13011












GO:0016072 rRNA	metabolic	process 1.73E-07 2.48E-06 9 130 178 27688 P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019
GO:0016197 endosomal	transport 9.25E-03 3.89E-02 4 127 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0016265 death 1.18E-02 4.76E-02 15 1212 178 27688
P0CG47|P02792|Q12988|P04406|Q9H3K2|P68032|P0CG48|Q8N8D1|P0938
2|P62987|P61247|P62979|P04792|P25116|P00441




GO:0017148 negative	regulation	of	translation 1.26E-02 4.91E-02 3 75 178 27688 P63244|P37108|P60228























GO:0019318 hexose	metabolic	process 1.28E-04 1.20E-03 8 230 178 27688 P13929|P00505|P40926|P04406|P40925|P17174|Q16654|P62158
GO:0019319 hexose	biosynthetic	process 2.96E-06 3.79E-05 6 62 178 27688 P13929|P00505|P40926|P04406|P40925|P17174
GO:0019362 pyridine	nucleotide	metabolic	process 1.52E-03 9.70E-03 6 191 178 27688 P13929|P40926|P04406|Q9NPI5|P07195|P40925




















GO:0019674 NAD	metabolic	process 3.87E-03 2.02E-02 3 49 178 27688 P40926|P07195|P40925








GO:0022403 cell	cycle	phase 1.31E-02 4.96E-02 6 299 178 27688 P0CG47|P42677|P62987|Q9Y5N6|P62979|P0CG48










GO:0022613 ribonucleoprotein	complex	biogenesis 2.43E-07 3.44E-06 12 275 178 27688
P08708|P62263|P18077|P83731|P62857|P62913|P46777|P62851|P62269|
P62753|P62249|P39019
GO:0022618 ribonucleoprotein	complex	assembly 1.01E-03 7.10E-03 5 118 178 27688 P08708|P62263|P83731|P62851|P62753










GO:0023014 signal	transduction	by	protein	phosphorylation 9.25E-03 3.89E-02 5 198 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0030029 actin	filament-based	process 3.25E-08 5.02E-07 17 505 178 27688
O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|Q01449
|P19429|P60660|P08590|P09493|P63313|P17081|P45379|P63316
GO:0030036 actin	cytoskeleton	organization 9.83E-03 4.07E-02 8 458 178 27688 O15273|P10916|P09493|P68133|P68032|P63313|P17081|P13533
GO:0030048 actin	filament-based	movement 3.00E-20 1.33E-18 15 60 178 27688
O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|Q01449
|P19429|P60660|P08590|P09493|P45379|P63316
GO:0030049 muscle	filament	sliding 1.04E-21 5.24E-20 14 38 178 27688
O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|P19429|
P60660|P08590|P09493|P45379|P63316
GO:0030162 regulation	of	proteolysis 4.30E-03 2.17E-02 9 485 178 27688
P0CG47|P01033|P63244|Q9NWT8|P62987|P62979|P25116|P0CG48|P0103
4
GO:0030168 platelet	activation 1.36E-03 9.02E-03 7 255 178 27688 P07602|P01033|P16615|P04275|P62158|P25116|P00441
GO:0030218 erythrocyte	differentiation 1.15E-03 7.85E-03 4 71 178 27688 P01033|P02144|P62263|P39019
GO:0030239 myofibril	assembly 4.91E-07 6.89E-06 6 46 178 27688 O15273|P10916|P09493|P68133|P68032|P13533
GO:0030240 skeletal	muscle	thin	filament	assembly 8.97E-06 1.07E-04 3 7 178 27688 O15273|P68133|P68032
GO:0030330 DNA	damage	response,	signal	transduction	by	p53	 2.14E-03 1.25E-02 4 84 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0030522 intracellular	receptor	signaling	pathway 5.50E-04 4.35E-03 6 157 178 27688 P0CG47|Q14192|P62987|P62979|Q13772|P0CG48










GO:0031032 actomyosin	structure	organization 1.05E-05 1.23E-04 6 77 178 27688 O15273|P10916|P09493|P68133|P68032|P13533




2.04E-03 1.20E-02 4 83 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0031329 regulation	of	cellular	catabolic	process 1.45E-03 9.50E-03 7 258 178 27688 P0CG47|P01033|P63244|P62987|P62979|P0CG48|P01034
GO:0031331 positive	regulation	of	cellular	catabolic	process 4.58E-03 2.28E-02 5 167 178 27688 P0CG47|P63244|P62987|P62979|P0CG48
GO:0031349 positive	regulation	of	defense	response 4.60E-03 2.28E-02 6 239 178 27688 P0CG47|P51452|Q14116|P62987|P62979|P0CG48
GO:0031397 negative	regulation	of	protein	ubiquitination 4.01E-03 2.07E-02 4 100 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0031398 positive	regulation	of	protein	ubiquitination 7.39E-03 3.22E-02 4 119 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0031571 mitotic	G1	DNA	damage	checkpoint 1.27E-03 8.50E-03 4 73 178 27688 P0CG47|P62987|P62979|P0CG48




5.22E-03 2.53E-02 11 690 178 27688
P0CG47|P51452|P01033|P63244|P62987|P37108|P62979|P04792|P60228|
P0CG48|P01034
GO:0032479 regulation	of	type	I	interferon	production 5.34E-04 4.28E-03 4 58 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0032480 negative	regulation	of	type	I	interferon	 5.16E-05 5.37E-04 4 32 178 27688 P0CG47|P62987|P62979|P0CG48






















GO:0032651 regulation	of	interleukin-1	beta	production 2.33E-03 1.33E-02 3 41 178 27688 Q14116|P04792|P25116
GO:0032652 regulation	of	interleukin-1	production 2.85E-03 1.57E-02 3 44 178 27688 Q14116|P04792|P25116






GO:0032781 positive	regulation	of	ATPase	activity 2.13E-06 2.78E-05 4 15 178 27688 Q14896|P08590|P09493|P45379
GO:0032787 monocarboxylic	acid	metabolic	process 1.62E-04 1.48E-03 13 607 178 27688
P13929|P04406|O14561|O14880|P51857|P35613|P41222|P07195|Q16654
|Q16698|P24752|Q13011|P48735
GO:0032970 regulation	of	actin	filament-based	process 1.91E-03 1.16E-02 6 200 178 27688 Q14896|P09493|O75116|P63313|P17081|P63316





GO:0033275 actin-myosin	filament	sliding 1.04E-21 5.24E-20 14 38 178 27688
O15273|Q14896|P10916|P68133|P17661|P68032|P13533|P12883|P19429|
P60660|P08590|P09493|P45379|P63316
GO:0034101 erythrocyte	homeostasis 1.41E-04 1.30E-03 5 77 178 27688 P01033|P02144|P08708|P62263|P39019
GO:0034130 toll-like	receptor	1	signaling	pathway 8.36E-05 8.24E-04 5 69 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034134 toll-like	receptor	2	signaling	pathway 8.36E-05 8.24E-04 5 69 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034138 toll-like	receptor	3	signaling	pathway 5.40E-05 5.59E-04 5 63 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034142 toll-like	receptor	4	signaling	pathway 1.33E-04 1.24E-03 5 76 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0034220 ion	transmembrane	transport 3.44E-04 2.90E-03 9 336 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P35613|P06576
GO:0034248 regulation	of	cellular	amide	metabolic	process 3.90E-03 2.03E-02 6 231 178 27688 P63244|P62263|Q14240|P37108|P04792|P60228
GO:0034249 negative	regulation	of	cellular	amide	metabolic	 1.30E-02 4.95E-02 3 76 178 27688 P63244|P37108|P60228
GO:0034470 ncRNA	processing 5.64E-05 5.79E-04 9 264 178 27688 P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|P39019
GO:0034614 cellular	response	to	reactive	oxygen	species 4.83E-03 2.38E-02 3 53 178 27688 Q14116|P09493|P00441
GO:0034622 cellular	macromolecular	complex	assembly 6.37E-03 2.83E-02 10 611 178 27688
O00217|O15273|P84243|P08708|P62263|P68363|P83731|O43920|P62851
|P62753



























GO:0034660 ncRNA	metabolic	process 1.62E-03 1.02E-02 10 503 178 27688
Q9NSD9|P08708|P62263|P18077|P62857|P62913|P46777|P62753|P62249|
P39019
GO:0035051 cardiocyte	differentiation 7.07E-04 5.38E-03 5 109 178 27688 O15273|P10916|Q14192|P68032|P13533
GO:0035150 regulation	of	tube	size 2.36E-03 1.34E-02 5 143 178 27688 P16860|P01160|P68871|P25116|P00441








2.58E-05 2.84E-04 4 27 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0038127 ERBB	signaling	pathway 2.04E-03 1.20E-02 4 83 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0038179 neurotrophin	signaling	pathway 2.87E-03 1.58E-02 6 217 178 27688 P0CG47|P51452|P62987|P62979|P62158|P0CG48




1.53E-04 1.40E-03 4 42 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0042060 wound	healing 1.51E-03 9.68E-03 12 677 178 27688
P07602|P01033|P13929|P84243|P68871|P09493|P16615|P04275|P62158|
P35613|P25116|P00441
GO:0042176 regulation	of	protein	catabolic	process 1.24E-03 8.37E-03 7 251 178 27688 P0CG47|P01033|P63244|P62987|P62979|P0CG48|P01034








GO:0042254 ribosome	biogenesis 2.23E-09 3.80E-08 12 180 178 27688
P08708|P62263|P18077|P83731|P62857|P62913|P46777|P62851|P62269|
P62753|P62249|P39019
GO:0042255 ribosome	assembly 1.94E-07 2.76E-06 5 21 178 27688 P08708|P62263|P83731|P62851|P62753
GO:0042273 ribosomal	large	subunit	biogenesis 7.85E-07 1.08E-05 4 12 178 27688 P18077|P83731|P62913|P46777
GO:0042274 ribosomal	small	subunit	biogenesis 1.90E-11 3.73E-10 7 19 178 27688 P08708|P62263|P62857|P62851|P62753|P62249|P39019




GO:0042451 purine	nucleoside	biosynthetic	process 2.66E-05 2.90E-04 8 184 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576
GO:0042455 ribonucleoside	biosynthetic	process 4.65E-05 4.86E-04 8 199 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576
GO:0042493 response	to	drug 8.47E-03 3.60E-02 9 540 178 27688 P13929|P16860|P09382|P19021|P47985|P37108|P22352|P68032|P00441
GO:0042542 response	to	hydrogen	peroxide 5.46E-04 4.34E-03 5 103 178 27688 P02144|Q14116|P68871|P69905|P00441
GO:0042692 muscle	cell	differentiation 3.16E-05 3.41E-04 9 245 178 27688 O15273|P10916|Q14192|P09382|P09493|P19022|P68133|P68032|P13533
GO:0042743 hydrogen	peroxide	metabolic	process 1.26E-04 1.19E-03 4 40 178 27688 P68871|P22352|P69905|P00441
GO:0042744 hydrogen	peroxide	catabolic	process 6.82E-04 5.23E-03 3 27 178 27688 P68871|P22352|P69905
GO:0042770 signal	transduction	in	response	to	DNA	damage 3.60E-03 1.89E-02 4 97 178 27688 P0CG47|P62987|P62979|P0CG48






6.33E-13 1.45E-11 11 68 178 27688
O00217|O95169|P51970|O43674|O14561|O00483|O43920|O95167|O9517
8|O96000|O15239
GO:0042776 mitochondrial	ATP	synthesis	coupled	proton	 2.48E-12 5.20E-11 7 15 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0042981 regulation	of	apoptotic	process 3.51E-03 1.85E-02 17 1270 178 27688
P0CG47|P01033|Q14116|P16989|P0CG48|P13693|P63244|Q05639|Q14192
|P09382|P62987|P62979|P02511|P04792|P62753|P25116|P00441






GO:0043066 negative	regulation	of	apoptotic	process 9.84E-04 6.93E-03 13 735 178 27688
P0CG47|P01033|P16989|P0CG48|P13693|Q05639|Q14192|P62987|P62979
|P02511|P04792|P25116|P00441
GO:0043067 regulation	of	programmed	cell	death 3.88E-03 2.02E-02 17 1283 178 27688
P0CG47|P01033|Q14116|P16989|P0CG48|P13693|P63244|Q05639|Q14192
|P09382|P62987|P62979|P02511|P04792|P62753|P25116|P00441
GO:0043069 negative	regulation	of	programmed	cell	death 1.06E-03 7.37E-03 13 741 178 27688
P0CG47|P01033|P16989|P0CG48|P13693|Q05639|Q14192|P62987|P62979
|P02511|P04792|P25116|P00441
GO:0043085 positive	regulation	of	catalytic	activity 6.42E-04 4.95E-03 15 887 178 27688
P07602|P0CG47|Q14896|P0CG48|P63244|P60033|P08590|P09493|P62987
|P62979|P62158|P45379|P25116|P20585|P00441
GO:0043086 negative	regulation	of	catalytic	activity 3.45E-03 1.83E-02 10 559 178 27688
P0CG47|P51452|P63244|P19429|P62987|P62979|P04792|P45379|P0CG48|
P01034
GO:0043122 regulation	of	I-kappaB	kinase/NF-kappaB	signaling 4.88E-04 3.94E-03 7 214 178 27688 P0CG47|P09382|P62987|P62979|P04792|P25116|P0CG48
GO:0043123 positive	regulation	of	I-kappaB	kinase/NF-kappaB	 1.09E-03 7.55E-03 6 179 178 27688 P0CG47|P09382|P62987|P62979|P25116|P0CG48













GO:0043405 regulation	of	MAP	kinase	activity 1.19E-03 8.04E-03 8 322 178 27688 P0CG47|P51452|P60033|P62987|P62979|P25116|P00441|P0CG48
GO:0043406 positive	regulation	of	MAP	kinase	activity 2.27E-03 1.31E-02 6 207 178 27688 P0CG47|P60033|P62987|P62979|P00441|P0CG48
GO:0043408 regulation	of	MAPK	cascade 7.55E-03 3.27E-02 9 530 178 27688 P07602|P0CG47|P51452|P60033|P62987|P62979|P25116|P00441|P0CG48
GO:0043410 positive	regulation	of	MAPK	cascade 1.26E-02 4.91E-02 7 385 178 27688 P0CG47|P60033|P62987|P62979|P25116|P00441|P0CG48
GO:0043434 response	to	peptide	hormone 7.28E-03 3.18E-02 9 527 178 27688 P01033|Q14116|P16860|P01160|P17174|P08574|P17081|P62753|P35613




GO:0043462 regulation	of	ATPase	activity 6.34E-11 1.23E-09 7 22 178 27688 Q14896|P19429|P08590|P09493|P45379|P13533|P63316


















GO:0043648 dicarboxylic	acid	metabolic	process 8.66E-04 6.35E-03 5 114 178 27688 P00505|P40926|P40925|P17174|P48735












GO:0044057 regulation	of	system	process 1.45E-08 2.28E-07 15 362 178 27688
Q14896|P10916|P17661|P13533|P12883|P16860|P19429|Q9UBY9|P08590
|P09493|P45379|P25116|O14558|P00441|P63316





GO:0044092 negative	regulation	of	molecular	function 6.16E-03 2.83E-02 11 706 178 27688
P0CG47|P51452|P63244|P19429|P62987|P62979|P62158|P04792|P45379|
P0CG48|P01034
GO:0044093 positive	regulation	of	molecular	function 4.16E-03 2.11E-02 15 1076 178 27688
P07602|P0CG47|Q14896|P0CG48|P63244|P60033|P08590|P09493|P62987
|P62979|P62158|P45379|P25116|P20585|P00441




























GO:0044246 regulation	of	multicellular	organismal	metabolic	 1.99E-04 1.76E-03 3 18 178 27688 Q14116|P25116|P01034
GO:0044248 cellular	catabolic	process 1.88E-03 1.14E-02 18 1301 178 27688
P0CG47|Q08493|P51857|P0CG48|P00505|P68871|P17174|P62987|Q14240
|P22352|Q16698|P62979|P69905|P62158|P60228|P24752|Q13011|P00441

















GO:0044262 cellular	carbohydrate	metabolic	process 1.00E-02 4.13E-02 5 202 178 27688 P40926|P07195|P40925|P62158|P48735



















































































GO:0044712 single-organism	catabolic	process 9.51E-04 6.74E-03 14 826 178 27688
P13929|Q08493|P04406|P51857|P00505|P68871|P07195|P17174|P22352|
Q16698|P69905|P62158|P24752|Q13011







































GO:0044770 cell	cycle	phase	transition 1.16E-02 4.67E-02 6 291 178 27688 P0CG47|P62987|Q9Y5N6|P83731|P62979|P0CG48
GO:0044772 mitotic	cell	cycle	phase	transition 1.16E-02 4.67E-02 6 291 178 27688 P0CG47|P62987|Q9Y5N6|P83731|P62979|P0CG48
GO:0044773 mitotic	DNA	damage	checkpoint 2.97E-03 1.62E-02 4 92 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0044774 mitotic	DNA	integrity	checkpoint 3.60E-03 1.89E-02 4 97 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0044783 G1	DNA	damage	checkpoint 1.27E-03 8.50E-03 4 73 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0044819 mitotic	G1/S	transition	checkpoint 1.27E-03 8.50E-03 4 73 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0044843 cell	cycle	G1/S	phase	transition 4.58E-03 2.28E-02 5 167 178 27688 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0045089 positive	regulation	of	innate	immune	response 4.70E-03 2.32E-02 5 168 178 27688 P0CG47|P51452|P62987|P62979|P0CG48
GO:0045214 sarcomere	organization 6.09E-04 4.74E-03 3 26 178 27688 O15273|P09493|P13533





GO:0045732 positive	regulation	of	protein	catabolic	process 2.82E-03 1.56E-02 5 149 178 27688 P0CG47|P63244|P62987|P62979|P0CG48
GO:0045787 positive	regulation	of	cell	cycle 4.89E-03 2.40E-02 6 242 178 27688 P0CG47|P51452|O75116|P62987|P62979|P0CG48
GO:0045859 regulation	of	protein	kinase	activity 9.52E-03 3.98E-02 10 649 178 27688
P0CG47|P51452|P63244|P60033|P62987|P62979|P04792|P25116|P00441|
P0CG48
GO:0045860 positive	regulation	of	protein	kinase	activity 9.85E-03 4.07E-02 7 367 178 27688 P0CG47|P60033|P62987|P62979|P25116|P00441|P0CG48
GO:0045862 positive	regulation	of	proteolysis 1.52E-03 9.70E-03 7 260 178 27688 P0CG47|P63244|Q9NWT8|P62987|P62979|P25116|P0CG48
GO:0045930 negative	regulation	of	mitotic	cell	cycle 8.59E-04 6.34E-03 6 171 178 27688 P0CG47|Q9NWT8|P62987|P83731|P62979|P0CG48
GO:0046031 ADP	metabolic	process 1.40E-03 9.28E-03 5 127 178 27688 P13929|P25705|P04406|P07195|P06576








GO:0046129 purine	ribonucleoside	biosynthetic	process 2.66E-05 2.90E-04 8 184 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576
GO:0046364 monosaccharide	biosynthetic	process 7.73E-06 9.35E-05 6 73 178 27688 P13929|P00505|P40926|P04406|P40925|P17174
GO:0046390 ribose	phosphate	biosynthetic	process 2.31E-06 2.99E-05 10 227 178 27688
O75947|P16860|P25705|P48047|P18859|P01160|P16615|P36542|P56381|
P06576
GO:0046394 carboxylic	acid	biosynthetic	process 9.71E-03 4.03E-02 7 366 178 27688 P41222|P00505|O14561|O14880|P17174|P51857|P24752
GO:0046395 carboxylic	acid	catabolic	process 4.16E-03 2.11E-02 6 234 178 27688 P00505|P17174|Q16698|P51857|P24752|Q13011










GO:0046496 nicotinamide	nucleotide	metabolic	process 7.49E-03 3.25E-02 5 188 178 27688 P13929|P40926|P04406|P07195|P40925




GO:0048011 neurotrophin	TRK	receptor	signaling	pathway 2.87E-03 1.58E-02 6 217 178 27688 P0CG47|P51452|P62987|P62979|P62158|P0CG48




















GO:0048545 response	to	steroid	hormone 1.07E-02 4.37E-02 9 561 178 27688
P41222|Q14192|P19021|P17174|P68133|P22352|Q13772|Q08431|Q8N8D
1
GO:0048644 muscle	organ	morphogenesis 2.62E-13 6.19E-12 11 63 178 27688
O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P45379|P13533|
P12883|P63316
GO:0048729 tissue	morphogenesis 5.42E-04 4.33E-03 12 601 178 27688
O15273|Q14896|P10916|P19429|P08493|P08590|P09493|P68032|P45379|
P13533|P12883|P63316










GO:0048738 cardiac	muscle	tissue	development 1.03E-10 1.99E-09 12 138 178 27688
O15273|Q14896|P10916|P19429|Q14192|P08590|P09493|P68032|P45379
|P13533|P12883|P63316
GO:0048747 muscle	fiber	development 9.33E-04 6.64E-03 3 30 178 27688 O15273|P68133|P13533










GO:0048872 homeostasis	of	number	of	cells 1.71E-04 1.54E-03 7 180 178 27688 P01033|P02144|P08708|P62263|P25116|P00441|P39019




GO:0050817 coagulation 2.00E-03 1.19E-02 10 518 178 27688
P07602|P01033|P84243|P68871|P16615|P04275|P62158|P35613|P25116|
P00441
GO:0050851 antigen	receptor-mediated	signaling	pathway 1.17E-02 4.71E-02 4 136 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0050852 T	cell	receptor	signaling	pathway 5.62E-03 2.70E-02 4 110 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0050878 regulation	of	body	fluid	levels 5.22E-03 2.53E-02 11 690 178 27688
P07602|P01033|P16860|P84243|P68871|P16615|P04275|P62158|P35613|
P25116|P00441
GO:0050880 regulation	of	blood	vessel	size 2.29E-03 1.31E-02 5 142 178 27688 P16860|P01160|P68871|P25116|P00441
GO:0051092 positive	regulation	of	NF-kappaB	transcription	 2.43E-03 1.37E-02 4 87 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051146 striated	muscle	cell	differentiation 5.96E-05 6.09E-04 7 152 178 27688 O15273|P10916|Q14192|P09493|P68133|P68032|P13533




















GO:0051248 negative	regulation	of	protein	metabolic	process 9.20E-03 3.89E-02 11 747 178 27688
P0CG47|P51452|P01033|P63244|P62987|P37108|P62979|P04792|P60228|
P0CG48|P01034
GO:0051259 protein	oligomerization 3.97E-03 2.06E-02 7 309 178 27688 P68871|P22352|Q16698|P02511|P04275|P69905|P24752
GO:0051260 protein	homooligomerization 8.16E-03 3.49E-02 5 192 178 27688 P22352|Q16698|P02511|P04275|P24752
GO:0051320 S	phase 1.17E-03 7.98E-03 5 122 178 27688 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0051325 interphase 3.34E-03 1.79E-02 5 155 178 27688 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0051329 mitotic	interphase 2.90E-03 1.59E-02 5 150 178 27688 P0CG47|P62987|Q9Y5N6|P62979|P0CG48
GO:0051336 regulation	of	hydrolase	activity 4.46E-03 2.23E-02 12 774 178 27688
P63244|Q14896|P19429|P08590|P09493|P62158|P45379|P13533|P25116|
P20585|P63316|P01034
GO:0051340 regulation	of	ligase	activity 4.93E-03 2.41E-02 4 106 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051345 positive	regulation	of	hydrolase	activity 4.43E-03 2.22E-02 8 399 178 27688 P63244|Q14896|P08590|P09493|P62158|P45379|P25116|P20585
GO:0051348 negative	regulation	of	transferase	activity 2.22E-03 1.28E-02 7 278 178 27688 P0CG47|P51452|P63244|P62987|P62979|P04792|P0CG48
GO:0051351 positive	regulation	of	ligase	activity 2.14E-03 1.25E-02 4 84 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051352 negative	regulation	of	ligase	activity 1.96E-03 1.17E-02 4 82 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051384 response	to	glucocorticoid 1.19E-02 4.79E-02 5 211 178 27688 P41222|P19021|P17174|P22352|Q8N8D1








1.21E-03 8.17E-03 4 72 178 27688 P0CG47|P62987|P62979|P0CG48




2.43E-03 1.37E-02 4 87 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051443 positive	regulation	of	ubiquitin-protein	 1.79E-03 1.10E-02 4 80 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051444 negative	regulation	of	ubiquitin-protein	 1.96E-03 1.17E-02 4 82 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0051592 response	to	calcium	ion 5.97E-04 4.67E-03 5 105 178 27688 P16860|P08493|P62158|P45379|P17535
















GO:0055001 muscle	cell	development 3.41E-06 4.34E-05 7 98 178 27688 O15273|P10916|Q14192|P09493|P68133|P68032|P13533
GO:0055002 striated	muscle	cell	development 2.07E-06 2.72E-05 7 91 178 27688 O15273|P10916|Q14192|P09493|P68133|P68032|P13533
GO:0055003 cardiac	myofibril	assembly 2.35E-04 2.08E-03 3 19 178 27688 O15273|P10916|P68032
GO:0055006 cardiac	cell	development 9.20E-06 1.09E-04 5 44 178 27688 O15273|P10916|Q14192|P68032|P13533
GO:0055007 cardiac	muscle	cell	differentiation 2.37E-04 2.09E-03 5 86 178 27688 O15273|P10916|Q14192|P68032|P13533
GO:0055008 cardiac	muscle	tissue	morphogenesis 1.34E-14 3.69E-13 11 49 178 27688
O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P45379|P13533|
P12883|P63316
GO:0055010 ventricular	cardiac	muscle	tissue	morphogenesis 1.63E-12 3.55E-11 9 37 178 27688 Q14896|P10916|P19429|P08590|P09493|P45379|P13533|P12883|P63316
GO:0055013 cardiac	muscle	cell	development 9.20E-06 1.09E-04 5 44 178 27688 O15273|P10916|Q14192|P68032|P13533















GO:0060047 heart	contraction 2.75E-12 5.64E-11 9 39 178 27688 O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P00441|P63316
GO:0060048 cardiac	muscle	contraction 7.24E-10 1.31E-08 7 30 178 27688 O15273|Q14896|P19429|P08590|P09493|P68032|P63316
GO:0060415 muscle	tissue	morphogenesis 5.31E-14 1.39E-12 11 55 178 27688
O15273|Q14896|P10916|P19429|P08590|P09493|P68032|P45379|P13533|
P12883|P63316
GO:0060537 muscle	tissue	development 1.70E-09 2.96E-08 14 261 178 27688
O15273|Q14896|P10916|P68133|P68032|P13533|P12883|P19429|Q14192
|P60660|P08590|P09493|P45379|P63316
GO:0060548 negative	regulation	of	cell	death 5.75E-04 4.52E-03 14 784 178 27688
P0CG47|P01033|P16989|P12235|P0CG48|P13693|Q05639|Q14192|P62987
|P62979|P02511|P04792|P25116|P00441
GO:0061024 membrane	organization 2.41E-03 1.37E-02 9 444 178 27688 P0CG47|P02792|P62987|P37108|P62979|Q08431|P19105|P00441|P0CG48
GO:0061061 muscle	structure	development 3.86E-08 5.91E-07 16 449 178 27688
O15273|Q14896|P10916|P19022|P68133|P68032|P13533|P12883|P19429|
Q14192|P60660|P09382|P08590|P09493|P45379|P63316
GO:0065003 macromolecular	complex	assembly 6.70E-04 5.15E-03 17 1086 178 27688
O00217|O15273|P08708|P68363|O43920|P84243|P68871|P62263|P83731
|P22352|Q16698|P02511|P04275|P69905|P62851|P62753|P24752











2.58E-05 2.84E-04 4 27 178 27688 P0CG47|P62987|P62979|P0CG48




GO:0070925 organelle	assembly 8.42E-07 1.15E-05 11 254 178 27688
O15273|P10916|P08708|P09493|P62263|P68133|P83731|P68032|P62851|
P13533|P62753
GO:0071156 regulation	of	cell	cycle	arrest 5.27E-03 2.54E-02 4 108 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0071158 positive	regulation	of	cell	cycle	arrest 1.79E-03 1.10E-02 4 80 178 27688 P0CG47|P62987|P62979|P0CG48




















GO:0071826 ribonucleoprotein	complex	subunit	organization 1.31E-03 8.70E-03 5 125 178 27688 P08708|P62263|P83731|P62851|P62753










GO:0071900 regulation	of	protein	serine/threonine	kinase	 1.26E-02 4.91E-02 8 479 178 27688 P0CG47|P51452|P60033|P62987|P62979|P25116|P00441|P0CG48
GO:0071902 positive	regulation	of	protein	serine/threonine	 5.71E-03 2.73E-02 6 250 178 27688 P0CG47|P60033|P62987|P62979|P00441|P0CG48
GO:0072330 monocarboxylic	acid	biosynthetic	process 1.04E-02 4.27E-02 5 204 178 27688 P41222|O14561|O14880|P51857|P24752
GO:0072331 signal	transduction	by	p53	class	mediator 4.15E-03 2.11E-02 4 101 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0072350 tricarboxylic	acid	metabolic	process 1.04E-02 4.27E-02 3 70 178 27688 P40926|P40925|P48735








GO:0072395 signal	transduction	involved	in	cell	cycle	 9.76E-04 6.90E-03 4 68 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0072401 signal	transduction	involved	in	DNA	integrity	 9.23E-04 6.59E-03 4 67 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0072413 signal	transduction	involved	in	mitotic	cell	cycle	 9.23E-04 6.59E-03 4 67 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0072422 signal	transduction	involved	in	DNA	damage	 9.23E-04 6.59E-03 4 67 178 27688 P0CG47|P62987|P62979|P0CG48
GO:0072431 signal	transduction	involved	in	mitotic	G1	DNA	 8.72E-04 6.35E-03 4 66 178 27688 P0CG47|P62987|P62979|P0CG48




GO:0072522 purine-containing	compound	biosynthetic	process 7.41E-06 9.01E-05 10 259 178 27688
O75947|P16860|P25705|P48047|P18859|P01160|P16615|P36542|P56381|
P06576
GO:0072524 pyridine-containing	compound	metabolic	process 2.01E-03 1.19E-02 6 202 178 27688 P13929|P40926|P04406|Q9NPI5|P07195|P40925
GO:0072593 reactive	oxygen	species	metabolic	process 1.17E-03 7.98E-03 5 122 178 27688 P68871|P22352|P69905|P62158|P00441
GO:0090068 positive	regulation	of	cell	cycle	process 3.43E-03 1.82E-02 5 156 178 27688 P0CG47|O75116|P62987|P62979|P0CG48
GO:0090257 regulation	of	muscle	system	process 1.00E-07 1.45E-06 9 122 178 27688 Q14896|P10916|P19429|P08590|P09493|P25116|O14558|P00441|P63316







GO:0090407 organophosphate	biosynthetic	process 6.93E-05 6.98E-04 13 557 178 27688
O75947|P06732|P48047|P01160|P16615|P36542|P16860|P25705|P18859|
P60033|Q9NPI5|P56381|P06576
GO:0098655 cation	transmembrane	transport 1.49E-03 9.57E-03 7 259 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0098660 inorganic	ion	transmembrane	transport 1.42E-03 9.32E-03 7 257 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0098662 inorganic	cation	transmembrane	transport 1.42E-03 9.32E-03 7 257 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:0098763 mitotic	cell	cycle	phase 7.00E-03 3.06E-02 6 261 178 27688 P0CG47|P42677|P62987|Q9Y5N6|P62979|P0CG48





GO:1901184 regulation	of	ERBB	signaling	pathway 1.48E-03 9.54E-03 4 76 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1901185 negative	regulation	of	ERBB	signaling	pathway 1.53E-04 1.40E-03 4 42 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1901293 nucleoside	phosphate	biosynthetic	process 2.20E-05 2.46E-04 11 358 178 27688
O75947|P16860|P25705|P48047|P18859|P01160|Q9NPI5|P16615|P36542|
P56381|P06576

















































GO:1901652 response	to	peptide 8.37E-03 3.57E-02 9 539 178 27688 P01033|Q14116|P16860|P01160|P17174|P08574|P17081|P62753|P35613




GO:1901659 glycosyl	compound	biosynthetic	process 7.74E-05 7.69E-04 8 214 178 27688 O75947|P25705|P48047|P18859|P16615|P36542|P56381|P06576




GO:1901988 negative	regulation	of	cell	cycle	phase	transition 8.29E-03 3.54E-02 4 123 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1901991 negative	regulation	of	mitotic	cell	cycle	phase	 7.61E-03 3.29E-02 4 120 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1902400 intracellular	signal	transduction	involved	in	G1	 8.72E-04 6.35E-03 4 66 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1902402 signal	transduction	involved	in	mitotic	DNA	 9.23E-04 6.59E-03 4 67 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1902403 signal	transduction	involved	in	mitotic	DNA	 9.23E-04 6.59E-03 4 67 178 27688 P0CG47|P62987|P62979|P0CG48









GO:1902600 hydrogen	ion	transmembrane	transport 8.78E-06 1.06E-04 7 113 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576
GO:1902806 regulation	of	cell	cycle	G1/S	phase	transition 3.09E-03 1.66E-02 4 93 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1902807 negative	regulation	of	cell	cycle	G1/S	phase	 1.63E-03 1.02E-02 4 78 178 27688 P0CG47|P62987|P62979|P0CG48












9.50E-03 3.98E-02 4 128 178 27688 P0CG47|P62987|P62979|P0CG48
GO:1903362 regulation	of	cellular	protein	catabolic	process 3.25E-03 1.74E-02 5 154 178 27688 P0CG47|P63244|P62987|P62979|P0CG48
GO:1903364 positive	regulation	of	cellular	protein	catabolic	 8.32E-04 6.23E-03 5 113 178 27688 P0CG47|P63244|P62987|P62979|P0CG48
GO:1903522 regulation	of	blood	circulation 4.52E-06 5.62E-05 9 192 178 27688 P16860|Q9UBY9|P08590|P09493|P17661|P45379|P13533|P25116|P12883
GO:1990267 response	to	transition	metal	nanoparticle 9.25E-03 3.89E-02 4 127 178 27688 P80297|P19021|P35613|P00441
GO:1990542 mitochondrial	transmembrane	transport 6.28E-09 1.01E-07 7 40 178 27688 O75947|P25705|P48047|P18859|P36542|P56381|P06576








1.48E-03 9.54E-03 4 76 178 27688 P0CG47|P62987|P62979|P0CG48
GO:2000134 negative	regulation	of	G1/S	transition	of	mitotic	 1.63E-03 1.02E-02 4 78 178 27688 P0CG47|P62987|P62979|P0CG48
Supplemental Table Viv. 2011 v 2016 comparison. A selection of Biological Process GO terms 
extracted from two BinGO analyses, using either the 2016 or the 2011 GO annotation dataset and adult 
ventricular cardiomyocyte data19 (2016-hA-VCMs and 2011-hA-VCMs, respectively). GO terms 
selected either align with the GO terms identified by Poon et al., 2013, or a descriptive GO term 
associated with a large proportion of the analysed dataset, or are terms from the ‘cardiac conduction’ 
domain of the ontology. n indicates the number of protein IDs associated with the GO term, corr p-
value is the p-value after Benjamini & Hochberg False Discovery Rate correction, x is the number of 
IDs in both the submitted list and associated with the GO term, #N/A indicates that this term was not 
significantly enriched in the dataset. The corrected p-values in the 2016 analysis are highlighted in 
green if the p-value is more significant in the 2016 analysis, and orange if the p-value is more significant 
in the 2011 analysis. 
 
 
Description n corr	p-value x n corr	p-value x
GO:0006614 SRP-dependent	cotranslational	protein	targeting	to	membrane 123 1.98E-52 37 #N/A #N/A
GO:0045047 protein	targeting	to	ER 127 4.39E-52 37 #N/A #N/A
GO:0072599 establishment	of	protein	localization	to	endoplasmic	reticulum 131 1.36E-51 37 #N/A #N/A
GO:0006414 translational	elongation 223 2.52E-47 40 110 1.40E-53 38
GO:0006091 generation	of	precursor	metabolites	and	energy 574 1.06E-34 43 552 1.89E-28 40
GO:0022904 respiratory	electron	transport	chain 157 1.67E-34 29 135 5.48E-34 29
GO:0022411 cellular	component	disassembly 673 2.76E-34 45 221 1.73E-39 37
GO:0045333 cellular	respiration 231 5.04E-34 32 206 6.99E-33 32
GO:0044419 interspecies	interaction	between	organisms 830 1.26E-31 46 781 5.40E-27 44
GO:0061024 membrane	organization 1211 1.16E-27 49 444 1.37E-02 9
GO:0003012 muscle	system	process 319 7.11E-27 30 233 1.38E-21 25
GO:0016071 mRNA	metabolic	process 743 7.53E-27 40 651 6.93E-27 41
GO:0006936 muscle	contraction 264 4.09E-25 27 205 1.36E-21 24
GO:0033275 actin-myosin	filament	sliding 39 3.13E-21 14 38 5.24E-20 14
GO:0070252 actin-mediated	cell	contraction 76 2.08E-18 15 40 1.19E-19 14
GO:0051234 establishment	of	localization 7073 2.56E-18 93 5116 1.50E-03 53
GO:0006810 transport 6916 3.12E-17 90 5023 1.00E-03 53
GO:0042775 mitochondrial	ATP	synthesis	coupled	electron	transport 77 1.12E-16 14 68 1.45E-11 11
GO:0006941 striated	muscle	contraction 101 1.74E-16 15 61 1.28E-10 10
GO:0060047 heart	contraction 80 1.96E-16 14 39 5.64E-11 9
GO:0060048 cardiac	muscle	contraction 69 1.03E-15 13 30 1.31E-08 7
GO:0032774 RNA	biosynthetic	process 3310 7.53E-15 57 669 3.45E-22 37
GO:0006937 regulation	of	muscle	contraction 179 4.80E-14 16 98 2.31E-07 9
GO:0010467 gene	expression 5483 1.09E-13 73 2206 4.58E-11 45
GO:0090257 regulation	of	muscle	system	process 230 1.48E-13 17 122 1.45E-06 9
GO:0061061 muscle	structure	development 502 6.98E-13 22 449 5.91E-07 16
GO:1903522 regulation	of	blood	circulation 326 3.31E-12 18 192 5.62E-05 9
GO:0009725 response	to	hormone 1187 3.76E-12 31 1086 2.69E-05 22
GO:0007005 mitochondrion	organization 679 4.56E-12 24 #N/A #N/A
GO:0008016 regulation	of	heart	contraction 243 5.04E-12 16 116 1.22E-04 7
GO:0055001 muscle	cell	development 153 3.42E-11 13 98 4.34E-05 7
GO:0048738 cardiac	muscle	tissue	development 164 8.07E-11 13 138 1.99E-09 12
GO:0008015 blood	circulation 401 9.50E-11 18 319 4.44E-08 15
GO:0042692 muscle	cell	differentiation 290 7.63E-10 15 245 3.41E-04 9
GO:0002027 regulation	of	heart	rate 90 7.84E-10 10 39 1.19E-02 3
GO:0051146 striated	muscle	cell	differentiation 211 1.74E-09 13 152 6.09E-04 7
GO:0044267 cellular	protein	metabolic	process 6461 4.75E-08 68 3447 4.00E-09 54
GO:0009888 tissue	development 1677 6.35E-08 30 1526 6.26E-03 21
GO:0032502 developmental	process 6093 1.82E-07 64 5680 4.09E-12 80
GO:0030029 actin	filament-based	process 823 2.13E-07 20 505 5.02E-07 17
GO:0072358 cardiovascular	system	development 915 2.40E-07 21 822 1.25E-06 21
GO:0006950 response	to	stress 4615 2.77E-07 53 3628 5.91E-03 39
GO:0007507 heart	development 537 3.74E-07 16 489 1.78E-06 16
GO:0009653 anatomical	structure	morphogenesis 2626 4.21E-07 37 2300 1.82E-02 26
GO:0034220 ion	transmembrane	transport 1636 4.90E-07 28 336 2.90E-03 9
GO:0009611 response	to	wounding 798 6.28E-07 19 835 7.37E-03 14
GO:0050896 response	to	stimulus 11437 6.60E-07 96 #N/A #N/A
GO:0010941 regulation	of	cell	death 1800 9.40E-07 29 1340 3.38E-03 20
GO:0006811 ion	transport 2414 1.56E-06 34 #N/A #N/A
GO:0002026 regulation	of	the	force	of	heart	contraction 31 5.93E-06 5 #N/A #N/A
GO:0043434 response	to	peptide	hormone 591 6.71E-06 15 527 3.18E-02 9
GO:0048468 cell	development 1903 9.01E-06 28 #N/A #N/A
GO:0030154 cell	differentiation 3701 1.36E-05 42 #N/A #N/A
GO:1903779 regulation	of	cardiac	conduction 68 1.57E-05 6 #N/A #N/A
GO:0048869 cellular	developmental	process 3946 6.01E-05 42 #N/A #N/A
GO:0010882 regulation	of	cardiac	muscle	contraction	by	calcium	ion	signaling 24 6.19E-05 4 #N/A #N/A
GO:0007596 blood	coagulation 541 2.54E-04 12 518 1.19E-02 10




20 9.48E-04 3 #N/A #N/A
GO:0007010 cytoskeleton	organization 1479 1.88E-03 19 #N/A #N/A
GO:1902533 positive	regulation	of	intracellular	signal	transduction 1054 2.67E-03 15 #N/A #N/A
GO:0033554 cellular	response	to	stress 2165 1.02E-02 22 #N/A #N/A
GO:0061337 cardiac	conduction 126 1.71E-02 4 #N/A #N/A
GO:0012501 programmed	cell	death 1204 1.83E-02 14 #N/A #N/A
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